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Abstract 
The first chapter contains a detailed explanation of the borylation of arenes using 
iridium catalysts with different ligands. Phosphine, N,N-aryl and carbene ligands have 
been studied previously for the borylation of substituted aromatic and heteroaromatic 
compounds. The importance of polymer supported catalysts is shown. Examples of 
polymer supported iridium catalysts for the borylation of arenes are given. Chapter 2 
discusses the preparation of 2-arylquinoline and quinolone derivatives. These were 
prepared by reaction of 3-methoxy and 3,5-dimethoxy aniline with malonic acid to 
generate the 2,4-dichloro quinoline derivatives. These in turn were then coupled with 
a range of aryl boronic acids in Suzuki-Miyaura cross-coupling reactions. A study 
documents the borylation selectivity of 2-(4’-methoxyphenyl)-4-chloro-7-
methoxyquinoline 230. Various conditions in Stille cross-coupling reaction were used 
to prepare nonsymmetrical 4,4’-substituted-2,2’-bipyridine derivatives 250 and 285 in 
chapter 3. These were prepared through coupling of stannyl pyridine 266 with 2-
chloro- and bromo-4-substituted pyridine derivatives in presence of metal salts. 
Ligands 250 and 285 were evaluated in the borylation of m-xylene and compared to 
the activity of the literature standard ligand 4,4’-di-tert-butyl-2,2’-bipyridine dtbpy 22. 
Chapter 4 describes the preparation of 2,4,6-substituted pyridine derivatives. These 
compounds were prepared by one of two methods. The borylation of 2-chloro-4-
substituted pyridine derivatives afforded the corresponding boronate esters, which 
were then coupled with a range of aryl halides. This was followed by an aromatic 
nucleophilic substitution reaction with a range of amines. Alternatively, aromatic 
nucleophilic substitution of 2-chloro-4-substituted pyridine derivatives with amines 
afforded the corresponding 2-aminopyridines. Subsequent borylation of these 
v 
 
subtrates followed by Suzuki-Miyaura cross-copuling was also an effective strategy. 
Chapter 5 reports the synthesis of symmetrical phenanthroline 347 using the Altman 
protocol. Attachment of a linker to enable coupling to a polymer support afforded 
modified ligand 367. Phenanthrolines 347 and 367 were evaluated in the borylation of 
m-xylene compared to the commercially available 3,4,7,8-tetra-methyl-1,10-
phenanthroline tmphen 66. The commercially available MCM-41 was chosen as a 
suitable polymer for the polymer supported iridium catalyst. Different strategies were 
investigated to attach the phenanthroline ligand to the polymer. These strategies 
involved attaching an amine linker to the polymer before coupling it with lithium 
phenanthroline carboxylate 368. Chapter 6 provides all the experimental details. 
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Chapter 1 
1 Introduction to this thesis 
Due to the widespread use of iridium metal in organic synthesis, such as the formation 
of C-B bonds, which in turn are used as intermediates in many different reactions, it is 
necessary to recycle the iridium catalyst to keep this metal from running out in the 
future. One method of particular interest is immobilising the iridium catalyst onto a 
polymer and the work described in this thesis is directed towards this goal. This thesis 
is composed of six chapters: The first chapter reviews the background of the borylation 
of heterocycles, and different ligands in the borylation of arenes which could be used 
as useful intermediates to attach to a polymer in polymer supported iridium catalysts. 
Chapter 2 discusses the borylation of quinoline derivatives that have potential 
applications in biological chemistry studies. Chapter 3 covers the formation of new 
bipyridine ligands with suitable linker, which could be applied in polymer supported 
iridium catalyst. Chapter 4 involves the development of one-pot C-H borylation/ 
Suzuki-Miyaura cross coupling reaction sequences followed by SNAr reactions as a 
highly efficient strategy in the preparation of 2,4,6-substituted pyridines. Chapter 5 
applies the same strategy to form a polymer supported ligand in chapter 3 to 
phenanthroline ligands. The last chapter of this thesis contains all the experimental 
procedures for the chapters 2, 3, 4 and 5.  
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1.1 CH Borylation 
1.1.1 Introduction 
Aromatic boronate esters have become one of the most important classes of reagents 
in organic synthesis.1 With many applications in diverse transformations such as the 
Suzuki-Miyaura cross coupling,2-6rhodium catalyzed conjugate addition to α,β-
unsaturated carbonyl compounds7 and the Cu catalyzed synthesis of C-O and C-N 
bonds8 (Figure 1).9 One example of this from our group is Tajuddin’s report.10 Tajuddin 
synthesised many functionalized aromatic and heteroaromatic compounds which were 
prepared by borylation and subsequent Suzuki-Miyaura cross-coupling reactions, or by 
rhodium-catalysed 1,4-conjugated addition reactions.  
Ar-B(OH) 2
Ar
'
-X, Pd
Ar'-Ar
Ar'-O-Ar
Ar'-NHR, Cu
Ar'-N-Ar
R
[Rh]-OH
O
Ar
O
Suzuki-Miyaura
Chan-Lam
Chan-Lam
Conjugated addition
Ar'-OH, Cu
 
Figure 1: Some applications of aryl boronic acid 
 
Reflecting this as shown in Figure 1, the synthesis and subsequent reaction of boronic 
acids has been key to the preparation of new drugs and herbicides. For example, 
boronic acid containing macromolecules have been utilized in some biomedical 
applications, including the treatment of HIV, multiple myeloma and diabetes as 
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saccharide sensors (Figure 2).11 Moreover, other biomedical applications of boronic 
acids include cell capture and culture and enzymatic inhibition agents (Figure 2).12,13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Some biomedical applications of boronic acid11-13 
 
Boronic acids can not only be used in new functional materials, but are an essential 
component in many natural product syntheses as well (Figure 3).14-17 Therefore, 
methods for the synthesis of aryl boronate ester are valuable. This review will briefly 
N
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H
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H O
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N
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O
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O
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n
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summarise classical methods before focusing on the Ir-catalyzed borylation of 
aromatic C-H bonds with a particular emphasis on heteroarenes as substrates. 
O
CO2H Me
Me
Me
OH
Me
Me
O
MeMe
(+)-Herboxidiene/GEX1A O
CO2H Me
Me
I
Me
OTBS
Me
MeMeMe
pinB
+
 
N
I
O O
Cl
H
6
B(OH) 2
O
+
N
O O
Cl
H
6
O
Malyngamide (K)
 
 
OH
OMe
4-O-methylhonokiol
OMe
OH
Br
KF3B
+
 
HN
NH
O
O
HOOH
Mycocyclosin
HN
NH
O
O
I OBnBnO I
+ B2pin2
Pd cat
 
 
Figure 3: Suzuki-Miyaura cross-coupling in natural product synthesis14-17 
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1.1.2 Synthesis of aryl boronate esters or boronic acids 
Classical approaches to the synthesis of aryl boronate esters 5 and 6 involve the 
treatment of tri-alkyl borates with aryl Grignard or lithium reagents 3 and 4 (Scheme 
1).18 
Br
1 (R= OMe)
2 (R= CN)
Mg, LiCl or iPrMgCl-LiCl
THF
MgX.LiCl
3 (R= OMe)
4 (R= CN)
X= Cl, Br
B(OMe)3, 0 
oC
B(OH) 2
5 (R= OMe) (92%)
6 (R= CN)    (72%)
R R R
acidic work-up
 
Scheme 1: Preparation of aryl boronic acids using Grignard reagent18 
 
This method is the cheapest and most commonly used to prepare aryl boronic 
acids. However, this reaction needs cryogenic conditions (-78 C (Li) and up to -10 
C (Mg)) that complicate large scale preparations. Moreover, this method is limited 
to substrates that are stable in the presence of nucleophilic and basic reagents. 
Another method to prepare aryl boronate ester 8 involves using palladium 
catalysts such as PdCl2(dppf) and the pinacol ester of diboronic acid B2pin2 or 
pinacol borane HBpin with 1-iodonaphthalene 7 (Scheme 2).19 
    +   HBpin
PdCl2(dppf)  3.0 mol%, Et3N
dioxane
I Bpin
+
8 (89%) 9  (6%)
7
 
Scheme 2: Preparation of aryl boronate esters using Pd catalysis19 
 
This method is considered a good method for synthesis of arylboronate esters 8, 12 
and 13. This reaction tolerates different functional groups on the aryl halides including 
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electron-donating and electron-withdrawing groups 10 and 11 (Table 1).19 However, 
this reaction is only viable for the more reactive aryl halides such as aryl iodides and 
bromides rather than aryl chlorides.  
 
R I      +      HBpin
PdCl2(dppf)  3.0 mol%, Et3N
dioxane
R Bpin
Comp No          R         Yield%
       12            CH3          79
       13            NO2          84
10 (R= Me)
11 (R= NO2)
Table 1: Preparation of aryl boronate esters19 
 
More recently, aryl boronate esters such as 15 have been prepared by the reaction of 
haloarene 14 with pinacolborane (Scheme 3)20 catalyzed by copper iodide in presence 
of a strong base such as sodium hydride. 
MeO I    +      HBpin
   CuI 10 mol%
THF/ NaH, 25 oC, 4 h
MeO Bpin
14 15 (75%)  
Scheme 3: Preparation of aryl boronate ester by copper catalysis20 
 
Copper catalysts are the cheapest for the preparation of aryl boronate esters and this 
reaction gives high yields of aryl boronate esters when using sodium hydride as a base. 
However, this method gives poor yields of aryl boronate esters when using aryl 
bromides. This could be due to the slower rate of oxidative addition of the aryl 
bromide compared to the aryl iodide. More recently, Marder and co-workers prepared 
arylboronate esters 12 and 18 using CuI with nBu3P. This reaction is viable for aryl 
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iodides and bromides that contain either electron-rich or electron-deficient groups 16 
and 17 (Table 2).21  
R Br     +      HBpin
   CuI, nBu3P, KO
tBu
THF, 25 oC
R Bpin
Comp No          R         Yield%
        12            CH3          83
        18            CF3          65
16 (R= Me)
17 (R= CF3)
 
Table 2: Preparation of a phenyl boronate ester from an aryl bromide21 
 
Although there are many methods to prepare boronic acids or boronate esters,22 there 
are drawbacks for each. This section illustrates this problem by reviewing the major 
methods. The disadvantage of these C-X borylation strategies is the need to have a 
halogenated starting material. Ir/catalyzed C-H borylation is another method used to 
form aryl boronate esters 23 and 24,23 and one in which aryl halides are avoided. This 
involves borylation of a C-H bond using [Ir(OMe)(cod)]2 21 with dtbpy 22 in presence of 
boron source. A second advantage of this approach is tolerance to a variety of 
electron-donating and electron-withdrawing groups 19 and 20 (Table 3).23 
R
R
+      B2pin2
      [Ir(OMe)(cod)]2 (21) 0.1 mol%
dtbpy (22), 0.2 mol%, THF, 80 oC
R
R
Bpin
Comp No       R          
    23             CH3              
    24             CF3
19 (R= Me)
20 (R= CF3)
 
Table 3: Borylation of arenes using Ir-Catalysis23 
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Thus, iridium C-H borylation has been reported and discussed for a variety substrates. 
The next section will focus on Ir- catalyzed C-H borylation and starts with the history of 
the borylation, mechanism and previous work in the group.  
 
1.1.3 History 
The first example of Ir catalyzed C-H borylation occurred in 1993 when Marder et al. 24 
reported that a small amount of C-H borylation was observed during the preparation 
of iridium tris-boryl complex [(ƞ6-C6H5Me)Ir(Bcat)3] 27 (Figure 4). This was prepared in 
the reaction of [(ƞ5-indenyl)Ir(cod)] 25 with excess HBcat in toluene 26, resulting in a 
small amount of tolylBcat 28 and 29 as identified by GC/ MS.24 In 199525 Hartwig et al. 
reported that the borylation of toluene 26 in stoichiometric photolytic reactions 
occurred using catalysts such as [Mn(CO)5(Bcat)], [Fe(Cp)(CO)2(Bcat)] and 
[Re(CO)5(Bcat)] (EQ 1) (Scheme 4). Additionally the same group26 used Cp*Mn(CO)3 30 
with benzene 31 in presence of  B2pin2 to prepare phenyl boronate ester 32 (EQ 2) 
(Scheme 4). 
 
Ir
B
B
B
O
O
O O
O
O
 
Figure 4: Structure of tris-boryl complex 2724 
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Me
[Fe(Cp)(CO)2(Bcat)]
hv 1 h
Me Me
Bcat
Bcat
+
70% (1.1:1.0) GC-MS
EQ 1
26
28 29
H
hv, CO (2 atom), 25 oC, 36 h
Bpin
EQ 2
31  32 (76%)
Cp*Mn(CO)3 10 mol%
+    B2pin2
Scheme 4: Photolytic aromatic borylation25,26 
 
Subsequently, in 199927 Iverson and Smith demonstrated a stoichiometric thermal 
reaction using HBpin with [Ir(Cp*)(PMe3)(H)(Ph)] 33 to form the complex species 
[Ir(Cp*)(PMe3)(H)(Bpin)] 34 together with the phenyl boronate ester 32 (Scheme 5). It 
was found that an aromatic C-H borylation could be obtained through using complex 34 
with HBpin at 150 oC for example borylation of benzene 31 needed 120 h to afford a 
53% yield of arylboronate 32 (Scheme 6).28 
+ 2 HBpin Ir
Cp
*
Me3P
Bpin
H
+ C6H5-Bpin +     H2
3234
Ir
Me3P
Ph
H
33
Cp
*
C6D6
150 oC
 
Scheme 5: Thermal method to form phenyl boronate 3227 
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H
150 oC, 120 h
Bpin
31  32 (53%)
[Ir(Cp*)(PMe3)(H)(Bpin)] 20 mol%
+    HBpin
 
Scheme 6: Borylation of arenes using [Ir(Cp*)(PMe3)(H)(Bpin)] 3428 
 
In 2002 Hartwig et al.29 and Smith30 independently reported that the C-H activation of 
arenes takes place using [Ir(Cl)(cod)]2. Hartwig et al. found that arylboronate esters 32 
and 39-41 could be obtained by the borylation of arenes (26, 31, and 35-36) with B2pin2 
catalyzed by [Ir Cl(cod)]2 37 and 2,2’-bipyridine 38 at 80 oC (Table 4).28 This gave nearly a 
2:1 ratio of meta- to para-borylated products for mono-substituted arenes with both 
electron-rich and electron-poor groups. The only exception to this selectivity is the 
borylation of anisole, which may be explained by the coordination of the oxygen of the 
methoxy group to the iridium catalyst leading to activation of C-3.31 Moreover, this 
reaction can take place at room temperature when using dtbpy 22.28 In the same year 
Ishiyama et al. also reported32 that the phenyl boronate esters can be prepared by 
reaction of arenes with a complex of tris(boryl) species Ir(Bpin)3(dtbpy)(COE) 42. The 
nature of the precatalyst complex impacts on the efficiency and rate of the borylation 
reaction. For example, it was found33 that a turnover number of 8000 was achieved 
through using 0.02 mol% 1/2[IrCl(coe)2]2 43 with dtbpy 22 at 100 oC. However, this 
reaction proceeds smoothly at room temperature using [Ir(OMe)(cod)]2 21 with dtbpy 
22.34,35 In general active catalysts 88A (Section 1.1.5, Figure 8,) generated from 
[IrX(cod)]2 pre-catalysts (where X= OH, OPh and especially OMe) offer faster reaction 
times than the chloro derivative.33,34 Since then there has been a large value of literature 
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explaining the variables that affect the efficiency of this reaction. There is too much to 
cover in the space available and, reflecting the focus of this thesis, the next section will 
concentrate on the role of the ligand in this process. 
R
+      B2pin2
80 oC, 16 h
R
Prod No              R                    Ar-Bpin           Yield% (o:m:p)                   
    32                   H                                           95                                         
    39                  OMe                                       95  (1:74:25)                       
    40                  Me                                          82  (0:69:31)                       
    41                  CF3                                         80 (0:70:30)
Bpin
OMe
Bpin
Me
Bpin
CF3
Bpin
Bpin
31 (R= H), 35 (R= OMe)
26 (R= Me), 36 (R=CF3)
[Ir(Cl(cod)]21.5 mol%, bpy 3.0 mol%
 
 
Table 4: Preparation of phenyl boronate esters28 
 
1.1.4 Ligands Discussion 
1.1.4.1 Introduction 
In addition to the nature of the metal complex used, the nature of the ligands plays a 
major role in the iridium catalyzed C-H borylation reaction. Reflecting this, many 
different ligands have been described including phosphines, hydrazones, carbenes etc. 
This section will review the different ligands based on the nature of the ligating atoms/ 
group. 
1.1.4.2 Phosphine based Ligands 
The first examples of arene C-H borylation were reported, using a iridium tris boryl 
complex with Cp* or indenyl ligand systems.24,27 These reactions were either 
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stoichiometric reactions or showed low TON. The key breakthrough was reported by 
Smith and co-workers who introduced phosphine ligands which provide the first 
example of substoichiometic reactions (Section 1.1.3, Scheme 6).28 Subsequently 
Smith and coreported the use of bidentate phopshines such as PMe3 44, dppe 45 and 
dmpe 46 with an Ir(Ind)(cod) pre-catalyst 25 and HBpin as the boron source in the 
borylation of arenes 31 and 47 to afford arylboronate esters 32 and 4830. It was found 
that the highest yields of borylated product were obtained, using a 2:1 ratio of PMe to 
Ir-precursor or 1:1 ratio of dmpe and dippe to Ir-precursor to generate the catalytically 
active species which is believed to be the trisboryl complexes Ir(Bpin)(PR3)n. This 
species tolerated a variety of functional groups, both electron-donating and electron-
withdrawing (Table 5).36 
RR
R
+    HBpin
Ir(Ind)(cod) 2.0 mol%
L (2.0 mol%), 150 oC
Compd No       R             (L)            Ar-Bpin          Yield%
      32              H              44                                 88
      32              H              45                                 95
      48              F              46                                  63
Bpin
Bpin
Bpin
F
F
F
RR
R
Bpin
31 (R= H)
47 (R= F)
 
Table 5:Borylation of arenes using Ir(Bpin)(PR3)n36 
 
Steric factors also play a significant role. For example borylation using Ir(Bpin)(dippe) 
50 afforded a > 99% conversion of 1,3-di-(tri-fluoromethyl)benzene 20 after 48 h at 25 
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oC whereas the use of the corresponding t-butyl ligand dtbpe (complex 49) afforded 
only a 10% conversion (Scheme 7).37  
P
P
Ir
Bpin
Bpin
Bpin
+
CF3
F3C
25 oC
CF3
F3C Bpin
23 (10%)conversion after 48 h
P
P
Ir
Bpin
Bpin
Bpin
+
CF3
F3C
25 oC
CF3
F3C Bpin
23 (> 99%)conversion after 48 h
49 20
20
50
C6D12
C6D12
 
Scheme 7: Borylation of 1,3-CF3-C6H4 using dippe and dtbpe ligands37 
  
More recently, monodentate phosphine ligands have been developed as these can 
enable directed boryaltion of specific substrates. Electron-poor phosphine ligands can 
dissociate and allow the carbonyl oxygen of the substrate to coordinate to the iridium 
complex (Scheme 8).38,39 Ishiyama, Miyaura and co-workers were able to use 
monodenate phosphine ligands with [Ir(OMe)(cod)]2 21 for the borylation of arenes.1,38 
Preshlock reported that the borylation of methylbenzoate 52 using 3,5-(CF3)2(C6H3)3P 
51 afforded a 7:1 mixture of mono- and bis-borylated products 53 and 54 (Scheme 
9).40 A silica-supported monophosphine ligand 55 (Figure 5), reported by Sawamura, 
also enabled directed ortho-borylation of methylbenzoate derivatives 56-58 to afford 
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the aryboronate ester 59-61 (Table 6).41 Although an electron-rich phosphine ligand is 
used in this process, the silica supported phosphine ligand forms a mono phosphine 
complex, which allows coordination of the carbonyl oxygen to the iridium centre. 
Methoxy-substituents in 2- or 4-positions of methylbenzoate have minor effects on the 
borylation reaction. This could be due to the stronger coordination of the carbonyl 
oxygen of the substrate to the iridium centre compared to the methoxy group. Ligand 
55 was also used for the directed ortho-borylation of phenol derivatives such as 62 
(Scheme 10).42 
Ir
Bpin
Bpin
Bpin
L
vacant or weakly 
coordinated site
DMG
Ir
Bpin
Bpin
Bpin
L
GMD H
L = phosphine or SMAP ligands
DMG = directed metalating group  
Scheme 8: Ortho borylation strategies with DMG39 
 
O O
Bpin
[Ir(OMe)(cod)]2 2.5 mol%
B2pin2 1.0 eq., L (51) 10 mol%
80oC, 16h
OMe OMe O
Bpin
OMe
pinB
P
CF3F3C
CF3
CF3
F3C
CF3
53 54
51
52
1H NMR ratio (53:54) 
                        7:1
+
 
Scheme 9: Directed ortho-borylation of methylbenzoate 52 using 51 ligand40 
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Si
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O OSi
O
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O SiO2
SiMe3
O
O
 
 
Figure 5: Silica-SMAP ligand 5541 
MeO
Bpin
hexane, 2 h
56 = R
1
, R
2
= H
57 = R
1
= OMe, R
2
= H
58 = R
1
= H, R
2
= OMe
O MeO O
R
1
R
2
R
1
R
2
Comp No         R1,R2                 T              Yield%a
                                                           oC
    59                 H,H               25               89
    60                 OMe, H         25               85
    61                   H, OMe       40               96
aisolated yield of product based on B2pin2
Silica-SMAP-Ir 0.5 mol%
B2pin2 0,5 eq.
 
 
41Ir 55-SMAP-: Borylation of methylbenzoate derivatives using a Silica6Table  
 
O
O
MeO O
O
MeO
Bpin
Silica-SMAP-Ir 0.5 mol%
HBpin 0,5 eq.
Octane, 100 oC, 24 h
  ratio 
o:(m+p)
 100:0
62 63
 
Scheme 10: Borylation of phenol derivatives using a Silica-SMAP-Ir 5542 
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1.1.4.3 N-N based Ligands 
Although phosphine ligands make functional catalysts in the borylation reaction, 
Iridium catalysts generated with nitrogen chelating ligands have been found to provide 
higher reactivity.30 For example, it was found that the borylation of 3-methyl-N,N-
dimethylaniline 64 using [Ir(OMe)(cod)]2 21 and dppe 45, dmpe 46 and dmpbz 65 did 
not give the borylated product whereas using the ligands dtbpy 22 and tmphen 66 
afforded mono-borylated product 67 (Table 7).43 The active catalyst bearing phosphine 
ligands likely requires higher temperatures in order to display improved reactivity. 
NMe 2
+ HBpin
L= 1-3 mol%, THF, 80 oC, 8 h
1.5 eq.
[Ir(OMe)(cod)]2 5mol%
PMe2Me2PPPh2Ph2P PMe2Me2P
64
entry No        (L)          yield%a
    1               45              0
    2               46              0
    3               65              0
    4               22             14
    5               66             64
ayields determined by HPLC
N N NN
NMe 2
Bpin
67
6545 46 22 66
 
Table 7: Borylation of 3-methyl-N,N-dimethylaniline using different ligands43 
 
Recently a variety of N,N bidentate ligands have been used in the borylation of arenes 
including tmphen 66, phene 68, dtbpy 22, dmobpy 69, dmabpy 70, 8-aminoquinoline 
71, box 72, diim 73, hydrazone 74, imine 75 and  pyridine amine derivatives (76 and 
77-83) (Figure 6).40,44-46Among N,N ligands, bipyridine ligands have shown high activity 
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in the borylation of arenes, as reported by Ishiyama, Miyaura, Hartwig and co-
workers.29,47 It was found that electron-donating functional groups at 4- and 4’-
position of 2,2’-bipyridine such as OMe 69, tBu 22 and NMe2 70 improve the reactivity 
for the borylation of 31 and 86 with HBpin or B2pin2 resulting in arylboronate esters 32 
and 87  (Table 8, Table 9) compared to electron-withdrawing groups such as Cl 84 and 
NO2 85.33  
N N NBn2 NN ph N NR2 N
NH2
N N
R R N N
N N
O N
O N
727322 (R= 
tBu), 69 (R= OMe)
70 (R= NMe2)
N
NH2
74 75 77-83 76
NN
NN
71 66
68
R1
R1
R1
Ph
 
Figure 6: Variety of N-N bidentate ligands using in the borylation of arenes40,44-46  
 
R
2
R
3
Ir-catalyst 3.0 mol%
R
2
R
3
Bpin
Comp No       R1, R2, R3      Substrate      Boron source     R. time
                                           (eq.)                                            (h) 
   32              H, H, H               excess               B2pin2                     4 
    87              H, Cl, Cl           1.0                    HBpin                 8
R
1
hexane, 25 oC
31 R
1
, R
2
, R
3
= H
86 R
1
= H, R
2
, R
3
= Cl
 
Table 8: Preparation of aryl boronate esters with Ir-Cat.33 
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N N
R R
Ir
X
entry No               Ir(x)                      R               B2pin2%             HBpin%
   1                Ir(OMe)(cod)]2           NMe2               88                      88
   2                Ir(OMe)(cod)]2           OMe                90                       27
   3                Ir(OMe)(cod)]2              
t Bu                  83                      86
   4                Ir(OMe)(cod)]2              Cl                     0                        7
   5                Ir(OMe)(cod)]2            NO2                       0                        0
 
Table 9: The activity of dpy with different substitutions in 4- and 4’-positions33 
 
Although 4,4’-disubstituted-2,2’-bipyridine such as dtbpy 22 show a good activity with 
the Ir-catalyst to generate the active tris-boryl species Ir(Bpin)3(dtbpy) 88A, low 
loading of [Ir(OMe)(cod)]2 21 ligated by tmphen 66 led to the most active catalyst in 
the borylation of 89 to afford Ar-Bpin 90 (Table 10).43 It is unclear why tmphen under 
these conditions allows for the generation of a more active catalyst than dtbpy 22. 
However it may be postulated that the increased planarity of tmphen could explain 
this difference in catalytic activity.  
MeO
[Ir(OMe)(cod)]2, L
0.5 eq., B2pin2, THF, 80 
oC, 24 h
MeO Bpin
entry No     Ir mol%      (L) mol%            yield%
      1             0.25         tmphen   1.0         84
      2              1.5          dtbpy       3.0         56
89 90
 
Table 10: Borylation of 2,6-di-methylanisole using tmphen 66 and dtbpy 2243 
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Recently Chattopadhyay et al. used 8-aminoquinoline 71 with an Ir-catalyst in the 
borylation of substituted benzaldehydes using tert-butylamine as a protecting and 
directing group (Scheme 11) (Table 11).44,45 This ligand 71 was compared with tmphen 
ligand 66 through the borylation of 4-methoxybenzaldehyde 91 to afford Ar-Bpin 92 
and 93. Ligand 71 showed selectivity of the borylation at ortho position of the imine 
group. 
Ir
Bpin
Bpin
BpinN
N
vacant or weakly 
coordinated site
N
t
Bu
Ir
Bpin
Bpin
BpinN
N
N
R
H
dissociation of weaker N donor
 
Scheme 11: Directed ortho-borylation of benzaldehyde in presence of tBu-NH245 
 
1)  tBu-NH2 (4-10 eq.), DCM, r.t, 4 h,
evaporated under reduced pressure
entry No    (L)            ratio         yield%
                                 (92:93)           
      1         71             0:100           60
      2         66             81:19           74
O H
OMe
O H
OMe
O H
OMe
Bpin
Bpin
2) [Ir(OMe)(cod)]2 1.5 mol%, L (3 mol%)
    B2pin2 0,7 eq., HBpin 5 mol%, THF, 
    90 oC, 12 h
92 9391
 
Table 11: Borylation of 4-methoxybenzaldehyde using ligands 66 and 7144 
 
Chattopadhyay also reported hemilabile bidentate ligands such as hydrazone 
derivatives (74 & 75) and pyridine amine derivatives (76 & 77) for the borylation of 
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unsubstituted benzaldehyde 94. The reaction afforded a mixture of meta, para and 
ortho borylated products 95 (Table 12).44 These reactions showed high selectivity for 
the ortho-borylated products, due to the coordination of the nitrogen of the imine 
group to the iridium centre. 
 
1)  tBu-NH2,(4 eq.),DCM, r.t, 4 h,
evaporated under reduced pressure
entry No     L        ratioa       yield%
                           (o:m:p)                    
      1          74       86:8:6         57b                     
      2          75      100:0:0        66c          
      4          76       97:2:1         62d
       3          77       95:2:3         72e
O H O H
2) [Ir(OMe)(cod)]2 1.5 mol%, (L) 3 mol%
   B2pin2 0.7 eq., HBpin 5 mol%, THF, 
   90 oC, 12 h
Bpin
N N NBn2 NN ph N NH2 N
NH2
aratios determined by GC-MS analysis bmono:o,o-di 90:10   cmono:o,o-di 80:20
   
dmono:o,o-di 85:15 emono:o,o-di 87:13
Ph
74 75 77 76
94 95
 
Table 12: Borylation of benzaldehyde using pyridine derivatives44 
 
Clark et al. also reported hemilabile amine ligands 78-83 (Table 13)46 enabling directed 
ortho-borylation of N,N-di-methylbenzylamine 96 to afford a mixture of mono- and 
bis-borylated products 97 and 98. N,N-Di-methylbenzylamine 96 coordinates to the 
iridium centre alongside the diamine.48 This facilitates the directed borylation of 
substrate.  
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[Ir(OMe)(cod)]2 1.5 mol%
B2pin2 1.2 eq.,
entry No   (L)     conv.       ratioa       
                          (%)a         (97:98)                    
      1          78     79            97:3                         
      2          79     91            87:13
      3          80     96            85:15           
      4          81     88            93:7
      5          82     95            93:7
      6          83     98            89:11
NMe 2 NMe 2
L (3.0 mol%), Me-cyclohexene, 
70 oC, 16 h
N NH2
arconversion and ratio determined by 1H NMR
81 82 83
R
Bpin
97 (R= H)
98 (R= Bpin)
N NHMeN NMe2
N NH2 N NH2
N NH2
78 79 80
96
 
Table 13: Amine directed-C-H borylation46 
 
The two ligands box 72 and diim 73 were used in the borylation of 3-tri-
fluoromethylaniline 99 (Table 14).40 They showed lower activity with the Ir-catalysts in 
the borylation of 99 compared with bipyridine derivatives (dtbpy 22 and dmabpy 70) 
and [1,10]-phenanthroline derivatives (tmphen 66 and Phen 68). Dmaby, dtbpy and 
tmphen ligands showed comparable activity in the borylation of 99 leading to the meta 
and ortho borylated products 100 and 101. While box 72 and diim 73 showed the least 
activity with the Ir-catalyst. The selectivity of the borylation of aniline 99 was 
suggested to be due to hydrogen bonding of the N-H of the substrate with the boryl 
oxygen atom of the tris-boryl iridium complex, which would favor ortho-borylated 
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products. Using a polar solvent (THF), and high concentrations of B2pin2 might favour 
the formation of meta-borylated products. 
[Ir(OMe)(cod)]2 2.5 mol%, L
1.5 eq., B2pin2, THF, 80 
oC, 16 h
entry No     (L)              ratioa            yield%
                               100:101(m:o)
     1           66             1.0:1.4              86
     2           22             1.0:1.1              80
     3           70             1.0:1.6              86
     4           68             1.4:1.0              73
     5           72             1.0:1.5              10
     6           73             1.0:1.0              17
F3C
NH2
F3C
NH2
F3C
NH2
Bpin
Bpin
N N
N N
N N
N N
O N
O N
72
99 100 101
7370
aratio determined by 1H NMR
N N
N N
22
N N
66 68
+
 
Table 14: Borylation of 3-tri-fluoromethylaniline using different ligands40 
 
1.1.4.4 Carbene Ligands 
Another class of ligands which can be used in the borylation reactions are bidentate 
heterocyclic carbenes. Breinbauer and Peters reported a range of bidentate pyrido-
NHC complexes which were used in the borylation of 1,3-di-chloropyridine 86 (Scheme 
12).49  
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N
[Ir(OMe)(cod)]2 0.75 mol%
B2pin2 0.75 eq.,
NHC ligands 1.5 mol%, KOtBu 1.5 mol%
MTBE, -78 - 65 oC
N
N
R1
N
N
R2
R3
NHC ligand (102)
86
87
Cl Cl
Bpin
ClCl
 
Scheme 12: Borylation of 1,3-di-chlorobenzene using carbenes ligands49 
 
Although these ligands showed acceptable activity in the borylation of arenes, it was 
found that none of these carbene complexes give higher efficiency compared to dtbpy 
22 with Ir-catalyst. Also Hermann et al. demonstrated a range of iridium mono- and 
bis-carbene complexes 103-108 that can be used in the borylation of arenes (Figure 
7).50 They showed that these complexes can be used in the borylation of benzene 31, 
yielding only mono-borylated product with good yield, however these reactions need a 
higher temperature to 65 oC, which is not ideal due to the lower selectivity in the 
borylation reactions at elevated temperatures (Table 15).50  
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N
NIr
N N
103
N
NIr
N N
104
CF3COOCF3COO
N
NIr
N N
105
CF3COO
N
NIr
RCl
R
106 (R= iPr)
107 (R= Cy)
108 (R= Mes)  
Figure 7: A range of iridium mono- and bis-NHC complexes50 
 
Ir-catalyst 1.5 mol%
HBpin 0.25 mmol
excess
dodecane, µw 35 min 300 W
Bpin
entry No        Ir-catalyst           Yield%
   1                     103                  48
   2                     104                  89
   3a                    105                  87        
   4                     106                  72
   5                     107                  68
   6                     108                  75
32
31
areaction time 1 h  
Table 15: Borylation of benzene using different iridium mono- and bis-NHC 
complexes50 
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1.1.5 Mechanism 
A catalytic cycle for arene borylation with the Ir(Bpin)3(dtbpy) 88A complex has been 
suggested by Miyaura et al. (Figure 8).29 The active 16 electron species 88A is formed 
by reversible dissociation of COE from 42 and this conversion must take place before 
the borylation process.51 The structure of 42 was confirmed by X-ray diffraction and 
studies have shown that the dissolution of the tris(boryl) species 42 in C6D6 at r.t gives 
3 eq. of C6D5-Bpin 109 (Scheme 13). Collectively this evidence supports the idea that 
the tris (boryl) complex 42 is a key intermediate in borylation reactions.29 Furthermore, 
in 2005 Hartwig et al. noted that complex 42 could be produced from the reaction of 
[Ir(OMe)(cod)]2 21 with HBpin (Scheme 14).51 
[Ir(coe)(-Cl]2
dtbpy, B2pin2
C6H3Me3
Ir
Bpin
Bpin
N
N
Bpin
COE
C6D6
r.t
109 (80%)4243
3 C6D5-Bpin
 
Scheme 13: Dissociation of tris(boryl) species 4229 
[Ir(OMe)(cod)]2
1) HBpin, COE
2) dtbpy, 40 C, 30 min
Ir
Bpin
Bpin
N
N
Bpin
42
21
 
Scheme 14: Preparation of tris(boryl) species 4251 
 
A plausible mechanistic pathway29 commences with dissociation of COE from 42 to 
form the putative active Ir(III) complex 88A. In the rate limiting step C-H activation of 
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the arene occurs to produce Ir(Ar)(H)(dtbpy)(Bpin)3 88B through oxidative addition of 
the arene to the 88A, followed by reductive elimination of Ar-Bpin 88C to give 
Ir(H)(dtbpy)(Bpin)2 88D. 88A is then regenerated through oxidative addition of B2pin2 
and reductive elimination of HBpin (Figure 8). 
[Ir(OMe)(cod)]2   +   dtbpy     +     2B2pin2
- MeO-Bpin
Ir
Bpin
BpinN
N
Bpin
42
Ir
Bpin
BpinN
N
Bpin
88A
ArH
Oxidative addition
Ir
Bpin
Bpin
N
N
Bpin
88B
Ar
H
Ar-Bpin
Reductive elimination
Ir
Bpin
N
N
Bpin
H
B2pin2
HBpin
Oxidative additioin
Reductive elimination
88C
- COE
88D  
 
Figure 8: The proposed catalytic cycle29 
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This mechanism has been supported by computational results obtained by Sakaki et al. 
for the borylation of benzene.52 It was also suggested that the tris(boryl) complex 88A 
can be regenerated through oxidative addition of HBpin generated from the first cycle 
to the 88D complex (Figure 9).53 
Ir
Bpin
BpinN
N
88A
ArH
Ir
Bpin
Bpin
N
N
Bpin
88B
Ar
H
Ar-Bpin
Ir
Bpin
N
N
H
88C
88D
Ir
Bpin
Bpin
N
N
Bpin
H
B2pin2
HBpin
Ir
Bpin
Bpin
N
N
H
Bpin
H
H2
Bpin
Bpin
Bpin
 
 
Figure 9: Proposed regeneration of the tris boryl species 88A53 
 
1.1.6 Selectivity of Ir-catalyst for C-H borylation 
[Ir(OMe)(cod)]2 21 ligated by dtbpy 22 is considered to be the most active type of 
catalyst for the borylation of arenes and heteroarenes.54 Iridium catalysed C-H 
borylation is influenced by steric and electronic factors.33,55 Previous studies have 
shown that the orientation of arenes and heteroarenes is influenced by steric 
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hindrance due to the high sensitivity of iridium catalysts towards steric effects.33 This 
in turn affects the borylation process. However, for unsubstituted heteroarene C-H 
borylation, steric effects are largely absent. Mono-substituted aromatic C-H borylation 
at arenes that have electron-donating or electron-withdrawing groups gives a mixture 
of para and meta borylated products with the ratio determined by steric factors 29. 
Ortho borylation in arenes or heteroarenes, such as anisole 35, tri-fluromethylbenzene 
36, 2-chloropyridine 110 and quinoline 111, is very poor and sometimes does not 
occur (Figure 10).  
 
OMe CF3
N
Cl
N
1%74%
25%
70%
30%
29%
71%
100%
35 36 110 111
Figure 10: The orientations of arene and heteroarene C-H borylation33 
 
In addition, arenes which bear symmetrical di-substituted groups on 1,2-positions and 
1,4-positions give a single isomer33 for example, 1,2-di-chlorobenzene 112 gives the 
1,2,4 tri substituted product 115. Ortho borylated product 116 can occur through 
borylation of symmetrical 1,4-di-chlorobenzene 113 (Table 16), however, a mixture of 
borylated products is formed on the borylation of 1,4-substituted arenes that have two 
different groups.55 In addition, the borylation of 1,3-di-substituted arenes such as 114 
takes place at the meta position (product 117) even if the substituents are different or 
identical (Table 16).33  
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[Ir(OMe)(cod)]2- dtbpy
Comp No       R1, R2, R3, R4              R. time (h)              Ar-Bpin            Yield%            
    115             H, Cl, Cl, H                          8                                                 88
     116             H,  Cl, H, Cl                    24                                                 53
 
    117            Br, H, CN, H                    2                                                   83
R
4
hexane, 25 oC
R
2
R
3
+  B2pin2
Cl
Cl Bpin
Cl Cl
Bpin
R
1
R
4R
2
R
3
R
1
Bpin
NC
Bpin
Br
112 (R
1
, R
4
= H; R
2
, R
3
= Cl)
113 (R
1
, R
3
= H; R
2
, R
4
= Cl)
114 (R
1
= Br, R
3
= CN; R
2
= H, R
4
= H)
 
Table 16: Borylation di-substitutedbenzenes 
 
1.1.7 Borylation of heteroarenes 
The borylation of five-membered heteroarenes such as pyrrole, furan and thiophene, 
can also be catalyzed by iridium complexes.32,56 With these substrates 118-120, 
borylation takes place at the 2-position 121-123.57 2,5-Bisborylated products 124-126, 
however, are observed when the borylation of five-membered heteroarenes is 
achieved using excess of B2pin2 (Table 17).57 
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X
+  B2pin2
     
     118 (X= O)
     119 (X= NH)
     120 (X= S)
[IrCl(cod)]2- dtbpy
Octane, 80 oC, 16 h X X
Bpin Bpin
+
(X)     B2pin2    Arene   Prod No (A)       (A)Yield%      B2pin2    Arene    Prod No (B)     (B) Yield%
           (eq.)       (eq.)                                                      (eq.)        (eq.)                   
O          1.0        10            121                    83              1.1              1               124                    71
NH        1.0        10            122                    67              1.1              1               125                    80
S           1.0        10            123                    83              1.1              1               126                    80
A B
Bpin
Table 17: Borylation of five-membered heteroarenes57 
 
Furthermore, quinoline 111 and pyridine 127 should also be considered, as examples 
of the borylation of six-membered heteroarenes. Studies have found58 that the 
borylation of unsubstituted pyridine 127 is less reactive than benzene 31, and needs 
high reaction temperatures (100 oC), affording a meta and para borylated products 
128 and 129 with a 2:1 ratio (Scheme 15).32,58This is due to the fact that the pyridyl 
nitrogen coordinates to the iridium catalyst blocking access to the position required for 
C-H activation.58 
N
[IrCl(cod)]2 1.5 mol%, 
B2pin2  0.5 eq.
dtbpy 3.0 mol%, octane. 
100 oC, 16 h
N N
Bpin
Bpin
128 129
(2:1) 42%
127
+
 
Scheme 15: Borylation of pyridine compound32,58 
 
On the other hand, ortho substituents such as 2-phenylpyridine 130 give steric 
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inhibition of pyridyl nitrogen coordination allowing the efficient borylation of 2-phenyl 
pyridine. This yields a 1:1 mixture of 4- and 5-borylated products 131 and 132 (Scheme 
16).56 
 
N
[Ir(OMe)(cod)]2 2.5 mol%, 
B2pin2  0.5 eq.
dtbpy 5.0 mol%, hexane. 
25 oC, 16 h NN
Bpin
Bpin
132131
(1:1) > 90%
130
+
Ph PhPh
 
Scheme 16: Borylation of a 2-substituted pyridine compound 
 
Through studying the inhibitory effects on the borylation of substituted 
heteroarenes,58 it has been suggested that electronic effects possibly have a larger 
effect than steric hindrance. For example, the 5- and 5’ borylated product 133 was 
produced through the borylation of 69 (Scheme 17).56 However, this is almost certainly 
a substrate specific observation. 
 
[Ir(OMe)(cod)]2 5.0 mol%, 
B2pin2  2.0 eq.
dtbpy 10 mol%, hexane. 
80 oC, 16 h
N N
MeO OMe
N N
MeO OMe
BpinpinB
69 133 (85%)
Scheme 17: Borylation of 4, 4´-di-methoxy-2,2´-bipyridine compound56 
 
Another example of the issues affecting the borylation of heteroarenes comes from 
the use of quinoline 111. Previous studies have shown that the borylation of 111 by 
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[Ir(OMe)(cod)]2 21 occurs in excellent yield (84%) at the 3-position 134 (Scheme 18),59 
while increasing the amount of B2pin2 leads to bis-borylated products 135 and 136 
(Figure 11) in a 50:50 ratio. 
 
[Ir(OMe)(cod)]2 1.5 mol%, 
B2pin2  2.0 eq.
dtbpy 3.0 mol%, MTBE. 
80 oC, 16 h
111 134 (84%)
N N
Bpin
 
Scheme 18: Borylation of quinoline59 
 
N N
BpinBpin
pinB
pinB
135 136  
Figure 11: Bis-borylated quinoline59 
 
In addition, the blocking of the 2-position on quinoline by any group such as 2-
methylquinoline 137 leads to bis-borylated product at 4,6 (138) and 4,7 (139) with a 
small amount at 5,7 (140) positions;58 this is due to steric inhibition of pyridyl nitrogen 
coordination (Scheme 19). Furthermore, the borylation of the di-substituted quinoline 
at 4- and 7- positions 141 leads to mono-borylated product at the 3-position 142 
(Scheme 20). 
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[Ir(OMe)(cod)]2 1.5 mol%, 
B2pin2  2.0 eq.
dtbpy 3.0 mol%, MTBE. 
25 oC, 24 h
137
N NMe Me N Me
N Me
Bpin Bpin
Bpin
pinB
pinB
pinB
+
139 (68%)
140 (0%)
138 (32%)
 
Scheme 19: Borylation of 2-substituted quinoline58 
 
[Ir(OMe)(cod)]2 1.5 mol%, 
B2pin2 1.0 eq.
dtbpy 3.0 mol%, MTBE. 
100 oC, Mw, 1.5 h
141 142 (81%)
N N
Bpin
Cl
Cl
Cl
Cl
 
Scheme 20: Borylation of 4,7-di-chloroquinoline58 
 
1.1.8 Previous work in the group (application of pyridines and 
quinolines) 
The borylation of heteroarenes such as quinoline 111 and pyridine 127 were 
investigated by previous members of the research group. Quinoline 111 as a substrate 
showed more reactivity in the borylation reaction than pyridine 127 (Section 1.1.5, 
Scheme 15, Scheme 18). Mkhalid has studied the electronic and steric effects on 
heteroarene C-H borylation. It was found that blocking the 2-position on pyridine such 
as 2-methylpyridine 143 leads to good conversion in borylation reaction at 4- and 5-
positions 144 and 145 (Scheme 21).57 
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[Ir(OMe)(cod)]2 2.5 mol%, 
B2pin2  0.5 eq.
dtbpy 5.0 mol%, hexane, 
25 oC, 16 h
143
N N
Bpin
Me Me N Me
pinB
+ + Bis-borylated product
145
85-90% GC-MS
10-15% GC-MS
144 (81%)
 
Scheme 21: Borylation of 2-methylpyridine57 
 
This researcher also demonstrated that the dtbpy 22 can be borylated by using 
stoichiometric dtbpy 22 giving a bis-borylated product at the 6- and 6’-positions 146 
(Scheme 22). 
 
[Ir(OMe)(cod)]2 5.0 mol%, 
B2pin2  2.0 eq.
dtbpy 10 mol%, hexane. 
80 oC, 16 hN N
t
Bu
N N
t
Bu
pinB
22 146
Bpin
t
Bu
t
Bu
 
Scheme 22: Borylation of a 4, 4’-di-tert-butyl 2,2´-bipyridine compound57 
 
As mentioned in Section 1.1.5 (Scheme 17) that while 5- and 5’ borylated product was 
produced through the borylation of 69 from the results above, it was found that the 
selectivity of iridium C-H borylation of pyridines more commonly depends on steric 
hindrance rather than electronic effects. In addition, Tajuddin has studied the 
selectivity of iridium C-H borylation on variety of substituted pyridines.10 The 
borylation of 2-chloropyridine 110 afforded 6-borylated product 148 after initial 
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borylation at the 4-position 147 due to the electronic effects of pyridyl nitrogen 
(Scheme 23). 
[Ir(OMe)(cod)]2 5.0 mol%, 
B2pin2  1.2 eq.
dtbpy 10 mol%, MTBE, 
25 oC, 24 h
110
N
N
Bpin
Cl
Cl N ClpinB
+
N Cl N Cl
+
Bpin
BpinpinB pinB
147 148
149 150
Conv (%) GC-MS ratio (147:148:149:150)
       
      100                              29:40:26:5  
Scheme 23: Borylation of 2-chloropyridine10 
 
It was found that blocking the 2- and 4-positions on pyridine such as methyl-2-
chloroisonicotinate 151 led to ortho borylated product 152 (Scheme 24). This meant 
that the borylation alpha to the pyridyl nitrogen occurred as a result of the steric 
effects of the ester group at the 4-position. On the other hand, a mixture of 5- and 6-
borylated products 154 and 155 were observed when an ester group at the 4-position 
was replaced by a chlorine atom 153 (Scheme 25). 
[Ir(OMe)(cod)]2 1.5 mol%,
B2pin2 1.2 eq.
dtbpy  3 mol%, MTBE. 
r.t oC, 72 h
N Cl N Cl
151 152 (73%) 
1H NMR
pinB
O OMe O OMe
 
Scheme 24: Borylation of a 2,4-di-substituted pyridine10 
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[Ir(OMe)(cod)]2 5.0 mol%,
B2pin2 1.2 eq.
dtbpy  10 mol%, MTBE. 
25 oC, 24 h
N Cl N Cl
153 154
pinB
Cl Cl
N Cl
Cl
pinB
+
155
(95%) conversion  
Scheme 25: Borylation of 2,4 di-chloropyridine10 
 
Tajuddin has observed that the borylation of 2-CF3-substituted quinoline 156 giving a 
mixture of bis borylated products 157-159 (Scheme 26). 
[Ir(OMe)(cod)]2 1.5 mol%
B2pin2  2.0 eq.
dtbpy 3.0 mol%, MTBE. 
25 oC, 5 h
156
N NCF3 CF3 N CF3
N CF3
Bpin Bpin
Bpin
pinB
pinB
pinB
+ +
158
159
Conv (%) GC-MS ratio (157:158:159)
     > 90                             42:51:7
157
Scheme 26: Borylation of a 2-substituted quinoline10 
 
Harrisson21 also investigated the borylation of quinoline derivatives. It was found that 
the borylation of 4-Cl-7-CF3 substituted quinoline 160 gives only mono borylated 
product 161 depending on the functional groups on quinoline. Different results were 
found when the chlorine atom at the 4-position was replaced by a methoxy group 162 
(Scheme 27). These results are similar to those produced from the borylation of dtbpy 
22 and 2-chloroisonicotinate 151. 
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[Ir(OMe)(cod)]2 1.5 mol%, 
B2pin2 1.0 eq.
dtbpy 3.0 mol%, MTBE. 
100 oC, 1.5 h
160 161 (76%)
N N
Bpin
Cl
F3C
Cl
F3C
162
N
OMe
F3C
Trace amounts < 15% (GC-MS)
[Ir(OMe)(cod)]2 1.5 mol%, 
B2pin2 1.0 eq.
dtbpy 3.0 mol%, MTBE. 
100 oC, 24 h
 
 
Scheme 27: Borylation of 4,7-di-substituted quinolines21 
 
It was found that 4-borylated products 165 and 166 were observed during the 
borylation of 2,6-di-substituted quinolines 163 and 164 (Table 18). 
[Ir(OMe)(cod)]2 1.5 mol%, 
B2pin2 1.0 eq.
dtbpy 3.0 mol%, MTBE. 
100 oC, µw, 1.5 h
163 (R1= Me, R2= OMe)
164 (R1= Me, R2= Cl)
N N
Bpin
R
1
R
2 R
2
R
1
Prod No         R1, R2                      Yield%
    165           Me, OMe                 76
    166           Me, Cl                     79
 
Table 18: Borylation of 2,6-di-substituted quinoline21 
 
Borylation of 2,7-di-substituted quinolines 167 and 168 gives mixtures of 4 and 5-
borylated products 169 and 170 as observed by GC-MS (Table 19). 
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[Ir(OMe)(cod)]2 1.5 mol%, 
B2pin2 1.0 eq.
dtbpy 3.0 mol%, MTBE. 
100 oC, µw, 1.5 h
167 (R1= Me, R2= OMe)
168 (R1= Me, R2= Cl)
N N
Bpin
R
1 R
1
Prod No         R1, R2                  Conva          Ratioa        Yield%
                                                 %             (A:B)
    169            Me, OMe          > 95          90:10           nd
    170            Me, Cl                 92          65:35           61b
R
2 N R
1
Bpin
R
2
R
2
+
A B
aconversion and ratio determined by GC-MS; bminor isomer isolated in 11% yield  
Table 19: Borylation of a 2,7-di-substituted quinoline21 
 
Iridium C-H borylation of heteroaromatics such as quinolines and pyridines derivatives 
is more complicated than carbocyclic aromatics due to the electronic effects and 
challenges remain for future study. 
 
1.2 Polymer supported catalysis 
Polymer supported catalysis is an important area that has been investigated by many 
chemists. A large number of reviews on solid-supported catalysts have been published 
over the past few years.60-64For example Janda et al. recently reviewed polymer 
supported catalysts which can be used in different organic reactions such as oxidation, 
reduction and transition metal-catalysed reactions.60 The use of polymer supported 
catalysts helps the isolation of product, allows recycling of the expensive catalysts by 
simple filtration, increases the selectivity of the reactions and enables reuse the 
catalysts for further reactions.60,65 These criteria can be achieved by polymer 
supported ligands. This means that the ligands are a main key to achieving the desired 
goal in the polymer supported catalysis. Supported ligands can be prepared by the 
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reaction of a simple functionalized polymer with a derivative of the desired ligand.66 
Ley and co-workers prepared polymer supported perruthenate catalyst 171 which 
could be used to oxidise a primary alcohol 172 to aldehyde 173. This catalyst was 
prepared using tetra-propylammonium perruthenate TPAP with Amberlyst A-26 resin 
(Scheme 28).67 This catalyst showed selectivity for only primary alcohols. 
 
N
OH
10 mol% (171)
O2, toluene, 75 
oC
N
O
173 (> 95%)NMe3
+RuO4
-
172
171  
Scheme 28: Reduction of primary alcohol using 17167 
 
Wilkinson’s catalyst 174 is used for the hydrogenation of alkenes. This catalyst was 
prepared by phosphine bound to polystyrene and complexed to rhodium (I) chloride 
(Figure 12).68 
P
Ph
Ph
Rh(PPh 3)Cl
174  
Figure 12: Wilkinson’s catalyst 17468 
 
Catalyst 174 can be recovered and re-used for 10 cycles without loss in catalytic 
activity. For the reduction of ketones, the catalyst 175 was prepared by adding HBr in 
acetone to a mixture of di-phosphine polymer and Ru(cod)(bis-methallyl) (Figure 
13).60,69 This catalyst showed good activity in the formation of β-hydroxy ester 177 
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from β-keto ester 176 (Scheme 29).60 Additionally, this catalyst showed selectivity for 
the asymmetric hydrogenation of the olefin in amino acid 178 to give amino acid 179 
(Scheme 30).60 
P
P
Ru(bis-methallyl)
H
N
O
3
(Ph)2
(Ph)2
 
Figure 13: Ru(cod)(bis-methallyl) catalyst 17560,69 
 
OMe
O O
(175), H2
THF/MeOH
OMe
OOH
177 (99% yield, 99% ee)176  
Scheme 29: Reduction of β, keto ester using 17560 
 
Ac
H
N
OH (175), H2
THF/MeOH
179 (90% yield, 64% ee)
O
Ac
H
N
OH
O
178  
Scheme 30: Hydrogenation of the olefin in amino acid using 17560 
 
For transition metal catalysts, many different polymers were used in polymer 
supported catalysis. The most common polymer is polystyrene.70 For example, catalyst 
180 was prepared by the reaction of lithium di-phenylphosphide with 
chloromethylpolystyrene. The resulting product was then reacted with a Pd source 
(Figure 14).60 
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P
Ph2
PdL
180  
Figure 14: Polystyrene supported palladium catalyst 18060 
 
This catalyst showed good activity through the coupling of ArOTf 181 with Ar-B(OH)2 
182  to form bi-aryl 183 in Suzuki cross-coupling reactions (Scheme 31).71 
OTf
+
B(OH) 2
Me
Me
183 (90%)
1 mol% (180), dioxane
K3PO4
181 182  
Scheme 31: Suzuki Miyaura cross-coupling using 18071 
 
1.3 Polymer supported iridium catalyst 
Due to its high usage in many catalytic applications, iridium is predicted to become 
unavailable in the near future. One potential solution is to prepare heterogeneous 
catalytic complexes. The big challenge is, if it is possible, to recover and re-use the 
catalyst for further reactions without losing catalytic activity. Furthermore, the 
catalysts may not be air stable and may decompose over time. In the past years, 
different ligands were used to generate the catalytic borylation complex for arenes. 
Among these ligands, 2,2’-bipyridine derivatives were found to be the best class for 
generating the active iridium catalyst in the borylation of arenes.29,47 In 2007 Zhu et al. 
prepared ionic liquid-stabilised iridium complexes for the borylation of arenes.72,73 This 
iridium complex could be re-used six times. However, recovery of the catalytic complex 
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was difficult and the borylated product needed to be isolated by distillation.74 In 2009 
Nishida et al. used 2,2’-bipyridine-4,4’-di-carboxylic acid 184 as a ligand with 
[Ir(cod)Cl]2 37 in presence of B2pin2 for the borylation of benzene 31 (Scheme 32).75 
This borylation led to the generation of a heterogenous iridium catalyst (BPDCA-cat) 
185 which could be recovered and re-used 10 times. Unfortunately, the 
heterogeneous iridium complex was oxidised by air. 
[IrCl(cod)]2 1.2 mmol
B2pin2 8.0 mmol
240 mmol
 2.4 mmol (184), 80 oC, 4 h
N N
OH
O
HO
O
BPDCA
Bpin
+ Insoluble iridium catalyst
BPDCA-cat
32 (33% yield based 
on boron atom of B2pin2)
31
184
185
 
Scheme 32: Preparation of heterogeneous Ir-BPDCA-cat 18575 
 
Sawamura et al. used a silica supported iridium catalyst in the directed-ortho 
borylation of aromatic ester derivatives (Figure 15).41,42,76Although the silica supported 
iridium catalyst 186 showed good activity in the borylation reaction, the isolation of 
the Ir-complex was unsuccessful. This was due to instability of the supported iridium 
complex to air.43  
Si
P
O
Si
O O
Ir OMe
Si
O
O
O SiO2
SiMe3
O
O
 
Figure 15: Silica-SMAP-Ir-Cat 18642 
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In 2014, Jones et al.74 and Copéret et al.77 also prepared a silica supported iridium 
catalyst 187 and 188 (Figure 16). These supported iridium catalysts were generated 
using bipyridine-SBA-15 or bipyridine-PMO as the supported bipyridine ligand with 
[Ir(OMe)(cod)]2 21 and B2pin2. These heterogeneous iridium complexes can be 
recovered and re-used several times with a slight loss in the activity of the catalytic 
borylation. Additionally these catalyst showed good activity in the borylation of arenes 
and had tolerance for a wide variety of electron-withdrawing and electron-donating 
groups. 
Si
O O O
SiMe 3O
Me 3Si
MeO
N
N
Ir
N
N
Si
Si
O O
OSiMe 3
Ir
Ir-SBA-15-cat (187) Ir-PMO-cat (188)  
Figure 16: Silica supported iridium catalysts74,77 
 
Recently Lin et al.78 were prepared a range of MOF-Ir complexes for the borylation of 
arenes. These MOF-Ir complexes showed good activity in the borylation of arenes. It 
was found that with a loading of 0.5 mol% of MOF-Ir the catalyst could be recovered 
and re-used 10 times. Indole 189 can be borylated using mPT-MOF-Ir 190 in the 
presence of boron source such as B2pin2 to afford the 2-borylated product 191 
(Scheme 33). 
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N
H
 0.1 mol% (190)
B2pin2 0.508 mmol,
heptane, 115 oC, 11 h
1.02 mmol
N
H
Bpin
(191) 94%
189
 
NO2
N
N
Ir
mPT-MOF  
Scheme 33: Borylation of indole using mPT-MOF 19078 
 
1.4 In conclusion 
Ir‐catalysed C‐H borylation is a powerful strategy for arene functionalization. Ligands 
play a big role in the success of the borylation reactions. Many different ligands were 
used in the borylation of arenes, and bipyridine and tmphen ligands were found to be 
optimal with an Ir-catalyst to generate the active catalyatic species Ir(Bpin)3 ligand. 
These ligands were used in the borylation of specific substrates, however the design of 
ligands affording high regioselectivity in the borylation reaction remains a significant 
challenge.  
Polymer supported catalysts can be applied to many different reactions in organic 
chemistry. For example silica supported iridium catalysts 187 and 188 showed good 
activity in the borylation of arenes, enabling recovery and re-use for further borylation 
reactions by simple filtration. Bipyridines and tmphen were found to be the most 
active class of ligands in this process, allowing easy attachement to a polymer. 
45 
 
Preparation of ligands with suitable linkers remains a challenge in this area, which shall 
be discussed in chapters 3 and 5. 
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1.5 Aims and Objectives 
 
As discussed in Chapter 1, arylboronate esters have many applications in modern 
chemistry and CH borylation is arguably the best way to prepare these important 
reagents. The work undertaken in this thesis is comprised of three discrete areas both 
enhancing the efficiency of the borylation reaction and applying it to new heterocyclic 
systems and synthesis. Quinoline derivatives have been widely exploited as novel 
herbicides (Figure 17)79 and in a different biological project within the group, access to 
a series of 4,5 dihydroxy quinolones was required. It was anticipated that these could 
be obtained via borylation and oxidation (Chapter 2, Section 2.1, Figure 18). Previous 
studies within our group had addressed the borylation of 2,7- and 4,7-substituted 
quinolines (Chapter 1, Section 1.1.8, Table 19, Scheme 27) and the selectivity was 
found to be influenced by electronic effects. It was therefore of interest to prepare 2-
aryl quinoline and quinolone derivatives and borylated highly substituted 2-
arylquinoline derivatives to explore the selectivity of this borylation as a means of 
accessing the desired substituted quinolones. This work is discussed in detail in 
Chapter 2. 
NCl
Cl
COOH
NCl
COOH
QuinmeracQuinclorac  
Figure 17: Quinoline derivatives as novel herbicides79 
 
In a related project in the group the regiochemistry of the borylation of pyridines had 
been explored and it had been shown that this required a substituent in the 2 position. 
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If this group was sufficiently electron-withdrawing then it was possible to observe the 
6-boryl pyridine. Since pyridines represent a fundamental scaffold for pharmaceuticals 
and agrochemicals efficient ways to synthesise highly substituted derivatives are an 
important synthetic goal. By using suitably 2-halo-4-substituted pyridines, it was 
proposed that a borylation cross-coupling-SNAr strategy (Section 4.1, Figure 29) could 
be used in the preparation of 2,4,6-substituted pyridine derivatives. The chemistry 
undertaken to explore this concept is described in chapter 4. 
The final aim of this project was to explore the preparation of a polymer supported 
iridium catalyst. Whilst C-H borylation is probably the optimal method for the synthesis 
of aryl boronate esters the cost of iridium is problematic. Moreover, iridium resources 
are finite and are likely to run out in the future. The preparation of heterogeneous 
iridium catalysts could help to overcome this problem as the catalyst could then be 
recovered by simple filtration and then re-used for further reactions. In order to 
achieve this a suitable ligand, which could be attached to a polymer via a linker and 
then used to immobilize the iridium catalyst needs to be identified. It was envisaged 
that existing bipyridine and 1,10-phenanthroline ligands could be modified to 
incorporate a suitable linker. These could then be evaluated and compared to the 
commercially available equivalent homogeneous ligands for catalytic efficiency and 
recoverability. This work is described in Chapter 3 and 5. 
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Chapter 2 
2 Borylation of quinolines 
2.1 Introduction  
In previous work carried out within the group the borylation of 2-methylpyridine had 
been shown to occur exclusively in the heteroaromatic ring (Section 1.1.8, Scheme 
21).  In a related study the selectivity of the borylation of several azinyl derivatives had 
been studied.80 In particular the borylation of quinoline derivatives had provided 
insights into an electronic influence on selectivity (Section 1.1.8, Table 19). As means 
of gaining experience in borylation methodology an initial goal of the project was to 
prepare 2-arylquinoline derivatives and explore the selectivity of the borylation of 
these compounds. In particular 2-arylquinolone product 193 was of interest within the 
group as precursors for novel herbicides81 and the synthesis of this represented a 
second objective in this project. It was anticipated that this might arise from the 
regioselective borylation of quinolone 192B, which in turn might be prepared via the 
borylation of a 2 –aryl quinoline at C-4 (Figure 18). 
N
OMe
OMeMeO
O
R N
OMe
BpinMeO
O
R
HN
OMe
MeO
O
N
OMe
MeO
Bpin
N
OMe
MeO
2
4
193
192B
 
Figure 18: Retrosynthetic analysis of the desired 2-aryl-quinolone  
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2.1.1 Borylation of 2-arylquinoline derivatives 
2.1.1.1 Borylation of 2-phenylquinoline 
Initial experiments were undertaken using 2-phenylquinoline 194 (Scheme 34) to 
explore the intrinsic regioselectivity of the reaction. 194 was borylated using the 
catalytic species 88A prepared in situ from the reaction of [Ir(OMe)(cod)]2 21, dtbpy 22 
and B2pin2. 
N Ph
dtbpy
N Ph
Bpin
194 195
[Ir(OMe)(cod)]2,  B2pin2
 
Scheme 34: Borylation of 2-phenylquinoline derivatives 
 
Following the addition of all of the reagents, the reaction mixture was heated at 60 oC 
in a µW for 75 min. This afforded a complex mixture of mono- and bis-borylated 
products 195 with a small amount of unreacted starting material, 12% according to 
GC-MS trace (Scheme 35). More detailed analysis was achieved by GC-MS integrating 
the M+ peaks at Rt = 26.0-26.8 min; 31.7-36.9 min with m/z = 331 ([MH]+) and 457 
([MH]+), respectively. This indicated that the crude mixture contained 5 mono and 6 
bis-borylated products in a 57 % (19:6:15:12:5): 31% (5:5:6:10:3:2) ratio. 
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N
dtbpy 3.0 mol%, MTBE, 
60 oC 75 min
N
Bpin
Bpin
           conv (%) GC-MS   (mono):(bis)
                    
                         88               57:31
194
195
[Ir(OMe)(cod)]2 1.5 mol%, 
B2pin2 1.0 eq.,
 
Scheme 35: Borylation of 2-phenylquinoline 
 
Attempts to enhance the selectivity by carrying out the reaction at room temperature 
for 21 h were not successful and gave a similar result. This level of borylation implied 
that in contrast to 2-methylquinoline 137, reaction at the phenyl substituent must be 
occurring. To prevent this unwanted reaction the introduction of substituents in the 
phenyl ring was proposed. With this in mind the immediate objective of the project 
was the synthesis of suitable 2-arylquinolines and this is discussed in the next section. 
 
2.1.2 Synthesis of 2-(aryl-substitution)-quinolines derivatives 
As discussed above a route to 2-arylquinolines was needed. A survey of the literature 
revealed a recent report by Baran82 in which quinoline 111 could be substituted at the 
2-position using arylboronic acid 182 in presence of AgNO3, K2S2O8 and TFA (Scheme 
36). Importantly quinolines appeared to be viable in this transformation. This approach 
would allow a range of different 2-arylquinolines to be easily prepared and was 
therefore selected for exploration. 
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N
Me B(OH) 2+
1:1 H2O:MeOH, 
25 oC, 3-12 h
AgNO3/ K2S2O8, TFA
N
N
Me
Me
+
111 182
196
197
61% (C2:C4 2:1)
Scheme 36: Baran’s preparation of 196 and 19782 
 
Following the Baran precedent, a mixture of quinoline 111, 3,5-di-
methylphenylboronic acid 198, AgNO3 and K2S2O8 in TFA were stirred at 25 oC for 12 h 
(Scheme 37). After work up, analysis of the crude reaction mixture by GC-MS revealed 
the presence of a mixture of two mono substituted quinolines 199 and 200, as 
revealed by the presence of peaks with Rt = 11.1 and 12.0 min both with m/z = 233 
([MH]+). Following chromatography, the desired 2- and 4-arylquinoline derivatives (199 
and 200, respectively) could be isolated with yields of 34% and 39% respectively. 
Confirmation of the proposed structures was obtained from the 1 H NMR spectra. 
Compound 199 shows characteristic methyl signals for the xylyl group at δ = 2.5 and 
lacks a characteristic quinoline 2-H signal at δ = 8.9 ppm whereas compound 200 still 
has a signal for the 2-H at  = 8.9. For compound 200, substitution at C-4 was 
confirmed by a NOESY correlation between 2’-H and 5-H. 
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N
B(OH) 2+
1:1 H2O:MeOH, 
25 oC, 3-12 h
AgNO3/ K2S2O8, TFA
N
N
+
111 198 199 (34%) 200 (39%)
H
H
2
4
2'
5
Scheme 37: Preparation of 199 and 200 
 
The poor selectivity of the reaction coupled with the difficult column chromatography 
made this process an inefficient method for the preparation of the target compound. 
Consequently an alternative pathway was sought. A survey of the literature revealed 
that the 2-arylquinoline 202 can also be formed from the corresponding 2-
bromoquinoline 201 using Pd(PPh3)4 through the Suzuki-Miyaura cross-coupling 
reaction (Scheme 38).83 
N N
201 202 (84%)
Br
Br Br OMe
MeO B(OH) 2+
Pd(PPh3)4, Na2CO3
toluene:H2O:EtOH, 
reflux 24 h
5
Scheme 38: Preparation of a 2-arylquinoline derivatives83 
 
The conditions above were first tested using 2-chloroquinoline 203, Ar-B(OH)2 198, and 
PdCl2(dppf)2 (Scheme 39). This led to the desired product 199 along with 2-
ethoxyquinoline 204 as observed by GC-MS analysis. Formation of product 204 might 
be due to the ethanol in the reaction mixture. Although this method gave complete 
conversion, purification by column chromatography was very difficult and the desired 
product 199 could not be isolated.  
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N N
203
199
Cl
B(OH) 2+
PdCl2(dppf)2, K2CO3
toluene:H2O:EtOH, 
reflux 19 h
198
N OEt
204
+
Scheme 39: Preparation of 2-(3,5-di-methylphenyl)-quinoline 
 
To avoid this problem the reaction was then attempted using a toluene-water solvent 
mixture.84 Pleasingly, under these conditions, reaction of 203 with 5 and 198 afforded 
the desired 2-aryl quinolines 199 and 205 in 69-85% yields respectively (Table 20). 
N N
203
Cl
+
Pd(PPh3)4 (x) mol%
(2M) K2CO3, toluene,
160 oC, MW
5, 198
Comp No          Ar               Pd mol%      reaction time (s)           Rt min: (m/z)a                Yield%
   199                                         10                   10                     12.0: (233 [MH]+)                  69
   205                                          5                     60                    12.7: (235 [MH]+)                  85OMe
aRt and mass determined by GC-MS
Ar-B(OH) 2
R
H
H
3
2'
 
Table 20: Preparation of 2-aryl-quinoline derivatives 
 
These products 199 and 205 were confirmed by GC-MS analysis (Table 20). 
Furthermore, the 1H NMR spectrum contained a singlet at δ = 2.5 and 3.3 for the two 
CH3 and OCH3, respectively. For these compounds, substitution at C-2 was confirmed 
by a NOESY correlation between 2’-H and 3-H. 
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 2.1.3 The borylation of 2-(4-methoxyphenyl)-quinoline 
With the 2-arylquinolines available attention turned to their borylation. Surprisingly 
following the conditions described above (Section 2.1.1.1) led only to limited 
conversion of 205 (27% conversion after 120 min). Since this reaction gave low 
conversion of starting material to borylated compounds, the temperature and time of 
subsequent reactions was varied (Table 21). Ultimately heating the reaction at 100 oC 
for 4 h afford ≥ 95% conversion (entry 3). More detailed analysis of the crude reaction 
mixture by GC-MS using the M+ peaks at Rt = 28.3-29.2 min with m/z = 361 ([MH]+); 
and Rt = 37.5 and 43.0 min with m/z = 487 ([MH]+) suggested that this contained 3 
mono-and 2 bis-borylated products 206. 
N N
205 206
entry No         T           Time             conva            ratio (mono):(bis)a
                      oC             h                  %
                                                                                    
    1                 60            2                 27                       (9:7:11):----
    2                 80            15               90                   (12:17:17):(19:25)
    3                100            4                95                   (17:17:15):(18:28)
aconversion and ratio determined by GC-MS
OMe
[Ir(OMe)(cod)]2 1.5 mol%
B2pin2 1.0 eq.,
dtbpy 3.0 mol%, THF
OMe
Bpin
Bpin
 
Table 21: Borylation of 2-(4-methoxyphenyl)-quinoline 
 
Unfortunately it was not possible to separate these products by silica gel 
chromatography. Additionally determination of these isomers was difficult by NMR 
spectrum analysis. In conclusion, whilst good conversion could be achieved through 
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raising the reaction temperature from 60 oC to 100 oC this also led to the formation of 
additional bis-borylated products. Whilst the introduction of further substituents e.g 2-
aryl-7-methoxyquinoline would provide greater steric control over the second 
borylation at the 6- and 8-positions of quinoline it was deemed more efficient to 
explore alternative routes towards the desired quinolones 193. 
 
2.1.4 Preparation of 2-(aryl)-4-chloro-5-methoxy and 5,7-di-
methoxyquinoline derivatives 
Through retrosynthetic analysis of the desired product 193, it was proposed that these 
products could be prepared through the selective Suzuki cross-coupling of 2-chloro 4-
alkoxyquinoline 207 at the 2-position with an arylboronic acid. In turn 2,4-di-
chloroquinoline can be obtained from the reaction of quinoline-2,4-dione with POCl3 
(Figure 19). 
NH2
OMeR
+
HO
HO
O
O
R= H, OMe 213, 214 211, 212 209, 210 208
N
Ar
OMe
Cl
R N
Cl
OMe
Cl
R NH
O
OMe
HO
R
 
Figure 19: Retrosynthetic analysis of the desired quinoline 
 
2.1.4.1 Quinoline 2, 4-dione derivatives 
A review of the literature revealed that quinoline-2,4-dione 216 has been prepared by 
the reaction of 3,4-di-methoxyaniline 215 with malonic acid 208 in the presence of 
POCl3 (Scheme 40).85 
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MeO
MeO N
H
MeO
MeO
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+ HO OH
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O
50-90 oC, 2.5 h
POCl3
215 208
216 (79%)
Scheme 40: Preparation of quinoline 2, 4-dione derivatives85 
 
Following this precedent, quinoline-2,4-dione 211 was prepared  by heating malonic 
acid 208 with aniline 209  to afford, following trituration with ethanol, the desired 
quinolone 211 in 43% yield (Scheme 41). 
R N
H
MeO
+ HO OH
OO
OH
O
50-90 oC, 2.5 h
POCl3
209 (R= H)
210 (R= OMe)
208 211 (R= H, 43%)
212 (R= OCH3, 49%)
NH2
OMe
R
6
8
H
H
1
 
Scheme 41: Preparation of quinoline 2, 4-dione derivatives 
 
Confirmation of this product was obtained from analysis of the 1H NMR spectrum 
which contained two broad peaks with high chemical shifts δ = 11.1 and 11.0 
corresponding to the OH and NH signals, coupled with a characteristic methoxy signal 
at δ = 3.8. Further evidence for the quinolone tautomer was provide by a C=O stretch 
in the IR spectrum at 1626 cm-1. In a similar fashion di-methoxy analogue 212 could be 
prepared in 49% yield. The relatively low yield of these reactions may be due to the 
low solubility of the reactants in the reaction medium POCl3. Increasing the volume of 
POCl3 used led to the production of a mixture of mono chloroquinoline (217, 218), di-
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chloroquinoline 214 and quinoline 2,4-dione 212 as observed by LC-MS analysis (Figure 
20).  
 
N
H
OMe
MeO
OH
O N
OMe
MeO
OH
ClN
OMe
MeO
Cl
OH
N
OMe
MeO
Cl
Cl
212 218217 214
Figure 20: Mixtures of mono-chloro and di-chloroquinoline and quinoline-2,4-dione 
 
With products 211 and 212 in hand, the next step was the methylation of the OH 
group to form 4,7-di-methoxyquinoline-2-one 219 and subsequent chlorination 207 to 
enable a selective Suzuki-Miyaura cross coupling at C-2 220 (Scheme 42). 
 
N
H
OH
O
MeI, NaH
DMF, 100 oC
R N
H
OMe
OR
POCl3
N
OMe
ClR
Ar-B(OH)2
N
OMe
ArR
211 (R = OMe) 219 207 220
Scheme 42: Methylation of quinoline 2,4-dione 
A review of the literature86 revealed that the reaction of 6-chloro-4-hydroxy-3-propyl-2 
(1H)-quinoline 221 and bromomethylcyclopropane 222 resulted in selective o-
alkylation 223 (Scheme 43). 
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H
Cl
OH
O
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+
NaH
DMF, 100 oC,
N
H
Cl
O
O
223 (30%)221 222
Scheme 43: The alkylation of quinoline-2,4-dione86 
 
Following this precedent, the substrate 211 and methyl iodide 224 were heated in 
DMF at 100 oC for 2 h (Scheme 44). 
N
H
OH
O
MeI+
NaH
DMF, 100 oC
N
O
O
225 (7%)211 224
MeO MeO N
H
O
OMeO
+
226 (35%)
1
33
1 1
Scheme 44: Methylation of quinoline 2,4-dione 
 
However, following chromatography, two isomeric quinolones 225 and 226 were 
isolated in a yield of 7% and 35%, respectively. Confirmation of these products were 
obtained by GC-MS, which showed peaks with Rt = 19.9 and 20.5 at m/z = 233 ([M]+) 
and m/z = 219 ([M]+) for products 225 and 226 respectively. In addition, further 
evidence to support the proposed structure was obtained from the 1H NMR spectrum. 
Both compounds 225 and 226 show characteristic signals at  = 1.5 for the methyl 
groups at C-3 whilst the lack of the characteristic OH, and 3-H signals at = 11.1 and 5.6 
was consistent with a loss of the keto-enol functional group. With this disappointing 
result, synthesise of 2,4-di-chloroquinoline 213 was carried out to test the extent to 
which a regioselective Suzuki-Miyaura cross coupling could be achieved. 
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2.1.4.2 2, 4-Di-chloroquinoline derivatives 
A survey of recent methods87 revealed that di-chloroquinoline 228 could be prepared 
by heating 2,4-dihydroxy-7-(di-methylamino)quinolone 227 with POCl3 (Scheme 45). 
Since these hydroxyquinolones were the initial product formed in the reactions 
discussed above it was speculated that longer reaction times with excess of POCl3 
would provide the desired di-chloroquinoline. 
 
N
OH
OH
POCl3
heating
227
Me2N
N
Cl
Cl
228
Me2N
 
Scheme 45: Preparation of di-chloroquinoline 
 
Consistent with this idea, heating quinolone 211 in POCl3 following quenching and 
neutralizing of the crude mixture, afforded the desired quinoline 213 in a very good 
yield of 95% (Table 22). Confirmation of this product was obtained by GC-MS analysis 
which showed the correct isotopic ratio 1:6:9 of di-chlorine. Furthermore, the 1H NMR 
spectrum showed a characteristic 3-H signal in the de-shielded region at  = 7.4 and 
lacked the characteristic OH and NH signals at  = 11.1 and 11.0, respectively. In a 
similar fashion the di-methoxy analogue 214 was prepared in 71% yield. 
60 
 
N
H
MeO
OH
O
POCl3
heating
N
R
MeO
Cl
Cl
Comp No       R       T            R. time           Yield%
                             oC                 h  
      213         H        105              1                  95
                                                                                                                                                        
      214       OMe    50-105          2                  71a
NH2
OMeMeO
+
HO
HO
O
O
or
a: A yield over two steps
210 208 211 213, 214
 
Table 22: Preparation of di-chloroquinoline derivatives 
 
With these products in hand, synthesis of 2-arylquinoline was undertaken. Initially a 
SNAr strategy was explored. As such, 4-methoxy phenyl lithium 229 was prepared by 
the addition of nBuLi to arylbromide 1 at -78 oC (Figure 21, EQ 1). This reaction mixture 
was then added to the substrate 213 in THF at -78 oC for 1 h (Figure 21, EQ 2). 
Unfortunately, the reaction returned unreacted starting material along with 
undesirable products 231 and 232 as indicated by GC-MS analysis (Scheme 46). 
MeO Br
BuLi
THF, -78 oC
MeO Li
2291
(EQ 1)
NMeO Cl
Cl
+ 229
THF
-78 oC
NMeO
Cl
OMe
(EQ 2)
213 230  
Figure 21: EQ 1 & EQ 2: Preparation of 2-(aryl-substitution)-quinoline using alkyl 
lithium 
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MeO Br
BuLi
THF, -78 oC
1
MeO Bu
231
Bu-Bu++
232
35
 
Scheme 46: The undesirable products 231 and 232 through adding BuLi 
 
Consequently an alternative pathway based on Suzuki-Miyaura cross coupling was 
investigated. Following the procedure developed (Section 2.1.2, Table 20), reaction of 
di-chloroquinoline 213 and 214 with arylboronic acid 5 and 198 at 100 oC in the 
presence of Pd(PPh3)4 afforded the desired aryl quinolines 230, 233 and 234 in 32-75% 
yields (Table 23).  
NMeO
Cl
Cl
+ Ar-B(OH) 2
2M K2CO3, toluene
100 oC, MW
Pd(PPh3)4 5 mol%
NMeO
Cl
NMeO
+
213 (R= H), 214 (R= OMe)
H
H
2'
3
entryNo       Ar             time    Ar-B(OH)2 eq.     R      Pro. No     conv
a    ratio (A:B)a                  A : B  yield%
                                      h                                              A:B             %     
 1                                 2.5             1.5                  H       230:---        100           (89:11)                    75:----
 
 2                                1/2             1.0                  H       233:---          100           (99:01)                     60:-----
 
 3                                 1               1.15               OMe   234:235         100           (83:17)                    32:9
R
OMe
R
OMe
A (230, 233, 234) B (235)
R R
H
H
H
2
'
3
2"
R
aConversion was determined by GC-MS
Table 23: Preparation of 2-(4-methoxy and 3,5-di-methylphenyl)-quinoline 
derivatives 
 
Confirmations of these products were obtained by GC-MS, which indicated that the 
isotopic ratio of the fragmentations changed from 1:6:9 to 1:3 indicating loss of a 
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chlorine atom. For both analogues substitution at C-2 was confirmed by a NOESY 
correlation between 2’-H and 3-H. whilst for product 235 confirmations of substitution 
at C-4 was revealed by correlations between 2”-H and 3-H (Table 23).  
 
2.1.5 The borylation of 2-(4-methoxyphenyl)-4-chloro-7-
methoxyquinoline 
With compounds 230 and 233 available, the next task was to study the borylation 
reaction with the hope that the combination of substituents at the 4’-, 4- and 7-
positions would direct borylation to C-5. However this proved not to be the case and 
afforded a complex mixture of mono-borylated products with unreacted starting 
material (Table 24). More detailed analysis by GC-MS integrating the M+ peaks at Rt = 
32.9 and 32.3 min both with m/z = 425 ([M (35Cl)]+, indicated that the crude mixture 
contained 2 mono-borylated products 236 and 237. Such borylation ortho to a 
methoxy group is not unprecedented. It has been observed through the borylation of 
4,4’-di-methoxy-2,2’-bipyridine.88   
N
R
dtbpy 2(xx) mol%, THF
N
R
entry No   Ir mol%    B2pin2 (eq.)    T      Time         conv
a      ratio (236):(237)a           ratio (236):(237)b
                                                        oC       (h)            (%)             
    1            1.5              1.0             100      1               60            (6.5:1.0)                             ---------------
    2            2.5               2               100      1               73            (5.4:1.0)                              5.9:1.0:----                      
           
    3            5.0               2               100       2              74            (7.2:1.0)                              ----------------
R
Cl
N
R
[Ir(OMe)(cod)]2 xx mol%,
B2pin2 xx eq.,
Cl
Cl
Bpin
R
R
+
236 237230 (R = OMe)
aconversion and ratio determined by GC-MS; bratio determined by 1H NMR
pinB
Table 24: Borylation of 2-(4-methoxyphenyl)-4-chloro-7-methoxyquinoline 
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In order to enhance the percentage conversion, the loading of both catalyst and 
diboron reagent were increased (entry 2 and 3). Whilst modest enhancements in the 
selectivity could be obtained it was not possible to achieve a completely selective 
reaction under these conditions. However, even with increased catalyst loading and 
temperature the borylation of 2,4-di-chloro-7-methoxyquinoline 213 showed no 
conversion by GC-MS. The regiochemistry for each adduct 236 and 237 was 
ascertained by analysis of the 1H NMR spectrum which showed five characteristic 
proton signals for product 236 and seven characteristic proton signals for product 237. 
Significantly the alpha boryl hydrogen at 5-H and 2’-H showed a distinctive shift to 
higher frequencies, δ = 8.5 and 8.4 for 236 and 237, respectively.  
 
2.1.6 Preparation of N-methyl-2-(4-methoxyphenyl)-7-
methoxyquinoline-4-one 
Since the borylation reaction was not giving the desired regiochemistry; in order to 
complete the synthesis of quinolone 238, the selective hydrolysis of the 4-
chloroquinoline 230 was explored.  
NCl
Cl
NCl
OH
141 239 (88.5%)
CH3COOH glacial
125 oC, 1 h
H
+     (CH3CO)2O
 
Scheme 47: Preparation of 7-chloro-4-hydroxyquinoline hydrochloride 
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Based on literature precedent89 for this transformation 239 (Scheme 47), 4-chloro-
quinoline derivatives 230 were heated with glacial acetic acid at 125 oC for 1 h and 
then the mixture adjusted with 3M NaOH to pH = 8-9 (entry 1, Table 25). 
NH3CO
Cl
Ar
CH3COOH glacial
125 C, 1 h
NH3CO
OH
Ar
N
H
H3CO
O
H
H
entry No         Ar                R          prod.No           Yield%
                                                                       
1                                        H            192B                 45
                                                                                                  
 
2                                        H            240B                 37
                                                                                                 
3                                        OMe       241A                 45
R
OMe
241A 192B, 240B
R
R
R
OMe
230, 233, 234
2'
8
 
Table 25: Preparation of 2-aryl-7-methoxy and 5,7-di-methoxyquinoline-4-one 
derivatives 
Following trituration of the crude mixture, the desired product 192B was isolated in 
yield of 45%. Confirmation of this product was obtained by LC-MS which indicated a 
lack of the isotopic ratio for a chlorine atom. Additionally, the 1H NMR spectrum 
indicated a characteristic NH signal at δ = 11.4 showing a NOESY correlations between 
(2’-H and 8-H with NH). Further evidence for the quinolone tautomer was provide by a 
C=O stretch in the IR spectrum at 1626 cm-1. In a similar fashion quinolones analogue 
240B and 241A could be prepared in 37% and 45% yields respectively (Table 25). 
Having successfully established a route to the desired quinolone the final objective was 
to develop methodology for N-alkyltion of 192B. As discussed in section 2.1.4.1, similar 
compounds have been previously prepared. Following similar protocols 192B and MeI 
224 were heated at 100 oC for 2 h (Scheme 48). In the crude mixture, GC-MS analysis 
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showed two peaks at Rt = 27.2 and 30.9 min both with molecular ion at m/z = 295 
([M]+) with a 1:1 ratio of 242:238, indicating that the crude mixture contained 2 mono 
methylated products presumably 242 and 238.  
N
H
R
DMF, 100 oC, 2 h
N
R
R
O
N
R
OMe O
RR
+
242 (20%) 238
192B (R = OMe)
MeI, NaH
Me
H3
4
Scheme 48: Methylation of OH group 
 
However, following chromatography, only the undesired quinoline 242 could be 
isolated in a yield of 20%. The hypothetical N-methylated product 238 could not be 
detected. Confirmation of product 242 was obtained by GC-MS analysis. Additionally, 
the 1H NMR spectrum showed the characteristic methyl signal of the methoxy group at 
4-position at δ = 3.9, and lacked the characteristic NH signal at δ = 11.4 that appeared 
in compound 192B. Finally this compound substitution at C-4 was confirmed by a 
NOESY correlation between 4-OCH3 and 3-H (Scheme 48). 
 
2.17 Summary and Conclusions 
In this work 2-aryl quinoline derivatives were prepared using two strategies Baran’s 
and Suzuki-Miyaura coupling protocols. Borylation of 2-(4’-methoxyphenyl)-quinoline 
205 gave a complex mixture of mono- and bis-borylated products. In order to minimise 
the number of different borylated products, highly substituted 2-arylquinoline 
derivatives were successfully prepared starting from 3-methoxy and 3,5-dimethoxy 
aniline derivatives and malonic acid. The resulting 2,4-dichloro-quinoline derivatives 
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were then coupled with aryl halides in a Suzuki-Miyaura reaction. The borylation of 
highly substituted quinoline 230 unexpectedly afforded the two mono-borylated 
products at the 6- and 3’-position. This result was consistent with the borylation of 
4,4’-di-methoxy-2,2’-bipyridine 69. Methylation of quinolone 192B did not afford the 
desired N-alkylation product 238. Disappointingly, 2,4-dichloro-7-methoxy quinolone 
213 proved to be resistant to Ir(dtbpy)(Bpin)3 88A catalyst borylation (Section 1.1.5, 
Figure 8).  
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Chapter 3 
3 Preparation and evaluation of 4,4’-di-substituted-2,2’-bipyridine 
derivatives  
3.1 Introduction 
A major goal of the project was to synthesise a polymer supported iridium catalyst for 
the borylation of aromatic and heteroaromatic compounds, which could be recovered 
using simple filtration and then re-used for further reactions (Figure 22). As dtbpy 22 is 
a common ligand choice for borylation reactions, the aim of this work was to prepare 
model bipyridine derivatives bearing electron-donating groups at the 4- and 4’-
position, which are suitable for coupling to a polymer support (Figure 23). In addition 
to enhancing reactivity it was interesting to also test the selectivity of each new ligand 
in the borylation of non-symmetrical substrates and compare it to that obtained with 
dtbpy 22.  
N
N
Ir
Bpin
Bpin
Bpin
R
R= electron-donating  
Figure 22: Polymer supported iridium catalyst 
N
N
R
1
R
24
4'
R
1
, R
2 
= electron-donating groups  
Figure 23: 4,4’-di-substituted-2,2’-bipyridine derivatives 
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3.1.1 Preparation of 4,4’-di-substituted-2,2’-bipyridine derivatives 
As discussed above an efficient route to unsymmetrical bipyridine derivatives was 
needed. Initial studies focused on the simple addition of a α-pyridyl organometallic to 
a C-2 substituted pyridine. Precedents for this approach can be found in a report by 
Gros et al.90 (Table 26). In this work, the reaction of 2-methoxypyridine 243 with BuLi-
LiDMAE afforded the lithiated pyridine, which could then be combined with a range of 
heteroaromatic compounds to afford new bipyridine derivatives 244-246 in reasonable 
yields. 
 
N N HetArMeO
1) BuLi-LiDMAE (4 eq.)
 hexane, 0 oC
2) HetArH-THF
    0 oC to r.t
MeO
Comp No        HetAr                   Products                Yield %
     244                                                                           64
     245                                                                           60
     246                                                                           58
N
N OMe
N
N
N N
OMe
N N
OMeMeO
N N
N
MeO
243
 
Table 26: Coupling of pyridine with heteroaromatic compounds90 
 
Following this example, DMAP 247 was metallated, using n-BuLi-LiDMAE (2.0 eq) at -5 
oC to give the lithiated pyridine complex 248 as a red solution. Then 4-tert-
butylpyridine 249 (1.2 eq) in toluene was added and the mixture heated at 88 oC for 22 
h (Scheme 49). GC-MS analysis of the reaction mixture revealed that the formation of 
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two products, corresponding to the desired product 250 (m/z = 255) and dtbpy 22 (m/z 
= 268).  
N
N
BuLi-LiDMAE (2.0 eq.)
-5 oC N
N
Li
Li
ON
N
N
N
N
N
N
+
247 248 250 22
toluene, 88 oC
Scheme 49: Addition of 2-lithiated-DMAP 248 to 4-tert-butylpyridine 249 
 
The formation of dtbpy 22 suggested that the proton transfer between the pyridines is 
faster than nucleophilic attack. Attempts to increase the selectivity to form the 
bipyridine 250, by either slow addition of the anion 248 to tert-butylpyridine 249, or by 
forming the anion of tert-butylpyridine 251 first and adding DMAP 247, were not 
successful (Scheme 50).  
N
+
N
N
Toluene
88 oC
Li
Li
ON
N
N
N N
N
+
251 247 250 22
Scheme 50: Addition of 2-lithiated-4-tert-butylpyridine 251 to DMAP 247 
 
With the idea that introducing a better leaving group would enhance the substitution 
reaction, the use of 2-bromopyridine 252 (the synthesis of which is discussed in 
section 3.1.3.1) as the electrophile was explored. Disappointingly initial experiments 
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using lithiated DMAP 248 as the nucleophile were not successful giving only low 
conversion as determined by GC-MS analysis (Scheme 51).  
N
+
N
N
Toluene
88 oC
Li
Li
ON
N
N
N N
N
+
248 252 250 22
Br
N
N
N
N
70  
Scheme 51: Addition of 2-lithiated-DMAP 248 to 2-bromo-4-tert-butylpyridine 252 
 
Given these selectivities as well as the difficulties in separating the desired product by 
chromatography it was decided to explore alternative routes to bipyridines using 
transition metal coupling reaction.91 The first coupling reaction to be investigated was 
the Hiyama cross-coupling reaction. This will be discussed in the next section. 
 
3.1.2 Preparation of 4,4’-substituted-2,2’-bipyridine derivatives via the 
Hiyama cross-coupling reaction 
A literature search revealed that similar compounds have been prepared by coupling 
of 2-bromopyridine 253 and 4-chloro-2-tri-methylsilylpyridine 254 using PdCl2(PPh3)2 
as the catalyst in presence of TBAF and CuI as an activating agent to afford the desired 
bipyridine product 255 in 90% yield (Scheme 52).92 
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N
Cl
SiMe 3
+
N Br
PdCl2(PPh3)2  5 mol%
PPh3 10 mol%, TBAF (2 eq.)
CuI (1 eq.)
DMF, r.t, 12 h
N
N
Cl
 255 (90%)
254 253
 
Scheme 52: Hiyama cross-coupling reactions92 
 
Following this precedent for the synthesis of 4’-(di-methylamino)-4-tert-butyl-2,2’-
bipyridine 250, 2-(tri-methylsilyl)-4-tert-butylpyridine 256 and 2-bromo-4-di-
methylaminopyridine 257 were required (Figure 24). 
N
N
N
N SiMe 3
+
N
N
Br
Pd
256 257250  
Figure 24: Retrosynthetic analysis of 4’-di-methylamino-4-tert-butyl-2,2’-bipyridine 
250 
3.1.2.1 Preparation of 2-(tri-methylsilyl)-4-substituted pyridine 
Fort et al.93 have shown that similar compounds have been prepared through lithiation 
of 4-chloropyridine 258 using BuLi-LiDMAE (Scheme 53). 
N
Cl
2) Electrophile (5 eq.), THF
    -78 oC, 1.5 h
1) n-BuLi-LiDMAE (4 eq.)
N
Cl
SiMe 3
254 (85%)
258
 
Scheme 53: Preparation of 4-chloro-2-tri-methylsilyl pyridine 25493 
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Following this precedent, a 99% conversion of 4-chloropyridine 258 with a ratio of 91:8 
(254:259) was obtained (Scheme 54). Analysis of the crude reaction mixture by LC-MS 
revealed the presence of a mixture of mono and di-substituted pyridine, with peaks at 
Rt = 2.4 and 3.7 min with m/z = 188 ([MH (28Si, 37Cl)]+ and 258 ([MH (28Si, 28Si, 35Cl)]+) 
respectively. Following purification by chromatography, the desired silyl product 254 
was obtained in 44% yield. 
N
Cl
1) n-BuLi-LiDMAE (2 eq.)
2) Electrophile (2.5 eq.), hexane,
-78 C, 1.5 h N
Cl
Si
+
N
Cl
                         LC-MS Conv (%)  ratio  (254  :  259)       (254) Yield%
 
                                   99                        91  :  8.0                44
254 259
2
34
CH3
H
258
TMS
TMS
 
Scheme 54: Preparation of 4-chloro-2-tri-methylsilylpyridine 254 
 
Confirmation of the proposed structure was obtained from a NOESY spectrum, which 
showed a correlation between the SiCH3 (=0.6 ppm) and the 3-H signal (=7.82).  
 
3.1.2.2 Preparation of 4-chloro-2,2’-bipyridine92  
With silyl pyridine 254 in hand, cross coupling with 2-bromopyridine 253 was explored 
(Scheme 55). LC-MS analysis of the reaction mixture revealed that complete 
conversion of starting material had occurred, which resulted in the formation of two 
products with a ratio of 84:16, the desired product 255 at Rt = 3.0 with m/z = 193 ([MH 
(37Cl)]+, 35%), 191 ([MH (35Cl)]+, 35%) and the homo coupling product 84 at Rt =3.8 with 
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m/z = 229 ([MH (37Cl,37Cl)]+, 11%), 227 ([MH (35Cl,37Cl)]+, 55%), 222 ([MH (35Cl,35Cl)]+, 
100%) (Scheme 55). 
 
N
Cl
TMS
+
N Br
PPh3 20 mol%, CuI 1.0 mmol
TBAF (2.0 mmol, 1 M THF)
DMF
PdCl2(PPh3)2 10 mol%
255 84
       LC-MS conv (%)  ratio (255  :  84)         (255) Yield%
                       100                     84 : 16               54%
254 253
N
N
Cl
N
N
Cl
Cl
2'
6
'
26
+
 
Scheme 55: Preparation of 4-chloro-2,2’-bipyridine 255 
 
Following chromatography the desired 4-chloro-2,2’-bipyridine 255 was isolated in 
54% yield. The structure was confirmed by the presence of characteristic 6’-and 6-
signals in the 1H NMR spectrum [ = 8.7 (1H, d, J = 4.8 Hz) and 8.6 (1H, d, J = 5.3 Hz), 
respectively]. With the viability of a Hiyama cross-coupling strategy established, 
attention then turned to the bipyridine 250. In order to prepare the desired bipyridine 
250, 4-tert-butyl-2-tri-methylsilylpyridine 260 was needed. As before, lithiation of 4-
tert-butyl pyridine 249 followed by reaction with TMSCl afforded the desired silylated 
pyridine 260 albeit in only 17% yield (Scheme 56).  
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N
t
Bu
1) n-BuLi-LiDMAE (2 eq.)
2) Electrophile (2.5 eq.), hexane,
-78 C, 1.5 h N
t
Bu
Si
+
N
t
Bu
                LC-MS Conv (%)  ratio  (260  :  261)       (260) Yield%
                           48                        48  :  0                 17
260 261
2
34
CH3
H
249
TMS
TMS
 
Scheme 56: Preparation of 4-tert-butyl-2-tri-methylsilylpyridine 260 
 
A possible reason for the low yield of the desired silyl product 260 might be due to a 
need for an electron withdrawing group.92-95Despite considerable experimentation no 
significant improvement in yield could be obtained. Consequently attention turned to 
the use of the Stille cross-coupling reaction, described in the next section. 
 
3.1.3 Preparation of 4,4’-substituted-2,2’-bipyridine derivatives via the 
Stille cross-coupling reaction 
A survey of the literature revealed that similar compounds have been prepared 
through the Stille cross-coupling reaction. For example Schubert et al.96 have described 
the reaction of 2-bromo-4-methylpyridine 262 with 2-tri-butylstannyl-4-methylpyridine 
263 using Pd(PPh3)4 as the catalyst to afford bipyridine 264 in 67% isolated yield 
(Scheme 57).  
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N
N
N Br N SnBu3
263 264 (67%)
+
262
Pd(PPh3)4 5.6 mol%
Toluene, 110 C, 48 h
 
Scheme 57: Preparation of 4,4’-di-methyl-2,2’-bipyridine 26596 
 
 
In order to exploit this precedent for the synthesis of 4’-(di-methylamino)-4-tert-butyl-
2,2’-bipyridine 250, 2-bromo- or 2-chloro-4-tert-butylpyridine (252 and 265 
respectively) and 4-(di-methylamino)-2-(tri-butylstannyl)-pyridine 266 were required 
(Figure 25). 
N
N
N
N X
+
N
N
SnBu3
252 (X= Br)
265 (X= Cl)
266250
Pd
 
Figure 25: Retrosynthetic analysis of 4’-di-methylamino-4-tert-butyl-2,2’-bipyridine 
250 
3.1.3.1 Preparation of 2-bromo and tri-butylstannyl-4-substituted 
pyridine 
Fort et al.97 have shown that a range of 2-functionalised pyridines 266-269 can be 
generated through trapping of a 2-lithiated pyridine 247 with diverse electrophiles 
(Table 27).  
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N
N
2) Electrophile (2.5 eq.), hexane
    -78 oC, 1.5 h
1) n-BuLi-LiDMAE (2 eq.)
N
N
R
Electrophile    Prod No         R           Yield%
ClSnBu3          266            SnBu3          70       
CBr4                267              Br              94
I2                     268               I                81
C2Cl6               269              Cl              90
247
 
Table 27: Preparation of 2-substituted DMAP97 
 
Following this precedent, lithiation of DMAP 247 with n-BuLi-LiDMAE, followed by 
addition of tri-butyltin chloride, afforded, following purification by chromatography, 
the desired stannyl product 266 in 61% yield (Table 28). 
N
R
1
2) Electrophile (2.5 eq.), hexane
    -78 oC, 1.5 h
1) n-BuLi-LiDMAE (2 eq.)
N
R
1
R
Prod No          Electrophile        R1                  R               Yield%
  266               ClSnBu3             N(CH3)2         SnBu3           61
 
  267               CBr4                   N(CH3)2         Br                 45
  252               CBr4                   (CH3)3            Br                 52
247 (R1= NMe2)
249 (R1= tBu)
 
Table 28: Preparation of 2-substituted DMAP and terbutylpyridine 
77 
 
Confirmation of 266 was obtained from LC-MS analysis, which showed a peak at Rt = 
2.55 min with the expected Sn isotope pattern [m/z = 416 ([M]+, Sn124), 414 ([M]+, 
Sn122), 410 ([M]+, Sn120)]. Further confirmation of the proposed structure was obtained 
from the 1H NMR spectrum which showed characteristic butyl signals at  = 0.86, 1.32, 
1.55 and 1.1 ppm and the correct number of proton signals at  = 6.6, 6.3 and 8.3 ppm 
for the protons at the 3-, 5- and 6-positions of the pyridine ring with the expected 
coupling pattern for a 2,4-di-substituted pyridine. In a similar fashion substituting tri-
butyltin chloride for CBr4 afforded, following chromatography, 2-bromopyridines 267 
and 252 in 45 and 52% yield respectively. The proposed structures of these products 
were confirmed by GC-MS analysis, which showed the bromine isotope pattern. The 2-
chloro analogue 265 was prepared by an alternative, simpler protocol involving 
oxidation to the N-oxide [Rt = 2.05 (m/z = 151 [M]+)], and subsequent chlorination 
using POCl398 (Scheme 58). 
N
H2O2/ CH3COOH
80 oC, overnight
N
O
105 oC, 12-16 h
POCl3
N Cl
35
6
249 270 (82%) 265 (79%)  
Scheme 58: Preparation of 2-chloro-4-tert-butylpyridine 26598 
 
Confirmation of this product was obtained by GC-MS, which contained a single 
component with Rt = 6.1 min. The molecular ion showed the expected Cl isotope 
pattern [m/z = 169 ([M (35Cl)]+, 100%) and m/z = 171 ([M (37Cl)]+, 32%)].  
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3.1.3.2 Preparation of 4’-di-methylamino-4-tert-butyl-2,2’-bipyridine 
With the key building blocks in hand, attempts to generate the desired bipyridine 250 
explored the cross-coupling of 2-bromo and chloro-4-tert-butylpyridine 252 and 265 
with 4-di-methylamino-2-tri-butylstannylpyridine 266 using palladium complexes as 
the catalyst (Table 29).96,97,99 
entry No    Pd complex                  X          solvent       T        time       conv          yield%
                                                                                      oC        (h)           (%)            (250)
   1          Pd(PPh3)4 3.6 mol%             Br            toluene      110      48           84
a             ---          
                   
   2         PdCl2(PPh3)2 10 mol%       Br         DMF          110      18          100
a                13
                                                                                                                                  
                                   
  3         PdCl2(PPh3)2 5 mol%             Br            xylene       130      24             100
b
               32
*
                   PPh3 10 mol% 
                  
  4         PdCl2(PPh3)2 10 mol%        Cl          DMF          100      18          100
b             32
 aratio determine by  GC-MS, bratio determine by LC-MS, *(14% yield of 22 could be isolated)
N X
252 (X= Br)
265 (X= Cl)
+
N
N
SnBu3
250 22266
N
N
N
N
N
6'
6
+
Pd complex
 
Table 29: Stille cross-coupling reaction using Pd catalysis 
 
The first experiment (Table 29, entry 1) followed the precedent reported by Schubert96 
(Scheme 57), affording a 84% conversion of the starting material 252 as determined by 
GC-MS analysis. New signals were observed at Rt = 12.4 min with m/z = 255 ([M]+) and 
Rt = 10.9 min with m/z = 268 ([M]+) consistent with the formation of 250 and 22. 
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Attempts were then made to form the only bipyridine 250 by varying the conditions 
and catalyst (Table 29, entries 2-4). Replacing Pd(PPh3)4 with PdCl2(PPh3)2 as reported 
by Verniest99 gave completely conversion of starting material 252 and 265, but led to a 
mixture of 250 and 22 (Table 29, entries 2 & 4). Ultimately the best conditions for the 
Stille cross-coupling reaction were found to be PdCl2(PPh3)2 with PPh397 (Table 29, 
entry 3). Purification of product 250 from the tin residues could be achieved by 
extraction with 6 M HCl. However, this led to considerable loss of yield. Consequently, 
although more challenging, direct chromatography of the crude reaction mixture on 
silica gel, eluting with 5:1:5 Et3N:EtOAc:hexane afforded 250 in 32% isolated yield 
accompanied by 22 in 14% yield (Table 29, entry 3). Confirmation of these products 
was obtained by LC-MS or GC-MS analysis, which showed the correct mass spectra for 
products 250 and 22. Additionally, confirmation of the proposed structure was 
obtained from the 1H NMR spectrum. Compound 250 shows characteristic methyl 
signals at  = 1.38 and  = 3.11 for the tert-butyl and N,N-di-methy groups at 4-
position, while compound 22 only shows the characteristic tert-butyl signal at  = 1.4. 
Compound 250 showed characteristic 1H NMR signals at  = 8.6 (1H, d, J = 5.2 Hz), and 
8.3 (1H, d, J = 6.0 Hz) assigned to the 6- and 6’ -hydrogens respectively, while 
compound 22 only showed characteristic 1H NMR signals at  = 8.6 (1H, d, J = 5.2 Hz) 
for both 6- and 6 ʹ -hydrogens. Both 2-chloro and 2-bromo-4-tert-butylpyridine were 
used for the cross-coupling reaction with 4-di-methylamino-2-tri-butylstannylpyridine 
266 (Table 29, entries 3 and 4). Although LC-MS showed 100% conversion of the 
starting material for both reactions it proved not possible to translate this into good 
yields of the desired bipyridine product 250. Attempts to enhance the yield of the 
desired bipyridine product 250 by increasing the amount of palladium (II) to 10 mol% 
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at 110 oC in DMF were not successful. This result may be due to coordination of the 
palladium catalyst by the pyridyl nitrogen. It was subsequently reasoned that use of an 
N-oxide would minimise the homocoupling of 274 owing to electronic repulsion from 
the mutually ortho N-oxides. This suggestion was supported by the observation that 
similar compounds have been prepared by coupling 2,6-di-bromopyridine-N-oxide 271 
with 2-tri-butylstannylpyridine 272 using 1 mol% Pd(PPh3)4 (Scheme 59).100 
N BrBr
O
+ N SnBu3 toluene, 110 
oC, 16 h N
N
Br
O
273 (66%)271 272
Pd(PPh3)4 1 mol%
 
Scheme 59: Preparation of 6-bromo-2,2’-bipyridine-N-oxide 273100 
 
N
N
N
250
N
N
N
N
N
275
N Cl
+
SnBu3
O
N Cl
274 266
265
PCl3
Pd (0)
[O]
O
Figure 26: Retrosynthetic analysis of 4’-(di-methylamino)-4-tert-butyl-2,2’-bipyridine 
250 
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3.1.3.2.1 Preparation of 2-chloro-4-tert-butylpyridine-N-oxide 
Consequently 2-chloro-4-tert-butylpyridine-N-oxide 274 was prepared through 
reaction of 265 with H2O2/ AcOH (Scheme 60)98. Confirmation of this product was 
obtained by LC-MS analysis which showed a peak at Rt = 2.3 min with m/z = 185 ([M 
(35Cl)]+). With 274 available, the next step was to explore the coupling of 274 with 265 
in a Stille cross-coupling reaction. Following the precedents described above, coupling 
of 2-chloro-4–tert-butylpyridine-N-oxide 274 with 4-(di-methylamino)-2-tri-
butylstannylpyridine 266 (1.2 eq.), using 1 mol% Pd(PPh3)4, afforded the desired 
bipyridine-N-oxide 275 (Scheme 61). Although the bipyridine-N-oxide 275 was 
afforded without any homo coupling of 274, the reaction did not proceed to 
completion. It was suggested that this may be due to oxidation of Pd(0) to Pd(II).  
N Cl
H2O2/ CH3COOH
80 oC, overnight N Cl
O
265 274 (83%)  
Scheme 60: Preparation of 2-chloro-4-tert-butylpyridine-N-oxide 27498 
N Cl
O
274
+
N
N
SnBu3
266
Toluene, 110 oC, 18 h
Pd(PPh3)4 1 mol%
N
N
N
275
O
+
N
N
N
N
70
Conv (%) LC-MS           ratio (275   :   70)
        41                                      16   :    25  
Scheme 61: Preparation of 4’-(di-methylamino)-4-tert-butyl-1-oxy-2,2’-bipyridine 275 
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Given this disappointing result, an alternative means of control for the coupling 
reaction was sought. It was then predicted that the presence of an additional ortho 
chlorine substituent could facilitate the coupling reaction by sterically hindering the 
pyridyl nitrogen’s ability to coordinate. In order to test this hypothesis 2,6-di-chloro-4-
tert-butylpyridine 276 was required. The synthesis and subsequent reaction of this 
compound is discussed in the next section. 
 
3.1.3.3 Preparation of 4’-di-methyl-amino-4-tert-butyl-6-chloro-2,2’-
bipyridine 
3.1.3.3.1 Preparation of 2,6-di-chloro-4-tert-butylpyridine 
In an analogous fashion to that described above, treatment of N-oxide 274 with POCl3 
afforded, following chromatography, 2,6-di-chloro-4-tert-butylpyridine 276 in 70% 
yield (Scheme 62)98. 
N Cl
O
274
POCl3
105 oC, 20 h N Cl
276 (70%)
Cl
 
Scheme 62: Preparation of 2,6-di-chloro-4-tert-butylpyridine 27698 
 
Confirmation of this product was obtained by GC-MS, which showed a peak at Rt = 7.1 
min with the correct isotopic ratio 1:6:9 for two chlorine atoms. Furthermore, the 1H 
NMR spectrum showed a characteristic 3,5-H signal at  = 7.18 and lacked the 
characteristic 6-H signal at  = 8.26. With di-chloropyridine 276 available it was 
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attempted to generate the desired bipyridine 277. Following the cross-coupling 
conditions described above (Section 3.1.3.2, entry 2, Table 29), complete consumption 
of starting material 276 was observed. Analysis of the crude mixture by LC-MS, showed 
peaks at Rt = 2.3 and 1.2 min with m/z = 289 ([M (35Cl)]+) for 277 and m/z = 242 ([M]+) 
for 70 respectively, indicated that the crude mixture contained a mixture of the 
desired bipyridine together with bis amine arising from homocoupled stannane in a 
ratio of 86:14 (Scheme 63). 
N
N
N
N
N Cl N
N
SnBu3
70
N
N
N
277 (31%)
Cl
PdCl2(PPh3)2 10 mol%
DMF, 110 C, 18 h+ +
276 266
Cl
 
Scheme 63: Preparation of 4’-di-methyl-amino-4-tert-butyl-6-chloro-2,2’-bipyridine  
277 
Following chromatography, 4’-di-methyl-amino-4-tert-butyl-6-chloro-2,2’-bipyridine 
277 was isolated in a yield of 31%. The low yield of 277 may be due to difficulties 
purifying the product. Extraction of the crude mixture with HCl was necessary to 
separate the tin salts from the product prior to chromatography. In conclusion the 
introduction of the 6-chloro-substituent enabled the successful synthesis of the 
desired bipyridine 277. However the low overall yield of the coupling step necessitated 
a change in strategy. Fujita et al. have reported that the addition of metal salts (LiCl) 
can enhance the efficiency of Stille cross-coupling reactions (Scheme 64).101 To explore 
this possibility a model reaction was conducted to prepare the bipyridine product, 
using LiCl to aid the transmetallation (Table 30). 
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N
SnMe 3
+
Br
Br
PdCl2(PPh3)2 10 mol%
LiCl 10 eq., toluene,
 reflux, 2-3 days
N
N
280 (99%)279278  
Scheme 64: Preparation of 4-[3-(4-pyridinyl)-phenyl]-pyridine 281101 
N X N SnBu3 N
N
N
N
N
N
+
PdCl2(PPh3)2 3.75 mol%
LiCl
Toluene, 120 oC, 2 days + +
281 22 38
entry No   X      Conva       ratioa         (281) yield%
                             %    (281:22:38)
    1          Br       100      80:10:10              40
    2          Cl       100      77:12:11              32
a ratio determined by LC-MS
252 (X= Br)
265 (X= Cl)
272
 
Table 30: Preparation of 4-tert-butyl-2,2’-bipyridine 281 
 
After extraction of the crude mixture with HCl (6 M) to remove tin salts, purification by 
reversed phase chromatography, afforded a 40% yield of the desired bipyridine 
product 281 (M+ peaks at Rt = 2.5 min with m/z = 212 ([M]+)), when starting from 2-
pyridyl bromide. The use of Cu salts has also been reported to enhance efficiency 
through promotion of the transmetallation step (Scheme 65).102 This proved to be 
more successful, enabling the isolation of unsymmetric bipyridine 285 in 50% yield, 
following purification by column chromatography (Table 31). 
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N  Br
+
N SnBu3 Dioxane, refluxe 15 h
283 (74%)
Pd(PPh3)4 5 mol%
CuBr 7 mol%
O O
254 282
N
N
O O
 
Scheme 65: Stille cross-coupling reaction using CuBr102 
 
N
O O
X
+
N
N
SnBu3
Dioxane, refluxe 101 oC,
17 h
Pd(PPh3)4 5 mol%
CuBr 7 mol%
+
285 286266151 (X= Cl)
284 (X= Br)
entry No      X          Conv.a             Ratio                  Yield% 
                                  %                (285:286)a             (285:286)
     1            Cl          100                  6.5:1.0                   50:2
     2            Br          100                 11.0:1.0                  50:2
N
N
O OMe
N N
N
O OMe
O
OMe
6'
6
aconversion and ratio determined by 1H NMR
Table 31: Preparation of bipyridine 285 
 
Following the same precedent, 2-bromo-4-tert-butylpyridine 252 and 4-di-
methylamino-2-tri-butylstannylpyridine 266 were reacted in a similar fashion to afford 
bipyridine 250 in 47% isolated yield (Scheme 66). 
N Br N
N
SnBu3
Dioxane, refluxe 101 oC,
17 h
Pd(PPh3)4 5 mol%
CuBr 7 mol%
+
250 22
6'
6
266252
         Conv. (%)a        Ratio (250:22)a   (250) Yield%
               100                      11.0:1.0           47
N
N
N
N
N
aconversion and ratio determined by 1H NMR
+
Scheme 66: Preparation of bipyridine 250 
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Having successfully prepared unsymmetrical bipyridines 250 and 285, the next stage 
was to compare their efficacy as ligands in the borylation reaction with that of 
commercially available dtbpy 22. This is discussed in the next section. 
 
3.2 Ligands evaluation 
3.2.1 Borylation of anisole 
In order to compare the relative activity and regioselectivity of ligand 250 with the 
literature gold standard, dtbpy 22, used in most borylation reactions, the initial 
experimental was to borylate anisole using [Ir (OMe) (cod)]2 21 and B2pin2. 
OMe
[Ir(OMe)(cod)]2 1.5 mol%, L
B2pin2 1 eq., THF, 18 h r.t
OMe OMe OMe
BpinBpin
Bpin
pinB
+ +
entry No    Ligand      Conv.a         ratioa                 ratiob
                   ( L)             %      (15 & 288:287)        (15:287:288)
                                
  1                250           90            66:24               1.0:0.6:4.3
  2                22             99            66:33               1.0:1.0:4.2
15 287 288
aconversion and ratio were determined by GC-MS
bratio was determined by 1H NMR
35
 
Table 32: Borylation of anisole using ligands 250 and 22 
 
The reactions in Table 7 were carried out at room temperature for 18 h and analysed 
by GC-MS and 1H NMR spectrums. In both cases near complete consumption of 
starting material was obtained, affording a mixture of mono- and bis-borylated 
products (Table 32). Over this time frame this suggested that the activity of ligand 250 
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is comparable to the activity of dtbpy 22. However a more detailed kinetic analysis of 
the progress of the reaction was not undertaken. Regioisomeric analysis by 1H NMR 
spectroscopy followed the assignments previously described by Tajuddin10 and 
suggested that 250 afforded decreased amounts of meta borylation. The reasons for 
this are not immediately apparent, but suggest that other nonsymmetrical ligands may 
provide a solution to the regiocontrol challenge. Similar analysis by GC-MS was 
attempted but in the absence of calibrated response factors proved more challenging 
to interpret. For example, integrating the M+ peaks at Rt = 15.1-16.0 min and 22.1-22.6 
min with m/z = 234 ([M]+) and 360 ([M]+), suggested that the crude mixture contained 
3 mono and 3 bis-borylated products in similar ratios for both ligands. In order to 
simplify the analysis the test system was modified to use 1,3-di-substituted benzene 
derivatives. 
 
3.2.2 Borylation of m-xylene 
As above, m-xylene 19 was borylated using 1.2 eq of B2pin2 at r.t and 80 oC with 
reaction conversions being determined by 1H NMR analysis using undecane as a 
standard (Table 33).  
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[Ir(OMe)(cod)]2 1.5 mol%, L
B2pin2 1.2 eq., THF
Bpin
entry No    Ligand       T                                  conv%a
                    (L)         oC           2 h    4 h     6 h      24 h    72 h     168 h
   1               250          r.t         ----      -----     ----      19       31         49
   2               22           r.t         ----      ----     -----       19       51         79
   3               285         r.t         -----     ----     -----       13       19         29  
   4               250         80         66      85       90        ----        ----        ----
   5               22           80         85      88       89       -----       ----        ----
   6               285         80         34      38       43       -----       ----        ----
aconversion determined by 1H NMR
2319
 
Table 33: Borylation of m-xylene using 250, 22 and 285 
 
In all cases, as expected, only a single monoborylated product was observed in GC-MS 
(Rt = 6.8 min; m/z = 232 ([M]+)). Of the three ligands evaluated 22 showed the highest 
activity at room temperature. Interestingly the formation of the borylated product 23 
was slower when ligand 250 was used instead of dtbpy 22, suggesting that the 
formation of the active complex was slower. Consistent with this, when the reactions 
were heated at 80 ˚C, the difference between 250 and 22 was less pronounced. The 
more electron withdrawing ligand 285 was significantly less effective to coordinate the 
iridium catalyst suggesting that the linker should not contain EWGs directly attached to 
the 4–position.  
  
89 
 
3.2.3 Borylation of methyl-(2-methyoxy)-benzoate 
Since the borylation of anisole 35 suggested that an unsymmetrical ligand could 
modulate the activity, it was of interest to further probe this observation. In earlier 
work the room temperature borylation of 2-methoxy-methylbenzoate 57 had been 
shown to give a 289:290 mixture of regioisomers 10 and was thus a good substrate to 
verify this observation (Table 34).  
OMe
O OMe
[Ir(OMe)(cod)]2 1.5 mol%, L
B2pin2 1.2 eq., THF, r.t, 16 h
OMe
O OMe
OMe
O OMe
Bpin
+
entry No   Ligand     Conv. (%)a    ratiob
                   (L)           (289&290)   (289:290)
  1               250             98            7.1 : 1.0
  2              285              78            5.4 : 1.0
  3               22               97            6.5 : 1.0
289 290
aconversion determined by GC-MS
bratio determined by 1H NMR
pinB
57
Table 34: Borylation of methyl-(2-methoxy)-benzoate using 250, 22 and 285 
 
Reflecting the higher reactivity of this substrate all the ligands afforded good 
conversion of the substrate to the corresponding arylboronate at r.t. Consistent with 
the results from the borylation of anisole regioisomeric analysis by 1H NMR 
spectroscopy showed marginal difference in selectivity in the borylation reaction when 
using ligand 250 compared to dtbpy 22.  
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3.3 Synthesis and evaluation of 2-(4’-di-methylamino-2,2’-bipyridine-4-
yl)-N-methylacetamide) 
From the work described above (Section 3.2.2, Table 33), it was clear that the 
presence of an EWG directly attached to the bipyridine was not desirable. 
Consequently it was decided to prepare bipyridines with a reversed amide linker 
attached to 4-amino-pyridine. The initial target was therefore chosen to be the 2-(4’-
di-methylamino-2,2’-bipyridine-4-yl)-N-methylacetamide 296. Similar structures have 
been prepared before, utilising the Stille cross-coupling reaction of 2-chloro-pyridines 
151 with 2-tri-butylstannylpyridine 266 (Section 3.1.3.3.1, Table 31). Adopting this 
strategy (Figure 27) the initial goal became the preparation of the two precursors N-(2-
chloro-pyridin-4-yl)-N-methyl-acetamide 294 and 4-di-methylamino-2-tri-
butylstannylpyridine 266.  
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N N
N N
O
296
N
N
SnBu3 N
N
Cl
O
R
N
N
H
Cl
N
N
H
Cl
OEt
O
N
NH2
Cl
294 (R= H)
295 (R= Cl)
293
266
291
292
+
 
 
Figure 27: Retrosynthetic analysis of 296 
 
3.3.1 Preparation of 2-chloro-4-(N-methylamino)-pyridine 
 
N
NH2
298 (74%)
nBuLi/ THF
0 oC - r.t
N
NHLi
MeI
N
NH
297  
Scheme 67: Preparation of N-methyl-4-aminopyridine103 
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Based on the precedent established by Singh et al. (Scheme 67),103 2-chloro-4-(N-
methylamino)-pyridine 293 was prepared through the addition of n-BuLi to 2-chloro-4-
aminopyridine 291 at 0 oC and trapping of the resultant anion with methyl iodide 224 
at room temperature (Scheme 68).  
N
NH2
BuLi 1.2 eq., THF
N
NH
Cl Cl
+
N
N
Cl
293 299
Conv (%) GC-MS           ratio ( 293  :    299)
      86                                        26   :   60
MeI 2 eq, stir r.t 1 h
291
 
Scheme 68: Preparation of 2-chloro-N-methyl-4-aminopyridine 293 
 
Although this reaction gave good conversion of starting material 291 (86%), di-
alkylation to the undesired side product 299 was problematic. Consequently an 
alternative pathway was sought, and a survey of the literature revealed that the similar 
4-(N-methylamino)-pyridine 301 can be formed by reduction of carbamate 300 using 
LiAlH4 in THF (Scheme 69).104 
N
HN
O
O
LiAlH4 5.2 eq
THF, 0- reflux 4h
OH
N
HN
OH
301 (99%)300  
Scheme 69: Preparation of 4-(N-methylamino)-pyridine 301104 
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In order to explore this approach the desired carbamate 292 was readily prepared in 
excellent yield following literature protocols combining 2-chloro-4-aminopyridine 291 
and ethyl chloroformate in DCM at room temperature (Scheme 70).105 Confirmation of 
this product was obtained from a molecular ion peak in the GC-MS trace at Rt= 8.3 min 
m/z = 202 ([M (37Cl)]+), 200 ([M (35Cl)]+) coupled with the characteristic ethyl signals at 
 = 4.2 and  = 1.3 for the ethyl carbamate and a downfield shift in the N-H signal to 
=7.6 in the 1H NMR spectrum. Finally a peak at 1736 cm-1 in the IR spectrum 
confirmed the formation of the carbamate (C=O stretch). 
N
NH2
Cl
ethyl chloroformate 1.5 eq
Et3N, DCM, 0 - r.t overnight
N
HN
O
O
292 (96%)
Cl
291
 
Scheme 70: Preparation of carbamate 292 
 
In order to generate the desired mono-methyl amine it was necessary to next reduce 
the carbamate and following Spivey et al.104, carbamate 292 was treated with LiAlH4 in 
THF at room temperature to afford, following chromatography, the desired 
methylamine 293 in 76% yield (Scheme 71).  
N
HN
O
O
LiAlH4 1.2 eq
THF, 0- r.t, 17 h
N
HN
Cl
Cl
293 (76%)292  
Scheme 71: Preparation of 293 
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Confirmation of a successful reduction was obtained from the 1H NMR spectrum which 
showed a characteristic methyl signal at  = 2.8 ppm coupled with a shift to lower 
frequency for the N-H signal (=4.9 ppm) consistent with the reduction of the carbonyl 
group. Finally conformation for the retention of the chloro substituent was obtained 
by GC-MS that showed a peak at Rt= 6.9 min with the expected Cl isotope pattern m/z 
= 144 ([M (37Cl)]+, 34%), 142 ([M (35Cl)]+, 100%). With N-methylaminopyridine 293 
available the next task was to attach a suitable linker group. This is discussed in the 
next section. 
 
3.3.2 Preparation of N-(2-chloropyridin-4-yl)-N-methylacetamide 
derivatives 
The first approach was to combine mono-methylamine 293 with ethylhaloacetate. 
According to procedure from Evstratova et al.106 a similar compound 304 could be 
prepared by alkylation of 2-di-methylamino-3-cyano-4-benzylaminopyridine 302 with 
ethylbromoacetate 303 in presence of NaH as base (Scheme 72). 
N
NH ethylbromoacetate,
NaH 1.5 eq
DMF, 75-80 oC, 3 h
N
N
NMe 2 NMe 2
Ph
CN
Ph
OEtO
CN
N NMe 2
N
NH2
COOEt
Ph
20%
302 304
HCl 10%
 
Scheme 72: Alkylation of sec amine106  
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Following this precedent, heating of methylamine 293 with ethyl bromoacetate 303 in 
DMF at 40 oC (Scheme 73) afforded [(2-chloropyridine-4-yl)-methylamino]-acetic acid 
ethyl ester 305.  
N
NH
NaH 1.5 eq
DMF, 40 oC, 18h
N
N
Cl Cl
OEt
O
+
305 306
conv. (%) GC-MS          Ratio (305 :  306)
           52                                   17 : 35
Unknown
293
 
Scheme 73: Preparation of [(2-chloropyridine-4-yl)-methylamino]-acetic acid ethyl 
ester 
However, the conversion of the starting material 293 (GC-MS analysis) was low and 
there was a significant amount of an unknown byproduct 306 (10.6 min, m/z = 286) 
formed. Attempts to improve the yield of 305 by using Bu4NI and Cs2CO3 in DMF at 100 
oC or replacing the ethylbromoacetate 303 with glutaric anhydride were not successful. 
The low yield of the desired product 305 may be due to the conjugated nature of the 
amine, which lowers reactivity. Switching to the more electrophilic acyl chloride 
successfully overcame this problem enabling the isolation of 294 and 295 in 42% and 
90% yield respectively (Table 35). 
 
96 
 
N
NH
Cl
Acyl chloride1.5 eq
Et3N, DCM, 0 - r.t overnight
N
N
O
R
Cl
Prod No      R        Yield%
  294           H          42
  295           Cl         90
293
 
 
Table 35: Preparation of acetamide 294 and 295 
 
In both cases formation of the amide was ascertained from the IR spectrum in which a 
peak at 1650-70 cm-1 (C=O stretch) could be observed. Confirmation of the pyridine 
294 was obtained by GC-MS analysis, which showed a peak at Rt = 7.1 min [m/z = 186 
([M (37Cl)]+, 8%), 184 ([M (35Cl)]+, 25%). Similarly formation of amide 295 was also 
confirmed by GC-MS, which showed a peak with Rt = 8.4 min with the correct isotopic 
ratio 1:6:9 of di-chlorine [m/z = 222 ([M (37Cl,37Cl)]+, 6%), 220 ([M (35Cl,37Cl)]+, 35%), 
218 ([M (35Cl,35Cl)]+, 54%)]. With 294 in hand, synthesis of 2-(4’-Di-methylamino-2,2’-
bipyridine-4-yl)-N-methylacetamide 296 was undertaken, using the procedure 
optimized for the syntheses of bipyridines 285 and 250 (Section 3.1.3.3.1, Table 31). 
However, this proved very difficult to purify, ultimately producing a very low yield of 
isolated material (5%) (Scheme 74). Characterisation of the product was complicated 
by the presence of amide rotamers but confirmation of the molecular formula 
[C15H19N4O] was obtained by HRMS analysis, which showed the correct mass 271.1554, 
([MH]+ requires M, 271.1559). 
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N
N
Cl
+
N
N
SnBu3
Dioxane, refluxe 101 oC,
17 h
Pd(PPh3)4 5 mol%
CuBr 7 mol%
296 (5%)
6
266294
O
N
N
N
N O
6'
 
Scheme 74: Preparation of bipyridine 296 
 
Although the difficulty in purification resulted a low yield of the bipyridine 296, 
sufficient material could be prepared to enable the testing of the activity of this ligand. 
This is discussed in the next section. 
 
3.3.3 Borylation of m-xylene using bipyridine 296 as ligand 
Following the protocols established above (Section 3.2.2), 296 was used as a ligand in 
the borylation of m-xylene at r.t and 80 ˚C, enabling a comparison with ligand 285 
(Section 3.2.2, Table 33). Based on the conversion of starting material, 296 showed 
higher activity (Table 36, entry 3), confirming the hypothesis that the linker at C-4 
must not contain an electron withdrawing group directly attached to the pyridyl ring.  
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[Ir(OMe)(cod)]2 1.5 mol%, L
B2pin2 1.2 eq., THF
Bpin
entry No     Ligand        T                                  conv%a
                     (L)           oC           2 h    4 h     6 h      24 h    72 h     168 h
   1                296          r.t          -----    -----     ----        26        41        69
   2                285          r.t           ----      ----     -----      13        19        29
   3                296          80           50      67       75       ----       ----        ----
   4                285          80           34      38       43       -----       ----       ----
aconversion determined by 1H NMR
2319
 
Table 36: Comparison of Ligands 285 and 296 
 
3.4 In conclusion  
In this work, a range of 2-functionalised pyridines were synthesised using Fort’s 
protocol. Asymmetrical bipyridines were successfully prepared in a Stille cross-coupling 
reaction using CuBr to aid transmetallation. These bipyridine ligands were evaluated 
with different substrates to explore the activity and selectivity compared with the 
active dtbpy ligand in a borylation reaction. Ligands 22 and 250 showed comparable 
activity in the borylation of m-xylene after heating in an oil bath at 80 oC for 6 h, while 
285 showed less activity in the borylation of substrates due to the elctron-withdrawing 
group at the 4-position of the pyridine ring. In addition, a method was discovered to 
prepare bipyridine 296 with a reversed amide linker, which could then be used to 
attach the ligand to a polymer. Ligand 296 was similarly prepared to ligands 250 and 
285 using a copper salt Unfortunately, concurrent with these studies Jones et al. 
published a paper, showing the synthesis of a silica supported Iridium catalyst 187 with 
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a bipyridine ligand (Figure 16).74 In this report they demonstrated that the silica 
supported iridium catalyst is stable in air and can be recovered by simple filtration and 
re-used for further borylation reactions. This catalyst showed good activity in the 
borylation of various arenes. Therefore alternative ligands were explored. Based on 
Hartwig’s reports107 of the high activity of phenanthroline derivatives as ligands in the 
borylation reaction, attention turned to the preparation of a modified phenanthroline 
ligand, which could be used in the synthesis of a polymer supported iridium catalyst. 
This work is described chapter 5. 
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Chapter 4 
4 Multidirectional synthesis of pyridines 
4.1 Introduction 
Pyridines are an important motif in agrochemicals and pharmaceuticals.108 For 
example Henke et al. reported that 2-amino-4,6-di-arylpyridine derivatives may have 
efficacy in the treatment of diseases caused by the loss of estrogen (Figure 28).109 
Common methods for the preparation of 2,4,6-substituted pyridines use three halide 
groups on pyridine which react in turn to produce the desired pyridines along with 
many halogenated side products.110 Therefore, a key solution for this problem is to 
borylate substituted-pyridine as previously studied in the group. Tajuddin reported10 
that blocking 2- and 4-positions of pyridine such as methyl-2-chloroisonicotinate 151 
led to ortho borylated product 152. 
NN
OH
R
3
R
4
R
1
R
2
 
109arylpyridine derivatives-di-4,6-amino-Preparation of 2: 28Figure  
 
Following this strategy, the aim of this work was to prepare functionalized pyridine 
building blocks, which can be further used in the multidirectional synthesis of 
substituted pyridine derivatives, using Suzuki-Miyaura coupling of aryl boronate esters 
with a range of aryl halides and subsequently aromatic nucleophilic substitution with a 
range of amines (Figure 29). 
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Figure 29: Preparation of 2,4,6-substituted pyridine derivatives 
 
4.1.1 Preparation of 2,4,6-substituted pyridine derivatives 
Retrosynthetic analysis of the desired 2,4,6-substituted pyridine derivatives 320-327, 
showed that these products could be prepared through two routes (Figure 30). The 
first route involves the reaction of 6-chloropyridine derivatives 310,313,318-319 with a 
range of amine derivatives via a SNAr reaction. 2-aryl-4-substituted-6-chloro pyridine 
derivatives 310-319 can be prepared by coupling of arylboronate esters 152, 307 and 
309 with a range of aryl halides in a Suzuki-Miyaura cross-coupling reaction. 
Arylboronate esters (152, 308 and 309) can be synthesized by the borylation of 2-
chloro-4-substituted pyridine derivatives 151, 265 and 307 using the active catalyst 
tris-boryl species Ir(Bpin)3(dtbpy). The second route to prepare compound 320, 
involves the coupling of 2-borylated pyridine 329 with 4-iodonitrobenzene in a Suzuki-
Miyaura cross coupling. 2-Borylated pyridine derivatives 329 can be prepared through 
two steps, starting with a SNAr reaction of 2-chloro-pyridine 307, followed by the 
standard borylation procedure using an Ir catalyst. Borylation of 2-chloro-4-substituted 
pyridine derivatives 152, 308 and 309 will be discussed first in the next section. 
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Figure 30: Retrosynthetic analysis of multidirectional pyridine derivatives 
 
4.1.1.1 Borylation of 2-chloro-4-substituted pyridine derivatives 
A survey of the literature revealed that 6-borylated product 152 can be prepared using 
the standard borylation procedure with methyl-2-chloroisonicotinate 151 (Scheme 24, 
chapter 1).10 Following this protocol, carrying out the borylation at 80 oC for 1 h in a 
µW reactor, a range of 6-borylated products 152, 308 and 309 was obtained (Table 
37). 
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N
R
Cl N
R
Cl Bpin
[Ir(cod)(OMe)]2 1.5 mol%,
dtbpy 3.0 mol%, B2pin2 1.0 eq.,
MTBE, 80 oC MW, 1 h
151 (R= COOMe)
265 (R= tBu)
307 (R= CF3)
      R                 Ar-Bpin No                  Rt min:(m/z)a                             Conv.a
                                                                                                                  %
       tBu                  308                          8.9: 297 [M, 37Cl]+, 33%                 88
                                                                   295 [M, 35Cl]+,100%
    CF3                       309                          6.5: 309 [M, 
37Cl]+, 32%                 88
                                                                   307 [M, 35Cl]+, 100% 
   COOMe            152                           9.2: 299 [M, 37Cl]+, 33%                 68
                                                                   297 [M, 35Cl]+, 100%
aconversions determined by GC-MS analysis  
Table 37: Borylation of 2-chloro-4-substituted pyridine derivatives 
 
Although both 151 and 307 have electron-withdrawing groups, GC-MS analysis 
unexpectedly showed a lower conversion for 151 compared to 307. Because of the 
importance of the ester group of 152, which could be used to further functionalize at 
the 4-position of the pyridine ring, we attempted to increase the yield of 6-borylated 
product 152. In order to explore the best conditions for the borylation, a fractional 
design of experiments approach was employed. Five factors were suggested that could 
influence the borylation of methyl-2-chloroisonicotinate. These were the mol% of 
[Ir(OMe)cod]2, the equivalents of B2pin2, the temperature, the time and the 
concentration (Table 38). To explore all combinations of these variables at two settings 
would require a minimum of 32 experiments. This was not possible in the time 
available and consequently a fractional approach was adopted in which a quarter 
fraction (8 experiments) were undertaken with two control experiments at the mid-
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point values. This gave the results shown in (Table 38). Analysis of each set of variable 
at both high and low settings (Figure 31) suggested that the effect of time, 
concentration and diboron stoichiometry had relatively little effect on conversion but 
that higher Ir loading and temperatures afforded better yields. Consequently a final 
experiment was identified to give the most efficient conditions for the borylation of 2-
chloropyridine 151 (Scheme 75). 
N
O OMe
Cl
[Ir(OMe)(cod)]2 (X mol%)
B2pin2 (Y eq.,)
dtbpy (2X mol%), MTBE, MW
N
O OMe
Cl Bpin
entry No      Ir-cat           B2pin2       Time        T           Conc.     Conv.
                  (mol%)           (eq.)          (min)     (oC)                         (%)a
     1              5.0                1.5             30        60             0.25        82
     2              5.0                0.9             90        60             0.25        79
     3              1.0                1.5             30        100           0.25        61
     4              1.0                1.5             90        60             0.75        56
     5              1.0                0.9             30        60             0.75        46
     6              1.0                0.9             90        100           0.25        64
     7              3.0                1.2             60        80             0.5          79
     8              5.0                0.9             30        100           0.75        88
     9              3.0                1.2             60        80             0.5          81
    10             5.0                1.5             90        100           0.75        92
151 152
aconversions determined by GC-MS  
Table 38: Borylation of 2-chloroisonicotinate using different conditions 
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low high
Time
low
highTemp.
46% entry 5
64% entry 6
79% entry 2
88% entry 8
Constant B2pin2 =0.9
low
high
low high
Time
low
high
Temp.
56% entry 4
61% entry 3
82% entry 1
92% entry 10
Constant B2pin2 =1.5
low
high
Ir Ir
 
low high
Time
high
Temp.
82% entry 1
92% entry 10
79% entry 2
88% entry 8
Constant Ir mol% =5
low
high
B2pin2
low high
Time
low
highTemp.
56% entry 4
61% entry 3
46% entry 5
64% entry 6
Constant Ir mol% =1
low
high
B2pin2
low
 
low high
Conc
low
highTemp.
82% entry 1
92% entry 10
79% entry 2
88% entry 8
Constant Ir mol% =5
low
high
B2pin2
low high
Conc
low
high
Temp.
56% entry 4
61% entry 3
46% entry 5
64% entry 6
Constant Ir mol% =1
low
high
B2pin2
 
low high
B2pin2
low
high
Temp.
82% entry 1
88% entry 8
61% entry 3
46% entry 5
Constant time= 30 min
low
high
low high
B2pin2
low
highTemp.
56% entry 4
92% entry 10
79% entry 2
64% entry 6
Constant time= 90 min
low
high
   Ir       Ir
 
Figure 31: Fractional design of borylation 2-chloropyridine 151 
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N
O OMe
Cl
[Ir(OMe)(cod)]2 (5 mol%)
B2pin2 (1.2 eq.,)
dtbpy (10 mol%), MTBE (0.4 M), 
MW 120 oC, 30 min
N
O OMe
Cl Bpin
151 152 (95% conv. by GC-MS)  
 
Scheme 75: The best condition to the borylation of pyridine 151 
 
Using fractional design of borylation 2-chloropyridine 151 suggested that the yield of 
6-borylated product 152 increased by increasing the mol% of [Ir(OMe)cod]2 and 
temperature. Entries 7 & 9 in (Table 38) had identical conditions and showed very 
similar conversions, suggesting that the method is consistent. With the 6-borylated 
products in hand, Suzuki Miyaura cross-couplings were carried out directly, without 
further purification, with aryl halide derivatives. This will be discussed in the next 
section. 
 
4.1.1.2 Preparation of 2-(aryl substituted)-heteroaromatics 
The first example was to directly coupling of pyridine 152, without further purification, 
with a range of aryl halides using 5.0 mol% of PdCl2(dppf)2 and Cs2CO3 in DMA at 120 
oC in a µW (Table 39). Product 310, was obtained via a cross coupling reaction with 4-
iodo-nitrobenzene. GC-MS showed a 100% conversion of SM and the M+ peak was 
observed at Rt = 11.7 min with m/z = 294 ([M (37Cl)]+, 33%), 292 ([M (35Cl)]+, 100%). 
Following chromatography, the desired product 310 was isolated in 45% yield. This 
compound substitution at C-2 was confirmed by a NOESY correlation between 2’-H and 
3-H. In a similar fashion 2-aryl-4-substituted-6-chloropyridine derivatives 311-319 
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could be prepared in 10-67% yield. The low yields for product 310 could be due to the 
rather low conversion of 68% of methyl-2-chloroisonicotinate 151 to the crude 
arylboronate. However, for not obvious reason the yield for product 311 did not 
improve, when different borylation conditions were used. 
Prod No       R                      Ar-x (eq.)                       Borylation condition         Time                yield%
                                                                                                                                h           
    310          COOMe                             1.5                       Table 37                         3                       26
   
    310          COOMe                            1.5                        Scheme 75                     3                       45
    311          COOMe                             1.5                       Scheme 75                     3                       10
    312          COOMe                             1.5                       Scheme 75                     3                       48
    313            tBu                                  1.5                       Table 37                          3                       40
 
    314            tBu                                  1.5                       Table 37                          3                       66
    315            tBu                                  1.5                       Table 37                          3                       67
    316            tBu                                  1,5                       Table 37                          3                       42
 
    317           tBu                                   1,5                       Table 37                          3                       44
    318           CF3                                  1.5                       Table 37                          3                       36
    319           CF3                                  1.5                       Table 37                          3                       58
NCl Bpin
R
PdCl2 (dppf) 5.0 mol%,
 Cs2CO3 2 eq.,
Ar-X, DMA,MW, 100 oC
NO2I
OMeI
NO2I
NO2I
S Br
N
S
Br
OMeI
OMeI
NO2I
N
COOMeBr
NCl Ar
R
NCl
R
R
1
H
H3
2
'
S Br
NCl
R
[Ir(OMe)(cod)]2
B2pin2
dtbpy, MTBE, MW
151, 265, 307 152, 308, 309
 
Table 39: Coupling of 2-chloro-4-substituted-6-borylated products with arylhalides 
 
With the 2-aryl-6-chloropyridine derivatives in hands, it was decided to form a C-N 
bond in a SNAr reaction. This is discussed in the next section.  
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4.1.1.3 Preparation of [6-(4-nitrophenyl)-4-tri-fluoromethylpyridine-2-
yl]amine derivatives 
A survey of the literature revealed that similar products could be prepared through 
heating an amine with 2-chloropyridine 110 at 130 oC for 30 min in the µW (Scheme 
76).111 
N Cl
+
N
H
130 oC, 30 min
MW N N
331 (90%)
110 330
 
 
Scheme 76: Preparation of 2-pyrrolidinylpyridine111 
 
Following this precedent, a range of examples could be prepared by reacting 6-
chloropyridine derivatives 310,313,318 and 319 with a range of amines in a SNAr 
reaction (Table 40) (Scheme 77). 
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N
R
ArCl
Amine
130 oC, µw
prod No                R            Amine        Amine (eq,)       Ar                T                Yield%
                                                                                                       (min)
   320                   CF3                               5.5                                   60                  78
   321                   CF3                               5.5                                   60                  75
   322                   CF3                                5.5                                   60                  92
 
   323                   CF3                                29                                   360                 61
   324a                  CF3                               5.5                                   30                  20
   325                    tBu                                5.5                                   30                  31
  326                     CF3                               5.5                                   60                  0
HN O
NH2
N
H
NH2
NO2
OMe
NO2
NO2
NO2
NO2
N
H
N
H
NO2
ayield over three steps started with the borylation of 2-chloro-4-tertbutylpyridine
N
R
ArN
2
45
R
1
R
2
H
H
N
H
313, 318, 319
 
Table 40: Preparation of 2-aryl-4-substituted-6-alkylaminopyridine derivatives 
 
 
NCl
Amine 11 eq.,
130 oC, µw, 60 min
NN
2
45
H
H
O OMe
NO2 NO2
O N
327 (75%)310  
 
Scheme 77: Preparation of [2-(4-nitrophenyl)-6-pyrrolidin-1-yl-pyridin-4-yl]-
pyrrolidin-1-yl-methanone 
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Product 320 was prepared by reacting starting material 319 with pyrrolidine. GC-MS 
showed a 100% conversion with a peak at Rt = 12.1 min with m/z 337 ([M]+, which 
indicated that the crude mixture contained the desired pyridine 320. Following 
chromatography, the product 320 was isolated in 78% yield. Confirmation of this 
product was obtained by GC-MS, which lacked a signal with the isotopic ratio for a 
chlorine atom. Furthermore, the signal for the 5-H in the 1H NMR spectrum moved to a 
slightly lower frequency  =6.6 ppm. Additionally, the 1H NMR spectrum showed a 
NOESY correlation between N-CH2 and 5-H. In a similar fashion pyridine analogues 321-
327 could be prepared in 20-92% yield. However the SNAr reaction was not successful, 
when using aniline with 6-chloropyridine 319 and did not afford the product 326. This 
may be due to the aniline not being a good nucleophile. In order to obtain compound 
323 in good yield, an excess amount of diethylamine was used and a longer reaction 
time. This is due to the low boiling point of diethylamine compared with other amines. 
It was found that using excess of pyrrolidine with pyridine 310 not only resulted in a 
SNAr reaction to generate a C-N bond, but also hydrolysed the ester to generate an 
amide 327 (Scheme 77). In order to find the best route to prepare pyridine derivatives, 
pyridine 320 was also prepared using route 2, the results are discussed in the next 
section. 
 
4.1.1.4 Preparation of 4-tri-fluoromethyl-6-(N-pyrrolidinyl)-pyridine 
Following the second route above (Section 4.1.1, Figure 30) to prepare the 2,4-6-
substituted pyridine derivatives, Following the SNAr procedure applied above (Scheme 
76), 4-tri-fluoromethyl-2-(N-pyrrolidinyl)-pyridine 328 was obtained in a 90% yield 
(Scheme 78).  
111 
 
N
CF3
Cl 130 
oC, µw, 60 min N
CF3
N
pyrrolidine 5.5 eq.,
328 (90%)307  
Scheme 78: Preparation of 4-tri-fluoromethyl-2-(N-pyrrolidinyl)-pyridine 
 
In order to prepare the desired pyridine 320, according to the route 2 (Figure 30), 
borylation of compound 328 was needed. Following the standard borylation 
procedure, described before (Section 4.1.1.1, Table 37), a 84% conversion of pyridine 
328 was obtained by 1H NMR analysis. Ar-Bpin 329 was coupled directly with 4-
nitroiodobenzene to afford the desired pyridine 320 in 49% yield (Scheme 79). 
 
N
R
N
B2pin2 1.2 eq.,
MTBE, 80 oC, 3 h
[Ir(cod)(OMe)]2 5.0 mol%,
dtbpy 10 mol%,
N
R
N
Bpin
1.5 eq., DMA,100 oC,
 3 h
PdCl2(dppf) 5 mol%, 
Cs2CO3
N
R
N
NO2
320 (49%)
328 (R = CF3) 329 (84% by 1H NMR)
4-iodonitrobenzene
 
Scheme 79: Preparation of 4-tri-fluoromethyl-6-(N-pyrrolidinyl)-pyridine 
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4.2 Summary and Conclusions 
In this work, a range of multisubstituted pyridines was prepared over three steps in 
good yields. Both routes were effective for the preparation of the final pyridine 320. 
For unclear reasons borylation of pyridine containing CF3 and tBu at 4-position gave a 
better conversion of the starting material than with an ester group. Through fractional 
design of borylation reactions, it was found that increased loading of Ir-catalyst and 
higher temperature using microwave reactor led to greater conversion in the 
borylation of methyl-2-chloroisonicotinate 151. An 82% conversion of 328 was 
achieved with a high loading of Ir catalyst and B2pin2 with heating in microwave 
reactor for 3 h. A number of bi-aryl compounds were successfully prepared using the 
Suzuki-Miyaura cross-coupling reaction. In the solvent-free SNAr reaction, the aliphatic 
amines showed a better activity in the reaction compared with aromatic amines.  
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Chapter 5 
5 Synthesis of phenanthroline ligand using in polymer supported iridium 
C-H borylation  
5.1 Introduction 
As described in section 1.1.4.3 above, owing to the reported high activity achievable, 
the use of phenanthroline-type ligand systems in supported C-H borylation was an 
attractive approach.43,107 As with the bipyridine ligands discussed in chapter 3, the aim 
was to prepare modified phenanthroline derivatives that could be coupled to a 
suitable polymeric support (Figure 32). Ideally these ligands would contain bearing 
electron-donating groups as it was anticipated that these would unlock the highest 
activity. Therefore, ligand systems 332 and 333 were chosen as initial synthetic target 
for this aspect of the project. As before, it was of interest to compare the selectivity 
and activity of these phenanthroline derivatives in the borylation reaction with 
commercial available ligands such as 3,4,7,8-tetra-methyl-[1,10]-phenanthroline 66. 
NN
O O
NN
OO
or
RRR
4
5
333332  
Figure 32: Target Ligands 
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5.1.1 Preparation of 4,7-di-substituted-[1,10]-phenanthroline  
A review of the literature revealed that 4,7-di-substituted-[1,10]-phenanthroline may 
be accessed by heating 1,2-bis-[(2,2-di-methyl-4,6-dioxo-1,3-dioxan-5-ylidenemethyl)-
amino]-benzene derivatives 337, 340 and 341 (Figure 33). Compound 337 may be 
prepared in turn, by heating phenylenediamine 334 with Meldrum’s acid 335 in tri-
methyl orthoformate 336 (Scheme 80).112,113  
N N
HO
R
OH
NH
NH
O
O
O
O
O
O
O
O
R
R
NH2
NH2
+
O O
O OCH(OMe)3
335334 (R= H)
338 (R= Br)
339 (R= CN)
337 (R= H)
340 (R= Br)
341 (R= CN)
342 (R= H)
 
Figure 33: Retrosynthetic analysis of 4,7-di-hydroxy-[1,10]-phenanthroline112,113 
 
O O
OO
CH(OCH 3)3
NH HN
O
O O
O
O
O O
O
+
2)o-phenylenediamine (334),
   100 oC, 1 h
337 (77%)
12
335 336
1) 100 OC, 2 h
 
Scheme 80: Preparation of 1,2-bis[(2,2-di-methyl-4,6-dioxo-1,3-dioxan-5-
ylidenemethyl)-amino]-benzene112 
 
Following this precedent, a number of substituted 1,2-bis-aminobenzene derivatives 
337, 340-341 were prepared (Table 41). The sequence proved straightforward, with 
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the desired products being accessed in acceptable yields, after washing with ether. 
Each intermediate was characterised using a combination of LCMS, IR and NMR 
spectroscopy. 
O O
OO
CH(OCH 3)3
1) 100 OC, 2 h NH
NH
O
O
O
O
O
O
O
O
+
335
R
Comp. No    R               LC-MS                                  ATR                      yield%
                                  Rt min, m/z
     337          H        2.7, 854 [M2-H+Na]
+                 3264 (NH)                   82
                                                                                1725 (C=O)
     340          Br       3.0, 1012 [M2H+Na, 
79Br]+        3165 (NH)                   60
                              1014 [M2H+Na, 
81Br]+                1724(C=O)
     341          CN      2.7, 904 [M2-H+Na]
+                 3120 (NH)                    60
                                                                                 2239 (CN)
                                                                                 1724 (C=O)
NH2
NH2
R
2) 100 oC, 1 h
NN
HO OH
342 (R= H) 86%
260 oC, 30 min
Ph2O
336 334 (R= H)
338 (R= Br)
339 (R= CN)
R
 
Table 41: Preparation of 4-substituted-1,2-bis[(2,2-di-methyl-4,6-dioxo-1,3-dioxan-5-
ylidenemethyl)-amino]-benzene 
 
Presence of the final products was obtained by LC-MS analysis. For example, 
phenanthroline 342 showed a peak at Rt = 1.6 min m/z = 212 ([M]+, 100%), 214 
([M+2]+, 14%). Furthermore, the 1H NMR spectrum contained characteristic proton 
signals at  = 8.1, 6.3 and 7.6 for the protons of 2-, 3- and 5-positions, and lacked the 
characteristic NH signals at = 11.3 ppm observed in compound 337. However, 
compound 342 proved to be insoluble in hexane, THF and MTBE, the solvents required 
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for the borylation reaction. To help address this issue, and to test a possible strategy 
attachment to a solid support, the alkylation of 4,7-di-hydroxy-[1,10]-phenanthroline 
342 was explored.  
 
5.1.1.1 Alkylation of 4,7-di-hydroxy-[1,10]-phenanthroline 
A review of the literature revealed that 343 can be prepared by reaction of 4,7-di-
hydroxy-[1,10]-phenanthroline 342 with methyl iodide 224 using NaH in THF/DMF at 
room temperature (Scheme 81).113 
N
N
OH
HO
CH3I (224), NaH
THF/DMF (1:1) 0- R.T
N
N
O
O
343 (70%)342  
Scheme 81: Di-alkylation of 4,7-di-hydroxy-[1,10]-phenanthroline113 
 
However, these conditions afforded a mixture of mono- and di-alkylated products 
(entry 1, Table 42), as revealed by LC-MS analysis (Rt = 1.9, 2.6 and 2.0 min with m/z = 
240 ([M]+, 100%), 241 ([MH]+, 48%) for 343; m/z = 240 ([M]+, 61%), 241 ([MH]+, 100%) 
for 344;  227 ([MH]+, 100%) for 345. The difference between this outcome and that 
reported in the literature is not obvious.113 Following separation by chromatography, 
the 1H NMR spectra of the obtained compounds were analysed. Product 343 contained 
only 4 signals, including characteristic OCH3 signals at  = 4.1 ppm. Alkylation at 4-C-OH 
and 7-C-OH was confirmed by a NOESY correlation between the OCH3 protons with 3-H 
and 8-H. In contrast, product 344114 contained two characteristic CH3 signals at  = 4.1 
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and 4.6 ppm corresponding to alkylation at the 7-C-OH and 1-N positions, respectively. 
Again, this was confirmed through the NOESY spectrum which showed correlation 
between CH3 protons with 2-H and 8-H. The mono-alkylated product 345 could not be 
isolated in a pure form. However, using only 1.0 equivalent of MeI enabled 345 to be 
isolated in a low yield (26%). Attempts to enhance the ratio of the desired product 343 
using potassium carbonate or cesium carbonate as a base with heating at 100 oC were 
not successful (Table 42, entries 2&3). 
N
N
O
O
N
N
OH
HO
MeI (2.2 eq)
Base (6 eq), DMF
343 (10%)
N
N
OH
ON
N CH3
O
O
344 (8%) 345
100 oC, 6 h
entry         Base    eq.          Solvent           T         time             ratioa                             
                                                                  oC           (h)       (343:344:345)            
1               NaH    2.2            DMF:THF        r.t          18            2.0:2.8:1.0                 
2             K2CO3    6.0              DMF              100         6             1.0:5.3:---                       
3             Cs2CO3 6.0            DMF              100          6             1.0:9.0:----
+
+
342
HH
H
2
8
4
7
8
H
H
3
8
7
aratio determined by 1H NMR
Table 42: Attempted di-alkylation of compound 342 using different bases 
 
With a bis-alkoxy phen ligand in hand, it was of interest to compare the activity of 
ligand 343 with that of the well-established tmphen 66 in the borylation reaction. 
However ligand 343 proved to be insoluble in the solvents required in the borylation 
reactions (THF, MTBE and hexanes). Assuming that this insolubility related to π-
stacking, it was decided to explore alkylation with  steric larger alkyl halides such as 2-
iodopropane 346, which could be disrupt such interactions. Following the same 
procedure as Table 42, 2-iodopropane 346 and 4,7-di-hydroxy-[1,10]-phenanthroline 
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342 were heated at 100 oC for 6 h using cesium carbonate as base (Scheme 82). LC-MS 
analysis of the reaction mixture revealed a 97% conversion of starting material 342, 
with the observation of new peaks at Rt = 2.9, 2.8 and 3.5 min with m/z = 296 ([M]+) 
for 347; m/z = 255 ([MH]+) for 348; m/z = 296 ([M]+) for 349. This indicated that the 
crude mixture possibly contained two isomeric di-alkylation products 347 and 349 with 
mono-alkylation product 348 in a ratio 77:10:10 respectively. 
N
N
O
ON
N
OH
HO
(346) 2.2 eq.
Cs2CO3 (6 eq), DMF
347  (52%)
N
N
OH
O
N
N
O
O
348
349  (6%)
100 oC, 6 h
I 3
8
H
H
342
 
Scheme 82: Preparation of di-isopropoxyphenanthroline 347 
 
Following reversed-phase chromatography (silica C18), a 52% yield of product 347 and 
6% yield of product 349 were achieved. Confirmation of the proposed structures was 
obtained in a similar fashion to that described above. In particular for the symmetrical 
di-ether 347, alkylation at 4-and 7 was confirmed by a NOESY correlation between the 
CH3 signal of the isopropyl group and the protons at 3- and 8-positions. A similar 
sequence was used to prepare 5 substituted analogues 350 and 351 (Scheme 83). 
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NH
NH
O
O
O
O
O
O
O
O
R NN
O O
350  (R= Br)   51%
351  (R= CN)   65%
1) Ph2O, 260 
oC, 30 min
2) 2-iodopropane 2.4 eq.,Cs2CO3 6 eq.,
   DMF, 100 oC, 6 h
R
340 (R= Br)
341 (R= CN)  
Scheme 83: Preparation of 5-substituted-4,7-di-isopropoxy-[1,10]-phenanthroline 
 
5.1.2 Evaluation of Ligand 347 in the borylation of m-xylene 
Following the chemistry applied (Chapter 3, Section 3.2.2, Table 33), ligands 347 and 
tmphen 66 were used as ligands in the borylation of m-xylene 19 (Table 43). 
[Ir(OMe)(cod)]2 1.5 mol%, L
B2pin2 1.2 eq., THF
Bpin
entry No      Ligand       T                                                               conv (%)a
                      (L)            oC                                  2 h    4 h     6 h      24 h    72 h     168 h
   1                347           r.t                                   ----     ----     ----       ----       5          23
   2                66             r.t                                   ----     ----     ----         5       20        49
   3                347           80                                   58      78      82        ----       ----       ---- 
   4b              347           80                                   76      89      90        ----       ----        ----
 
   5                66             80                                   83      93      95        ----       ----        ----
aconversion determined by 1H NMR; b[Ir(OMe)(cod)]2, L (347) and B2pin2 were heated for 5 min at 80 
oC before 
adding starting material
2319
 
Table 43: Borylation of m-xylene using ligands 347 and 66 
 
120 
 
These reactions were followed by 1H NMR spectroscopy at both room temperature 
and 80 oC using undecane as a standard. Attempted reactions with ligand 347 at room 
temperature were not efficient, but at elevated temperatures (80 oC) ligand 347 
showed comparable activity to tmphen 66. When the ligand, precatalyst and B2pin2 
where heated together at 80˚C prior to addition of substrates (entry 4) the intial rates 
were faster suggesting that generation of the active iridium catalyst required heating. 
This is potentially due to the poorer solubility of these ligands. Having demonstrated 
that alkoxy substituted phenanthroline 347 was an active catalysts, the next objective 
was to attach this ligand, via a suitable linker, to a polymeric support.  
  
5.1.3 Preparation of suitable linker for attachment to a polymer  
5.1.3.1 Formation of C-C chain as suitable linker 
Based on the report by Jones,74 we initially explored the use of SBA-15 as a polymer 
supports, as these do not have C-H bonds to interfere in the borylation reaction. Of the 
various forms of silica support commercially accessible, MCM-41 was selected as a 
suitable model. MCM-41 is commercially available, whereas SBA-15 requires separate 
synthesis. From analysis of the desired phenanthroline polymer 356, it was initially 
proposed that coupling to the polymeric support 356 could be carried out through 
generation of the amide from ester 355. Compound 355 could be obtained through 
coupling of bromo-[1,10]-phenanthroline 350 with phenylboronate ester 354, through 
a Suzuki-Miyaura cross-coupling reaction (Figure 34). With this plan, the initial goal 
was the preparation of ester 354 which is discussed in the next section. 
121 
 
N
N
O
O
N
N
O
O
Br
O
O
EtO
Bpin
O
+O
EtO O
OH
+
Br
OEt
O
355
350354353352303
Si
O
Si
O
Si
O
Si
O
Si
OH
O
O
O
OH
Si
N
N
O
O
O
N
H
O
3
356
O
OEt
 
Figure 34: Strategy for immobilisation of [1,10]-phenanthroline ligands 
 
5.1.3.1.1 Borylation of (2,6-di-methyl-phenoxy)-acetic acid ethyl ester 
353 
It was planned that aryl boronate ester 354 could be obtained through the alkylation 
of 2,6-di-methylphenol 352 with ethylbromoacetate 303, followed by borylation of the 
resulting (2,6-di-methyl-phenoxy)-acetic acid ethyl ester 353. Ester 353 was prepared 
in good yield (96%) through heating of 2,6-di-methylphenol 352 with ethyl 
bromoacetate 303 in the presence of K2CO3 in acetone at 80 oC (Scheme 84). 
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OH
+ Br
OEt
O
K2CO3
Acetone, 80 oC, overnight
O
EtO O
353 (96%)352 303  
Scheme 84: Preparation of (2,6-di-methyl-phenoxy)-acetic acid ethyl ester 
 
Confirmation of the proposed structure was obtained by the 1H NMR spectrum which 
showed a shift in the CH2 signal from 3.8 ppm (BrCH2) to 4.4 ppm (ArOCH2). Borylation 
using [Ir(OMe)cod]2 21, dtbpy 22 and B2pin2 in THF proved to be efficient affording 354 
in 56% yield, following chromatography. 
 
O
EtO O
[Ir(OMe)(cod)]2 3.0 mol%,
B2pin2 1.5 eq., O
EtO O
Bpin
dtbpy 6.0 mol%, THF, 80 oC, 4 h
354 (56%)353
H
3
 
Scheme 85: Borylation of (2,6-di-methyl-phenoxy)-acetic acid ethyl ester 353 
 
This product was confirmed by the 1H NMR spectrum analysis, which showed a 
complex methyl signal multiplet integrating to 15H at  = 1.35-1.25 ppm for both Bpin 
moiety and CH3 of the ester. Moreover the 3-H signal shows the characteristic shift 
downfield from δ = 7.0 to δ = 7.5, due to the inductive effect caused by the ortho Bpin 
group. Having successfully generated the arylboronate ester 354, it was necessary to 
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attach the ligand 347 to a polymer. As described above, initial attempts explored 
Suzuki-Miyaura cross-coupling reactions. A survey of recent methods115 revealed that 
similar compounds have been prepared by the coupling of 5-bromo-2,9-di-methyl-
[1,10]-phenanthroline 357 with phenylboronic acid 358 using Pd(PPh3)4 and Ba(OH)2 in 
a 10:1 mixture of 1,2-di-methoxyethane:water (Scheme 86). 
N N
Br
+ B(OH) 2 1,2-dimethoxyethane:H2O 10:1
reflux, 18 h
Pd(PPh3)4 10 mol%, Ba(OH)2
N N
359 (65%)357 358  
Scheme 86: Preparation of 5-phenyl-2,9-di-methyl-[1,10]-phenanthroline115 
 
Despite this precedent, coupling of bromophenanthroline 350 with arylboronate ester 
354 following these conditions was unsuccessful. Attempts to vary the base, such as 
Cs2CO3 and K3PO4, and changing the catalyst to PdCl2(dppf) proved equally 
unsuccessful (Scheme 87). Control experiments using both unsubstituted 
phenylboronic acid and potassium phenyltri-fluoroborate also failed. It was speculated 
that either the steric bulk of the 4-isopropoxy group or coordination of Pd to the 
phenanthroline nitrogen’s inhibited any catalytic activity. 
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Scheme 87: Preparation of 5-aryl-4,7-di-ispropoxy-[1,10]-phenanthroline 
 
In an alternative pathway, a hydroxmethyl group at the 5-position of the 
phenanthroline ring 361, was proposed to enable introduction of tri-methoxysilane 
362 by simple alkylation (Figure 35). Compound 360 was obtained by lithiation of 4,7-
di-isopropoxy-5-bromo-[1,10]-phenanthroline 350 using n-BuLi in THF, followed by the 
addition of dry DMF116 at -78 oC (Scheme 88). 
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Figure 35: Retrosynthetic analysis of grafting tri-methoxysilane onto MCM-41 
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Scheme 88: Preparation of 4,7-di-isopropoxy-[1,10]-phenanthroline-5-carbaldehyde 
 
Although this reaction proceeded with complete consumption of the starting material 
350, only small amounts of the desired aldehyde 360 and two undesired products 347 
and 364 were obtained. Attempts to produce tri-methoxysilane 365 directly through 
anion alkylation, (Scheme 89) were similarly unsuccessful.  
N
N Br
O
O
THF, -78%, 18 h
N
N
O
O
365
Si(OMe) 3
3
350
(3-Iodopropyl)trimethoxysilane, n-BuLi
 
Scheme 89: Preparation of 4,7-di-isopropoxy-1,10-phenanthrolin-5-yl-propyltri-
methoxysilane 
 
Recognising that a similar aminomethyl linker 366 could be generated from nitrile 
reduction, the reduction of 4,7-di-isopropoxy-5-cyano-[1,10]-phenanthroline 351 was 
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then explored. However this could not be achieved using LiAlH4117 in THF or Pd/C118 
with H2 (Scheme 90). 
LiAlH4 2.0 eq.,
THF, 0- r.t,
NN
O O
CN
351
NN
O O
H2N
366
 
Scheme 90: Preparation of 4,7-di-isopropoxy-[1,10]-phenanthrolin-5-yl-methylamine 
 
From these attempts, it became clear that the formation of a C-C chain on the 5-
position of phenanthroline derivatives 332 (Figure 32) was challenging. Consequently, 
an alternative pathway to the desired material was sought. It was proposed that the 
formation of a O-C chain at the 4-position of the phenanthroline 333 (Figure 32) could 
function as a suitable linker to a polymer. In order to form a O-C bond, mono-
alkylation of 4,7-di-hydroxy-[1,10]-phenanthroline 342 was required. This is discussed 
in the next section. 
 
5.1.3.2 Formation of O-C chain as a suitable linker 
With the failure to develop a linker based on the 5- functionalised di-isopropyl ligands 
(361 & 366), attention turned to coupling to the polymer through one of the alkoxy 
substituents. Three strategies were envisaged to enable coupling of phenanthroline 
348 to an MCM-41 support. The first approach involved combining tri-methoxysilane 
with ligand 367, then grafting this to the polymer (Figure 36). The second approach 
involved building of a suitable linker on a polymer before adding the phenanthroline 
348 (Scheme 114). The final possibility involved attaching linker elements to both 
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components 368 and 369, which are then combined in a final step (Figure 38). Each of 
these strategies required the preparation of monoalkoxyphenanthroline 348 described 
in the following section.  
 
5.1.3.2.1 Preparation of 4-hydroxy-7-isopropoxy-[1,10]-phenanthroline 
As discussed above a key intermediate for immobilisation of the phen ligand was the 
monoalkoxy ether 348. This had previously been identified as a minor by-product from 
the preparation of di-alkoxy ether 347 (Section 5.1.1.1, Scheme 82). In order to 
generate the desired monoether 348 selectively, the reaction stoichiometry was 
investigated. Ultimately, heating 1.2 eq. 2-iodopropane with 4,7-di-hydroxy-[1,10]-
phenanthroline 342 at 100 oC for 7 h (Scheme 91) afforded a mixture of mono- and di-
alkylation in a ratio 1:4  of compounds 347 and 348, as observed by 1H NMR 
spectroscopy.   
N N
HO OH
I 1.2 eq.,
Cs2CO3 3.0 eq., DMF
100 oC, 7 h N N
O O
N N
O OH
+
342 347
348 (45%)
1H NMR ratio (347:348)
                     1.0:4.0  
Scheme 91: Preparation of 4-hydroxy-7-isopropoxy-[1,10]-phenanthroline 
 
Following extraction of the desired product 348 by 10% NaOH (aq.), a 45% yield of 
monoalkylated product 348 was obtained without the need for further purification. 
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Attempts to increase the proportion of mono to di-alkylation-phenantholine through 
controlling the rate of addition of the alkylating agent to the phenoxide anion gave 
surprising results. It was observed that adding the alkyl halide rapidly to the reaction 
mixture at 100 oC gave enhanced levels of monoalkyaltion whilst slow addition 
afforded a ~1:1 mixture of mono to bis-alkylated products. An explanation for this is 
not obvious. However this approach did allow reliable access to the desired 
phenanthroline building block 348. With ligand 348 in hand, the next objective was the 
preparation of a suitable linker to allow attachment to a polymer. The first approach 
involved heating mono-alkoxy-[1,10]-phenanthroline 348 with ethyl bromoacetate 303 
in DMF at 100 oC for 17 h in presence of cesium carbonate and tri-butylammonium 
iodide (Scheme 92).  
N N
O OH
N N
O O
+ Br
OEt
O
Bu4NI 10 mol%
Cs2CO3 3.0 eq., DMF
100 oC, 17 h
O
OEt
370 (21%)348 303  
Scheme 92: Alkylation of phenanthroline 348 with ethyl bromoacetate 
 
However, this afforded the undesired N-alkylated product 370 as confirmed through 
an observed NOESY correlation between the N-CH2 and 2-H signals. Further evidence 
was obtained from the IR spectrum which showed two carbonyl peaks at 1739 cm-1 
and 1623 cm-1 due to the stretching vibration of (C=O) ester and vinylogous amide 
bonds respectively. This undesired alkylation was observed in previous attempts using 
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methyl iodide.114 In this case the desired O-alkylation was achieved using 2-
iodopropane.113 Consequently, it was speculated that similar selectivity could be 
achieved using ethyl-2-bromopropanoate 371 instead of ethyl bromoacetate 303. 
Pleasingly this proved to be the case, affording the desired ether 367 as evidenced 
from LC-MS analysis which revealed a peak at Rt = 2.6 min with m/z = 354 ([M]+, 100), 
731 ([M2Na]+) with alkylation at 4-C-O-CH(CH3) being confirmed by a NOESY correlation 
between the alpha ester hydrogen (OCHCO2Et) and 3-H (Scheme 93).  
N N
O OH
N N
O O
+ Br
OEt
O
Bu4NI 10 mol%
Cs2CO3 3.0 eq., DMF
100 oC, 17 h
367 (66%)348 371
O
OEt
 
Scheme 93: Preparation of 2-(7-isopropoxy-[1,10]-phenanthrolin-4-yloxy)-propionic 
acid ethyl ester 
 
5.1.4 Evaluation of Ligand 367 in the borylation of m-xylene 
At this stage it was of interest to evaluate the efficacy of ligand 367 in the borylation 
reaction. Following the same procedure used previously (Section 5.1.2), the activity of 
ligand 367 was compared to that obtained using ligand 347. Importantly and, as 
expected, the two ligands showed comparable activity (Table 44). 
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[Ir(OMe)(cod)]2 1.5 mol%, L
B2pin2 1.2 eq., THF
Bpin
entry No      Ligand      temp.                                               conv (%)a
                     (L)           oC                                   2 h     4 h     6 h      24 h    72 h     168 h
                                 
   1                 347          r.t                                   ----     ----      ----        ----       5          23
   2                 367          r.t                                   ----     ----      ----         9        13        18
   3                 347          80                                   58      78      82         ----       ----       ---- 
   4b               347          80                                   76      89      90          ----       ----       ----
 
   5b               367          80                                   77      89      91          ----       ----       ----
   6b               367          80                                   75      90      92          ----       ----       ----
   7                 367          80                                   63     88       92          ----       ----       ----
a conversion determined by 1H NMR;   b[Ir(OMe)(cod)]2, L and B2pin2 were heated for 5 min at 80 
oC before adding starting 
material
2319
 
Table 44: Evaluation of ligand 367 in the borylation of m-xylene 
 
5.1.5 Attempted generation of MCM-41 supported Ligands  
Because of the difficulty in characterisation of the desired heterogeneous 
phenanthroline-MCM-41 372 (Figure 36), it was decided to attach the linker to the 
ligand and only then couple to the polymer support. As a result the first approach was 
to explore amide derivatives. This could simply be achieved by heating phenanthroline 
ester 367 with amine-tri-methoxysiliane 373 (Scheme 94). Disappointingly this reaction 
was unsuccessful even when using prolonged reaction times with base or acid 
catalysis119. With this, it was proposed that introducing an alkyne tail to the phen 
ligand would enable coupling to a polymeric azide 375 (Figure 37). The former could be 
obtained through the alkylation of alkoxyphenanthroline 348 with 2-bromo-N-(prop-2-
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yn-1-yl) propanamide 378. With this in mind preparation of propanamide 378 became 
the initial objective. This was prepared through facile reaction of 2-bromo-propionyl 
chloride 376 and propargylamine 377 (1.0 eq.) using Et3N in DCM at 0 oC (Scheme 95) 
 
N
N
O
O
O
N
372
(MCM-41)
 
Figure 36: Heterogeneous phenanthroline-MCM-41 (372) 
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Scheme 94: Preparation of amide 374 through coupling ester 367 with amine 
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Figure 37: MCM-41 supported ligand using triazole as linker 
Cl
Br
O
+
NH2
Et3N 1.2 eq.,
DCM, 0 oC, 17 h
N
H
Br
O
376 377 378 (88%)  
Scheme 95: Preparation of 2-bromo-N-(prop-2-yn-1-yl)-propanamide 378 
 
Product 378 was isolated in 88% yield. The proposed structure of this product was 
confirmed by 1H NMR, which showed a shift in the CH2 signal from 3.5 ppm (NH2CH2) 
to 4.05-3.94 ppm (NHCH2). With compound 378 in hand, alkylation of 4-hydroxy 
phenanthroline 350 was then attempted (Scheme 96). 
NN
O OH
+ N
H
Br
O
Bu4NI 10 mol%
Cs2CO3, DMF
NN
O O
HN
O
H
H
3
4
348 378
379 (17%)
Scheme 96: Preparation of 2-(7-isopropoxy-[1,10]-phenanthrolin-4-yloxy)-N-prop-2-
ynyl-propionamide 379 
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Following chromatography, the desired ether 379 was obtained, as characterised by a 
molecular ion at m/z = 364 and a distinctive NOESY correlation between the methane 
signal and the 3-H of the phen ligand (depicted in Scheme 96). Disappointingly the 
isolated yield was poor, and despite variations in the conditions above could not be 
further improved. Given this result, alternative modes to connect the two fragments 
based on an amide coupling were considered. In this approach the initial strategy 
involved the amide linker being assembled, coupled to the ligand and, subsequently, 
the polymeric support. This required access to 6-(2-bromo-propionylamino)-hexanoic 
acid 381 which could be generated through the reaction of 2-bromopropionyl chloride 
376 with 6-amino caproic acid 380 in presence of K2CO3 in DCM at 0 oC for 17 h 
(Scheme 97). 
 
Cl
Br
O
+
K2CO3 1.2 eq.,
DCM, 0 oC, 17 h N
H
Br
O
376 380 381 (43%)
H2N OH4
O
OH
O
4
 
Scheme 97: Preparation of amide 381 
 
Analysis by LC-MS showed complete conversion of carboxylic acid 380, indicating that 
the crude mixture contained the desired product 381. A 43% yield of the desired 
product 381 was obtained following acidification of aqueous solution (pH=2-3), with 
subsequent trituration from di-ethylether. Formation of amide 381 was confirmed the 
appearance of a peak in the LCMS spectrum at Rt = 2.2 min with m/z = 266 ([M (81Br)-
H]-, 100%), 264 ([M (79Br)-H]-, 100%) coupled with IR spectrum analysis, which revealed 
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two absorptions at 1700 cm-1 and 1652 cm-1 due to the C=O stretching vibrations of the 
acid and amide bonds respectively. Disappointingly, attempted alkylation of 4-
hydroxyphenanthroline 350 with 6-(2-bromo-propionylamino)-hexanoic acid 381 (1 
eq.) following the same protocol as described above, did not give the desired product 
382 (Scheme 98). 
+ N
H
Br
O
N
N
O
HO
Bu4NI 10 mol%
Cs2CO3, DMF
4
OH
O
4
NN
O O
O
NH
OH
O
348 381 382
Scheme 98: Preparation of 6-[2-(7-isopropoxy-[1,10]-phenanthrolin-4-yloxy)-
propionylamino]-hexanoic 382 
 
Assuming that the free carboxylic acid was interfering with the coupling, the 
corresponding methyl ester 383 was prepared using TMS-diazomethane120 in 
MeOH:EtOAc 1:1 at r.t overnight (Scheme 99).  
N
H
Br
O
OH
O
4
381
MeOH:EtOAC 1:1, 0 oC, overnight
TMS-diazomethane(2 M in hexane)
N
H
Br
O
OMe
O
4
383  (89%)  
Scheme 99: Preparation of 6-(2-bromo-propionylamino)-hexanoic acid methyl ester 
383 
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Ester 383 was obtained in 89% isolated yield and characterised by 1H NMR analysis 
which showed a characteristic methyl signal for the ester group at  = 3.5 (3H,s, OMe). 
Furthermore, a peak at 1734 cm-1 was observed in the IR spectrum, due to the 
stretching vibration of (C=O) ester bonds. With the ester 383, the alkylation proceeded 
efficiently to afford complete conversion of phenanthroline 348 as determined by 
LCMS (Rt = 2.5 m/z = 930 ([M2H]+, 30%), 454 ([MH]+, 100%)) (Scheme 100).  
+ N
H
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O
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N
O
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Bu4NI 10 mol%
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348 383 384
Scheme 100: Preparation of 6-[2-(7-isopropoxy-[1,10]-phenanthrolin-4-yloxy)-
propionylamino]-hexanoic acid methyl ester 384 
 
Unfortunately, all attempts to purify this compound were unsuccessful and, given the 
difficulties in assembling this linker, alternative modes of coupling to the polymer were 
investigated. With the unsuccessful attempt to couple the caproate to the phen ligand 
it was decided to explore building the linker onto the polymeric support and forming 
the key amide bond as the final step. Grafting N-methylaminopropyltri-methoxysilane 
onto MCM-41 therefore became the first objective 
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Figure 38: Retrosynthetic of the desired polymer 391 
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5.1.5.1 Grafting N-methylaminopropyltri-ethoxysilane 374 onto (MCM-
41) 385 
Following literature protocols,121-124 N-methylaminopropyltri-methoxysilane 373 was 
mixed with (MCM-41) 385 in dry toluene. The reaction mixture was then heated to 
reflux at 120 oC for 35 h (Scheme 101). 
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386373385  
Scheme 101: Grafting the N-methylaminopropyl-tri-ethoxysilane 374 onto (MCM-41) 
385 
 
Following washing with dry toluene and methanol, the desired aminofunctionalised 
polymer 386 was obtained (1.21 mmol/g polymer). The proposed compound was 
characterised by elemental analysis (CHN found C% 10.58, H% 2.69, N% 7.74; 
C5H13NOSi required C% 45.76, H% 9.98, N% 10.67) and 13C NMR solid state 
spectroscopy, revealing characteristic methyl signals at  = 50 for the MeOSi and NCH2 
groups, which confirmed that only one methoxy group remained after grafting the 
trimethoxysilyl 373 onto MCM-41. 
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5.1.5.2 End-Capping the functionalized MCM-41 
Because the residual hydroxyl groups on the MCM-41 polymer may interfere with 
subsequent reaction, these were then capped as silyl ethers. This was achieved by 
shaking the modified polymer 386 with HMDS in toluene at room temperature 
overnight (Scheme 102). Further 13C NMR solid state analysis showed characteristic 
methyl signals at  = 0.0 for the OSi(CH3)3 group. 
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Scheme 102: End-Capping the functionalized (MCM-41) 387 
 
Given the difficulties in assessing loading of aminomethyl group by simple 
measurements, it was decided to introduce an Fmoc group to exploit classical Fmoc 
analysis.125,126 This required a suitable Fmoc terminated linker. Consequently, following 
a reported protocol,127 6-(9H-fluoren-9-ylmethoxycarbonylamino)-hexanoic acid 389 
was prepared by stirring of 6-amino caproic acid 380 with Fmoc-Cl 388 and Na2CO3 in 
dioxane:H2O at r.t (Scheme 103). With Fmoc acid 389 in hand, coupling to the 
polymeric amine was then explored. Initially, a model reaction using N-
methylbenzylamine 392 was undertaken. Using EDCI in presence of DMAP and DIPEA 
in DCM at r.t,128 and following chromatography, a 27% yield of the desired amide 393 
was obtained (Scheme 104). The proposed structure was confirmed by LC-MS analysis 
139 
 
which showed a peak at Rt = 3.8 min m/z = 936 ([M2H+Na]+, 100%), 457 ([MH]+, 56%), 
indicating the correct mass for the desired product. Despite the low yield this positive 
result encouraged us to explore the coupling of sec amine-(MCM-41) 387 with Fmoc-
COOH 389. Following this precedent,128 the desired Fmoc polymer 390 was obtained 
through coupling of Fmoc-COOH 389 with N-methylamine-(MCM-41) 387 (Scheme 
105). 
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Scheme 103: Preparation of 6-(9H-fluoren-9-ylmethoxycarbonylamino)-hexanoic acid 
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Scheme 104: Preparation of 6-(9H-fluoren-9-ylmethoxycarbonylamino)-hexanoic acid 
393 
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Scheme 105: Immobilising the Fmoc onto (MCM-41) 390 
 
In order to ensure high conversion of the polymeric amine, the reaction was repeated 
twice. Formation of the desired amide was confirmed by solid state 13C NMR, showing 
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additional peaks at 40 and 27 ppm for the aliphatic groups, 125 ppm and 141 ppm for 
the aromatic of Fmoc ring, and 174 for the C=O amide. In addition, the IR spectrum 
showed a peak at 1600 cm-1 due to the stretching vibrations of (C=O) amide bond. 
Following standard literature protocols129,130 the Fmoc group was removed using 20% 
piperidine in DMF (Scheme 106). In this reaction 1 g of 390 was divided into two 
portions (X & Y) and each was shaken with the same volume of 20% piperidine to 
remove the Fmoc (Section 6.2.33, Table 45). UV measurement of the solution at λ = 
300 nm, followed by analysis using the Beer-Lambert law was used to determine the 
concentration of the piperidine fulvene adduct in both solutions (the equation of 
which is discussed in section 6.2.33.129 Disappointingly, this suggested that very low 
loading of the amine onto MCM-41 polymer (0.018 mmol/g) had been achieved. 
However it was decided to continue and explore the coupling of this amine to the Phen 
ligand 368. 
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Scheme 106: Deprotecting of amine using piperidine  
 
Based on the retrosynthetic analysis discussed in section 5.1.5, Figure 38, it was 
proposed that the amide could be prepared by coupling of an amine such as the MCM-
41 polymer 369 with either carboxylic acid or the corresponding lithium salt.128,131 
Consequently, the initial task was to hydrolyse the ester. This was achieved using LiOH 
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in methanol and and water with following acidification and extraction, gaving a 31% 
yield of 2-(7-isopropoxy-[1,10]-phenanthrolin-4-yloxy)-propionic acid 395 (Scheme 
107) as confirmed by LC-MS analysis which showed a peak at Rt = 2.2 min m/z = 651 
([M2-H]-, 100%), 325 ([M-H]-, 48%). In addition, the 1H spectrum NMR lacked the 
characteristic ethyl ester signals. With the acid 395 available, the first reaction 
undertaken was a model coupling with N-methylbenzylamine 392 (Scheme 108). 
However following the procedure previously used to generate amide 396 using EDCI 
was not successful. One possible reason for this observation could be the steric 
hindrance in both reagents. 
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Scheme 107: Hydrolysis of ester using LiOH  
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Scheme 108: Preparation of amide using EDCI 
 
Consequently, an alternative pathway was sought. A survey of the literature suggested 
that carboxylate salts provide greater reactivity in formation of sterically hindered 
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amides. For example, amide 399 can be prepared from the coupling reaction of amine 
398 with lithium carboxylate 397 using HBTU in DMF (Scheme 109).131 
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+ H2N COOBn
HBTU 1.1 eq.,
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399 (quant yield)398 (1.0 eq.)397 (1.1 eq.)  
Scheme 109: Preparation of amide 399 using HBTU131 
 
In order to follow this precedent, the preparation of the phenanthroline lithium 
carboxylate 368 was required. This lithium salt was accessed by hydrolysis of ester 367 
prior to removal of the solvent under reduced pressure. As before, prior to using the 
precious polymeric amine 369, a model study with N-methylbenzylamine 392 was 
undertaken (Scheme 110). Following the literature precedent131utilising HBTU afforded 
the desired amide 396, as charcterised by a new peak at Rt = 2.9 min m/z = 882 
([M2H+Na]+, 18%), 430 ([MH+]+, 100%) in the LC-MS trace. However, full conversion was 
not observed by LCMS, and following chromatography a 20% yield of the phenanthroline 
amide 396 was obtained.   
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Scheme 110: Preparation of N-benzyl-2-(7-isopropoxy-[1,10]-phenanthrolin-4-yloxy)-
N-methyl-propionamide 396 
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With successful formation of the desired amide bond, attention then turned to 
coupling of MCM-41 amine 369 with the phenanthroline lithium salt 368. Following 
the same procedure, but using 3 equivalents of phenanthroline salt 368 to MCM-41 
amine 369 to enhance conversion, the generation of the polymeric ligand 391 was 
attempted (Scheme 111).  
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Scheme 111: Preparation of the desired polymer 391 
 
Disappointingly, confirmation of the desired polymer using solid state NMR analysis 
was not possible. This may be due to the very low loading of the primary amine onto 
MCM-41. Consequently, in order to confirm whether the ligand had been immobilised 
onto MCM-41 coordination of the Ir catalyst was attempted. Following the standard 
procedure used to generate the tris boryliridium catalyst (Chapter 1, Section 1.1.5) 
500 mg of polymer 391, [Ir(OMe)(cod)]2 (1 eq.) and B2pin2 (3 eq.) were mixed in dry 
degased THF  (2 ml) at 50 oC for 10 min (Scheme 112). The polymer was then washed, 
under argon, with dry degased THF, dried in vacuo and then used directly to borylate 
m-xylene. This reaction was carried out at 80 oC for 6 h and, following washing with dry 
degased THF, the resulting solution was collected and concentrated in vacuo. 
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Scheme 112: Preparation silica supported iridium catalyst 399 
 
Disappointedly, no borylated product could be detected by GC-MS analysis. This may 
be due to the low loading of the ligand 368 on a polymer.  
 
5.1.6 Future work 
With the failure to develop the MCM-41 supported iridium catalyst, attention will turn 
towards immobilizing the ligand 368 on different resins. As before, the main criterion 
was a resin lacking aromatic rings, which could be borylated. PEG resins with terminal 
amines such as amine PEG A could be directly attached to the ligand. The amine PEG A 
is commercial available with good amine loading (0.35 mmol/g) and could be coupled 
with the lithium phenanthroline-carboxylate 368 or with the long chain-carboxylic acid 
381 and alkylated with mono-ether 348. In both cases, the resulting PEG supported 
ligand 398 and 401 could be coordinated with iridium catalyst to generate the active 
tris-boryliridium catalyst 399 (Scheme 113) and 402 and (Scheme 114).  
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5.1.7 In conclusion 
In this work, symmetrical phenanthroline 347 and the mono-alkylated 348 could be 
prepared by Altman’s procedure using different equivalents of 2-iodopropane. 348 
could then be converted to phenanthroline ester 367 in good yield. Attempts to 
introduce a linker at the 5-position of phenanthroline 350 and 351 by either Suzuki-
Miyaura cross coupling or reduction of the nitrile group were unsuccessful. Ligands 
347 and 367 showed comparable activity to the commercially available tmphen ligand 
for the borylation of m-xylene (Table 43,Table 44). A phenanthroline ligand with a 
suitable linker 367 and 368 was sucucessfully achieved. Coupling of amine-tri-
methoxysiliane 373 with ester 367 to generate amide 374 was not successful, while 
coupling of lithium carboxylate 368 with amine 392 was successfuly prepared using 
HBTU reagent. Unfortunately, low loading of the Fmoc onto MCM-41 led to decreased 
loading of the phenanthroline ligand onto MCM-41. Disappointingly, no borylation of 
m-xylene was achieved using the MCM-41-supported iridium catalyst.  
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6 Experimental Procedures 
6.1 General Considerations 
Borylation reactions 
All borylation reactions were carried out under a dry nitrogen atmosphere using 
standard Schlenk techniques. Glassware was dried in oven before using in the 
borylation reaction. Solvents were anhydrous and degassed 3 times using freeze-
pump.  
 
Coupling reactions  
Solvents were used without drying and degassed 3 times using freeze-pump. 
 
Solvents 
 Anhydrous methyl-tert-butyl-ether (MTBE) was purchased from Sigma Aldrich. DMF 
and DMA were purchased from Sigma Aldrich. All other reaction solvents were dried 
using an Innovative Technology Solvent Purification System (SPS) and stored under 
Argon. 
 
Reagents 
[Ir(OMe)(cod)]2 was prepeared according to a procedure described,132 from IrCl3.3H2O, 
obtained from Precious Metals Online. B2pin2 was received as a generous donation 
from Allychem Co. Ltd. (P.R.China) and was used without purification. All other 
reagents were supplied from Alfa-Aesar, Apollo Scientific, Fluorochem, Acros, Sigma-
Aldrich or Lancaster. 
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Microwave Reactor 
All microwave reactions were carried out in septum-containing, crimp-capped, sealed 
vials in a monomodal EmrysTM Optimizer reactor from Personal Chemistry. The wattage 
was automatically adjusted to maintain the desired temperature for the desired period 
of time. 
 
NMR Spectroscopy 
NMR spectra were recorded at ambient temperature on Varian VNMRS (13C); Bruker 
Avance-400 (1H), Varian VNMRS-700 (1H, 13C[1H], HSQC, HMBC, COSY) or Varian Inova-
600 (1H, 13C[1H], HSQC, HMBC, COSY) spectrometers. The 1H and 13C chemical shifts are 
reported in ppm using the residual solvent signal of the deuterated solvents (CDCl3: H 
= 7.26 ppm, c = 77.16; Benzene d6: H 7.16 ppm, c = 128.06; DMSO d6: H = 2.50 ppm, 
c = 39.52 ppm; Methanol d4: H = 3.31 ppm, c = 49.00 ppm; NaOD: H = 4.79 ppm). All 
chemical shifts are reported in parts per million relative to tetra-methylsilane (H = 
0.00 ppm). All coupling constants are reported in Hz. Multiplicities are reported using 
the following abbreviations; s (singlet), d (doublet), t (triplet), q (quartet), p (pentet), 
hep (heptet), m (unresolved multiplet). Assignment of spectra was carried out using 2D 
COSEY, HSQC, HMBC and NOESY techniques. 
 
Elemental Analysis 
CHN Analysis was performed on a Exter Analytical CE-440 Elemental Analyzer. 
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IR Spectroscopy 
Infrared spectra were measured on a Perkin-Elmer Paragon 1000 FT-IR spectrometer 
via the use of a Diamoned ATR (attenuated total reflection) accessory (Golden Gate). 
Assigned peaks are reported in wavenumbers (cm-1). 
 
Thin-Layer Chromatography (TLC) 
TLC was performed on “Polygram Sil G/UV” plastic-backed silica plates with a 0.2 mm 
silica gel layer doped with a fluorescent indicator. Plates were purchased from VWR 
International. 
 
Flash Column Chromatography 
Flash column chromatography refers to purification by automated operation using a 
Teledyne Isco CombiFlash RF machine on pre-packed silica Redisep® Rf cartridges with 
the stated solvent gradient and at a constant flow rate of 35 mL/min. Reverse phase 
chromatography used pre-packed C18 silica Redisep® Rf cartridges and a 0-100% MeOH 
in H2O (containing 0.1% HCOOH) gradient elution. 
 
Mass Spectroscopy 
GC-MS analyses were performed on an Agilent 6890N gas chromatography (column: 
HP-5MS, 10 m, Ø 0.25 mm, film 0.25 µm; injector: 250 oC; oven: 70 oC(2 min), 70 oC to 
250 oC (20 oC min-1), 250 oC (5 min); carrier gas: helium (1.6 mL min-1) equipped with an 
Agilent 5973 inert mass selective detector operating in EI mode and a custom built 
Anatune liquid handling system functioning as autosampler/injector. Electrospray (ES) 
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mass spectra were obtained on a Micromass LCT Mass Spectrometer. High Resolution 
mass spectra were obtained using a Thermo Finnigan LTQFT mass spectrometer or 
Xevo QToF mass spectrometer (Waters UK, LTd) by the Durham University Mass 
Spectrometry Service. 
 
Melting Point 
Melting points were recorded using an Electrothermal 9100 capillary melting point 
apparatus. 
 
UV-Vis-Spectrometry 
Measurements were performed on a Unicam UV-Vis Spectrometer UV2. 
 
 
 
 
 
 
 
 
 
 
 
 
151 
 
6.2 Experimental details 
Chapter 2 
6.2.1 General Procedure for the Preparation of Stock Solution for C-H 
Borylation 
In a glove box, supplied with inert gas atmosphere, a mixture of [Ir(OMe)cod]2 (0.1 g, 
0.15 mmol), dtbpy (0.08 g, 0.3 mmol) and B2pin2 (2.54 g, 10 mmol) was prepared in 
MTBE or THF (25 ml) by shaking vigorously in a volumetric flask. The resulting deep red 
coloured solution was then stored in a sealed tube at −20 C. 
 
6.2.2 Borylation of quinoline derivatives 
6.2.2.1 Protocol A1: 
The starting material, test substrate, (1.0 mmol) was placed in a reaction vessel, which 
was then sealed, evacuated under vacuum, backfilled with N2. A 2.5ml aliquot of the 
borylation stock solution containing [Ir(OMe)cod]2 (1.5 mol%), dtbpy (3 mol%) and 
B2pin2 (1 mmol) was added to the reaction vessel. 
 
6.2.2.2 Protocol A2: 
A mixture of the catalyst [Ir(OMe)cod]2 (X mmol, X mol%), dtbpy (2X mmol, 2X mol%), 
B2pin2 (X mmol) and the test substrate (1.0 mmol) were placed in the reaction vessel 
which was then sealed, evacuated, backfilled with N2 followed by addition of THF 
(2ml).  
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The reaction mixtures were then either heated up in a microwave reactor or under 
refluxe, subsequently, the reactions were quenched by adding DCM and the solvents 
were removed in vacuo to afford the crude products. 
 
6.2.3 Preparation of 2-(aryl substitution)-quinoline 
6.2.3.1 Baran Procedures B:82 
6.2.3.1.1 2-(3’,5’-Di-methylphenyl)-quinoline (199) 133 
6.2.3.1.2 4-(3’,5’-Di-methylphenyl)-quinoline (200)134 
 
 
 
A mixture of silver (I) nitrate (67.9 mg, 0.4 mmol) in water (0.5 ml) and K2S2O8 (0.81 g, 
3 mmol) was added to a mixture of quinoline 111 (0.118 ml, 1 mmol), TFA (77 µL, 1 
mmol) and 3,5-di-methylphenylboronic acid 198 (0.6 g, 4 mmol) in biphasic DCM (5 ml) 
and water (3 ml). The mixture was stirred at room temperature for 12 h. An equivalent 
amount of AgNO3 and K2S2O8 was added again if arylboronic acids not dissolve totally 
after 3 h. A mixture of DCM (12 ml) and (5%) NaHCO3 (20 ml) was then added to dilute 
and wash the solution respectively. The crude mixture was extracted with DCM, dried 
over MgSO4 and concentrated in vacuo. Purification by chromatography on silica gel 
(1:3 EtOAc:hexane) afforded two isomers: 2-(3’,5’-di-methylphenyl)-quinoline 199 was 
isolated as a green oil (0.08g, 34%); Product 199: rf 1: 3 EtOAc:hexane = 0.22; max 
(ATR) 1594, 1556, 1503, 1376, 1315, 1206, 856, 823, 788, 754, 700, 678, 624 cm-1; H 
N 2
1
4
7
6
5
9
10
8
3
3'
1'
2'
4'
5'
6'
200
N 2
1
4
7
6
5
9
10
8
3
3'1'
2'
4'
5'
6'
199
153 
 
(700 MHz, CDCl3) 8.2 (1H, d, J = 8.4 Hz, 8-H), 8.2 (1H, J = 8.5 Hz, 4-H), 7.8 (1H, d, J = 8.5 
Hz, 3-H), 7.82-7.79 (3H, m, 5-H, 2’,6’-H), 7.7 ( 1H, ddd, J = 8.4 Hz, J = 6.8 Hz, 1.5 Hz, 7-
H), 7.5 (1H, dd, J = 8.0 Hz, J = 6.8 Hz, 6-H), 7.1 (1H, s, 4’-H), 2.5 ( 6H, s, 3’-CH3, 5’-CH3); 
C (176 MHz, CDCl3) 157.6 (C-2), 148.1 (C-9), 139.5 (C-1’),138.2 (C-3’,5’), 136.5 (C-4), 
130.9 (C-4’), 129.5 (C-8), 129.4 (C-7), 127.3 (C-5), 127.0 (C-10), 126.0 (C-6), 125.3 (C-
2’,6’), 119.1 (C-3), 21.3 (C-2-(CH3)2); m/z (GC-MS, EI+) 234 ([MH]+, 17.9%), 233 ([M]+, 
100%), 232 ([M-H]+, 49.7%), 217 ([M-CH4]+, 27%). 
Furthermore, 4-(3’,5’-di-methylphenyl)-quinoline 200 was isolated as a yellow oil (0.09 
g, 39%); product 200 rf 1:3 EtOAc:hexane = 0.5; max (ATR) 1600, 1581, 1564, 1506, 
1390, 1288, 1029, 843, 762, 729, 704,638 cm-1; H (700 MHz, CDCl3) 8.9 (1H, d, J = 4.2 
Hz, 2-H ), 8.2  (1H, dm, J = 8.4 Hz, 8-H), 7.9 (1H, dm, J = 8.4 Hz, 5-H), 7.7 (1H, ddd, J = 
1.4 Hz, J = 7 Hz, J = 8.4 Hz, 7-H), 7.5 (1H, ddd, J = 1.4 Hz, J = 7 Hz, J = 8.4 Hz, 6-H), 7.3 
(1H, d, J = 4.2 Hz, 3-H), 7.1 (1H, s, 4’-H), 7.1 (2H, s, 2’,6’-H), 2.4 (6H, s, 3’,5’-CH3); C (700 
MHz, CDCl3) 150.1 (C-2), 149.0 (C-4), 148.8 (C-9) 138.3 (C-3’,5’), 138.1 (C-1’), 130.1 (C-
4’), 130.0 (C-8), 129.3 (C-7), 127.4 (C-2’,6’), 127.0 (C-10), 126.6 (C-6), 126.2 (C-5), 121.3 
(C-3), 21.5 (C-2-(CH3)2); m/z (GC-MS, EI+) 234 ([MH]+, 48.7%), 233 ([M]+, 100%), 232 
([M-H]+, 66.7 %), 218 ([M-CH3]+, 100%), 203 ([M-2CH3]+, 15%), 189 (14%), 176 (4%). 
 
6.2.3.2 Suzuki-Miyaura Cross-Coupling general procedure C:84 
Under N2, a mixture of 2-halo heteroaromatic (1 eq.), arylboronic acid (3.0 equiv) and 
Pd(PPh3)4  (X mol%) was dissolved in a degased mixture of toluene (3 ml) and 2 M (aq.) 
potassium carbonate (1.1 ml) in a closed microwave vessel. The mixture was heated in 
the microwave for the stated time at 160 oC and then cooled to room temperature. 
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The crude mixture was then washed with NaHCO3 (aq.) solution and extracted with 
EtOAc (2 × 20 ml). The combined organic extracts were then back extracted using 1 M 
hydrochloric acid. The aqueous layers were then neutralized (pH = 7) with 1 M sodium 
hydroxide and then extracted with ether (3×10 ml). The organic extracts were then 
dried (MgSO4) and concentrated in vacuo to afford the title biaryl compound. 
 
6.2.3.2.1 2-(3’,5’-Di-methylphenyl)-quinoline (199)133  
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Following Suzuki-Miyaura cross-coupling procedure C, 2-chloroquinoline 203 (36.8 mg, 
0.39 mmol) was reacted with 3,5-di-methylphenylboronic acid 198 (177 mg, 1.17 
mmol) in the presence of Pd(PPh3)4 (10 mol%), heated for 10 min to afford the title 
biaryl 2-(3’,5’-di-methylphenyl)-quinoline 199 as a green oil (69 %); Data have been 
identified above in 6.2.3.1.1.   
 
6.2.3.2.2 2-(4’-Methoxyphenyl)-quinoline (205)135 
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Following Suzuki-Miyaura cross-coupling procedure C, 2-chloroquinoline 203 (36.8 mg, 
0.39 mmol) was reacted with 4-methoxyphenylboronic acid 5 (177.8 mg, 1.17 mmol) in 
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the presence of Pd(PPh3)4 (5 mol%)  to afford after heating for (1 h) the title biaryl 2-
(4’-methoxyphenyl)-quinoline 205 as a brown solid (85 %), (mp = 121-122 oC, lit.,135 
123.7-125.6 oC); max (ATR) 1596, 1550, 1497, 1430,1248, 1175, 1027,815, 789, 
748,726 cm-1; H (600 MHz, C6D6) 8.4 (1H, d, J = 8.4 Hz, 8-H), 8.32-8.27 (2H, m, 2’-H, 6’-
H), 7.7 (1H, d, J = 8.6 Hz, 4-H), 7.5 (1H, d, J = 8.6 Hz, 3-H), 7.5 (1H, d, J = 8.1 Hz, 5-H), 7.4 
(1H, ddd, J = 8.4, J = 6.8 Hz, J = 1.5 Hz, 7-H), 7.21-7.17 (1H, m, 6-H), 7-6.9 (2H, m, 3’,5’-
H), 3.3 (3H, s, OCH3); C (151 MHz, C6D6) 161.6 (C-4’), 157.1 (C-2), 149.3 (C-9), 136.6 (C-
4), 132.8 (C-1’), 130.4 (C-8), 129.8 (C-7), 129.5 (C- 2’,6’), 127.8 (C-5), 127.5 (C-10), 126.1 
(C-6), 118.5 (C-3), 114.6 (C-3’,5’), 55 (C-OCH3); m/z (GCMS, EI+) 236 ([MH]+, 18%), 235 
([M]+, 100%), 220 ([M-CH3]+, 29%), 204 ([M-OCH3]+, 4%), 191 (30%). 
 
6.2.4 Preparation of quinoline 2,4-dione derivatives, procedure D85 
In a round bottom flask, a mixture of malonic acid (1.1 eq.), POCl3 (1 eq.) and an aniline 
derivative (1 eq.) was heated with stirring at 50 oC for 2 h. The temperature was then 
increased slowly to 90 oC over 30 min and the reaction was heated for another 30 min. 
Upon cooling down the reaction mixture to room temperature, 0.5 M sodium 
hydroxide was initially added to render the pH basic (pH = 14) followed by addition of 
concentrated hydrochloric acid (HCl) to render the solution acidic (pH = 2-3) causing 
the product to precipitate. The resultant precipitate was collected by filtration, washed 
with water and dried in a desiccator. The product was purified by trituration with 
ethanol to yield the desired quinoline-2,4-dione derivative. 
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6.2.4.1 4-Hydroxy-7-methoxyquinoline-2-one (211)136 
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Following procedure D, malonic acid 208 (2.6 g, 25.2 mmol), POCl3 (2.2 ml, 23.9 mmol) 
and m-anisidine 209 (2.7 ml, 23.9 mmol) were used in order to afford 4-hydroxy-7-
methoxyquinoline-4-one 211 as a white solid (2.0 g, 43%), (mp > 300 oC, lit.,136 >300 
oC); max (ATR) 3000-2672 (broad, NH), 2612 (OH), 1626 (C=O), 1600, 1552, 1509, 1463, 
1435, 1379, 1329, 1246, 1214, 1183, 1151, 1015, 802, 733, 632 cm-1; H (700 MHz, d6-
DMSO) 11.1 (1H, bs, OH), 11.0 (1H, bs, NH), 7.7 (1H, d, J = 8.7 Hz, 5-H), 6.8 (1H, d, J = 
2.4 Hz, 8-H), 6.7 (1H, dd, J = 2.4 Hz, J = 8.7 Hz, 6-H ), 5.6 (1H, s, 3-H), 3.8 (3H, s, OCH3); 
C (176 MHz, d6-DMSO ) 163.9 (C-2), 162.5 (C-4), 161.4 (C-7), 141.0 (C-9), 124.1 (C-5), 
109.7 (C-8), 108.8 (C-10), 97.9 (C-6), 95.9 (C-3), 55.3 (7-OCH3); m/z (LC-MS, ES+) 383 
([M2H]+), (192 [MH]+).  
 
6.2.4.2 4-Hydroxy-5, 7-di-methoxyquinoline-2-one (212) 
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Following procedure D, malonic acid 208 (2.6 g, 25.2 mmol), POCl3 (2.2 ml, 23.9 mmol) 
and 3,5-di-methoxy aniline 210 (3.7 g, 23.9 mmol) was used in order to afford 4-
hydroxy-5,7-di-methoxyquinoline-2-one 212 as a brown powder (2.61 g, 49 %), (mp = 
248-249 oC); max (ATR) 2969-2875 (broad OH), 3308 (NH), 1645 (C=O), 1606, 
1573,1452, 1421, 1390, 1229, 1202, 1197, 1135, 1049, 966, 819, 770 cm-1; H (700 
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MHz, d6-DMSO) 11.1 (1H, bs, NH), 9.8 (1H, bs, OH), 6.4 (1H, d, J = 2.3 Hz, 8-H), 6.3 (1H, 
d, J = 2.3 Hz, 6-H), 5.4 (1H, s, 3-H), 3.9 (3H, s, 5-OCH3), 3.8 (3H, s, 7-OCH3); C (176 MHz, 
d6-DMSO) 163.6 (C-2 or C-4), 163.3 (C-4 or C-2), 161.8 (C-7), 158.0 (C-5), 142.6 (C-9), 
98.4 (C-10), 96.4 (C-3), 93.1 (C-6), 91.2 (C-8), 56.3 (5-OCH3), 55.4 (7-OCH3) m/z (LCMS, 
ES+) 443 ([M2H]+), 222 ([MH]+), 221 ([M]+); HRMS (ASAP) found ([MH]+) 222.0769, 
C11H12NO4 requires M, 222.0766. 
 
6.2.5 2,4-Di-chloroquinoline derivatives87  
6.2.5.1 2,4-Di-chloro-7-methoxyquinoline (213)137 
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4-Hydroxy-7-methoxyquinoline-2-one 211 (23.8 mg, 0.125 mmol) was dissolved in 
excess POCl3 (0.9 ml, 1 mmol). The mixture was then heated for 1 h at 105 oC. The 
solution was then cooled down in an ice bath followed by addition of water (15 ml) 
and ammonium hydroxide (aq.) to neutralize the solution (pH = 7), causing the product 
to precipitate. The resultant solid was collected by filtration, washed with water and 
dried in a desiccator to afford the quinoline derivative 213 as a yellow powder (27 mg, 
95% ), (mp = 134-135 oC, lit.,137 132-133 oC); max (ATR) 3094, 1623, 1573, 1496, 1454, 
1439, 1224, 1091, 1024, 846, 819, 738, 698, 623 cm-1 ;H (700 MHz, CDCl3) 8.1 (1H, d, J 
= 9.2 Hz, 5-H), 7.4 (1H, s, 3-H), 7.3 (1H, d, J = 2.6 Hz, 8-H), 7.3 (1H, dd, J = 2.6 Hz, J = 9.2 
Hz, 6-H), 3.9 (3H, s, OCH3); C (176 MHz, CDCl3) 162.6 (C-7), 150.6 (C-2), 150.5 (C-9), 
144.4 (C-4), 125.6 (C-5), 121.2 (C-6), 120.5 (C-10), 119.9 (C-3), 107.5 (C-8), 56.1 (7-
OCH3) ; m/z (GC-MS, EI+) 231 ([M (37Cl,37Cl)-H]+, 10%), 229 ([M (35Cl, 37Cl)-H]+, 65%), 228 
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([M (35Cl,35Cl)]+, 12%), 227 ([M (35Cl,35Cl)-H]+, 100%), 212 ([M (35Cl,35Cl)-CH4]+ , 3%), 197 
([M (35Cl,35Cl)-OCH3]+, 17%), 184 (40%), 162 ([M (35Cl)-OCH3-(35Cl)]+, 35%), 157 ([M-H-
(35Cl,35Cl)]+, 12%). 
 
6.2.5.2 2,4-Di-chloro-5,7-di-methoxyquinoline (214)138 
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In a round-bottomed flask, a mixture of malonic acid 208 (520 mg, 5 mmol), POCl3 (4.2 
ml, 45 mmol) and 3,5-di-methoxy aniline 210 (766 mg, 5 mmol) was heated with 
stirring at 50 oC for 2 h. The temperature was then increased slowly over 30 min to 90 
oC and the reaction was heated for another 30 min before the temperature was then 
raised to 105 oC and the mixture was heated for a further 1 h. The reaction was then 
cooled down in an ice bath and water (15 ml) was added. Ammonium hydroxide (aq.) 
was then added to neutralize the solution, causing the product to precipitate (pH = 7). 
The resultant solid was collected by filtration, washed with water and dried in a 
desiccator. The crude product was then re-dissolved in POCl3 (4.2 ml) and heated at 
105 oC for 2 h. The solution was then cooled in an ice bath and precipitated by adding 
Ammonium hydroxide (aq.). The resultant solid was collected by filtration, washed 
with water and dried in a desiccator. The product was purified by recrystallization from 
ethanol to afford 2,4-di-chloro-5,7-di-methoxyquinoline 214 as a brown powder (0.92 
g, 71 %), (mp = 167-168 oC, lit.,138 172-173 oC); max (ATR) 1613, 1575, 1557, 1455, 
1394,1351, 1212, 1143,973, 828, 686 cm-1; H (700 MHz, CDCl3) 7.2 (1H, s, 3-H), 6.9 
(1H, d, J = 2.4 Hz, 8-H), 6.5 (1H, d, J = 2.4 Hz, 6-H), 3.91 (3H, s, 5-OCH3), 3.90 (3H, s, 7-
159 
 
OCH3); C (176 MHz, CDCl3) 162.3 (C-7), 157.3 (C-5), 152.2 (C-9), 150.4 (C-2), 143.1 (C-
4), 121.1 (C-3), 113.1 (C-10), 100.5 (C-8), 100.3 (C-6), 56.1 (C-5-OCH3), 55.8 (C-7-OCH3); 
m/z (LC-MS, ES+) 262 ([M (37Cl,37Cl)]+, 14%), 260 ([M (35Cl,37Cl), ]+, 67%), 258 ([M 
(35Cl,35Cl)]+100%). 
 
6.2.6 Methylation procedure86  
6.2.6.1 N-Methyl-3,3-di-methyl-7-methoxyquinoline-2,4-dione (225)139  
6.2.6.2 3,3-Di-methyl-7-methoxyquinoline-2,4-dione (226) 
 
 
 
A mixture of 4-hydroxy-7-methoxyquinoline-2-one 211 (100 mg, 0.5 mmol) and sodium 
hydride 60% dispersion in mineral oil (32.0 mg, 0.8 mmol) in dry DMF (6 ml) was stirred 
for 30 min and then heated at 100 oC for 5 min. Methyl iodide (163 µl, 2.6 mmol) was 
then added to the stirring mixture and the reaction was further heated for 2 h at 100 
oC. The solution was cooled down and then poured unto ice-water (20 ml). The crude 
mixture was extracted with EtOAc (2  10 ml), dried over MgSO4 and concentrated in 
vacuo. Purification using chromatography on silica gel (2:3 EtOAc:hexanes) afforded N-
methyl-3,3-di-methyl-7-methoxyquinoline-2,4-dione 225 as a yellow solid (9 mg, 7%), 
(mp = 84-85 oC, lit.,139 89-90 oC). Product 225 Rf 2:3 EtOAc:hexane = 0.36; max (ATR) 
1693 (C=O), 1656 (C=O), 1602, 1470, 1332, 1313, 1098, 1038, 799, 730 cm-1 ; H (700 
MHz, CDCl3), 8.0 (1H, d, J = 8.7 Hz, 5-H), 6.7  (1H, dd, J = 2.2 Hz, J = 8.7 Hz, 6-H), 6.6 
NH3CO
O
O2
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(1H, d, J = 2.2 Hz, 8-H) 3.9 (3H, s, OCH3), 3.4 (3H, s, N-CH3), 1.5 (6H,s, 3-(CH3)2); C (176 
MHz, CDCl3) 196.5 (C-4), 175.2 (C-2), 166.1 (C-7), 145.4 (C-9), 131.1 (C-5), 114 (C-10), 
108.4 (C-6), 101.1 (C-8), 56.1 (7-OCH3), 52.9 (C-3), 30.2 (N-CH3), 24.6 (3-(CH3)2); m/z 
(GC-MS, EI+) 234 ([MH]+, 14%), 233 ([M]+, 96%), 218 ([M-CH3]+, 17%), 204 ([MH-2CH3]+, 
9%), 190 (17%), 163 (100%), 134 (44%). 
Furthermore, 3,3-di-methyl-7-methoxyquinoline-2,4-dione 226 was isolated as a white 
solid (40.9 mg, 35%), (mp = 160-161 oC), Rf 2:3 EtOAc:hexane = 0.21; max (ATR) 3246 
(NH), 2934, 1698 (C=O), 1651(C=O), 1606, 1590, 1483, 1462, 1381, 1336, 1264, 1208, 
1116, 1032, 850, 810, 775 cm-1; H (700 MHz, CDCl3) 9.1(1H, bs, NH), 7.9 (1H, d, J = 8.4 
Hz, 5-H), 6.7 (1H, dd, J = 2.1 Hz, J = 8.4 Hz, 6-H), 6.4 (1H, d, J = 2.1 Hz, 8-H), 3.9 (3H, s, 
OCH3), 1.5 (6H, s, 3-(CH3)2); C (176 MHz, CDCl3) 196.2 (C-4), 176.8 (C-2), 166.0 (C-7), 
142.9 (C-9), 130.5 (C-5), 112.3 (C-10), 110.6 (C-6), 100.3 (C-8), 55.9 (7-OCH3), 52.4 (C-3), 
23.9 (3-(CH3)2); m/z (GC-MS, EI+) 220 ([MH]+, 13.7%), 219 ([M]+, 100%), 218 ([M-H]+, 
27%), 204 ([M-CH3]+, 52%), 191 (13%), 176 (21%), 149 (72%), 122 (25%).  
 
6.2.7 Preparation of 2-(aryl substitution)-4-,5- and 7-substituted 
quinoline derivatives Procedure E:84 
Under N2, a mixture of 2,4-di-halo heteroaromatic substrate (1 eq.), arylboronic acid (1-
1.5 eq.) and Pd(PPh3)4  5 mol% was dissolved in a degased mixture of toluene or DMF 
(4.1 ml) and 2 M K2CO3 (aq.) (1.4 ml) in closed microwave vessel. The mixture was 
heated in a microwave oven at 100 oC for the stated time and then cooled to room 
temperature. The crude mixture was then washed with NaHCO3 (aq.) solution and 
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extracted with EtOAc or DCM (2 × 20 ml), dried over MgSO4 and concentrated in 
vacuo. Purification by chromatography afforded the title biaryl compound. 
 
6.2.7.1 2-(4’-Methoxyphenyl)-4-chloro-7-methoxyquinoline (230) 
N 2
1
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Following procedure E, 2,4-di-chloro-7-methoxyquinoline 213 (501.6 mg, 2.2 mmol), 4-
methoxyphenylboronic acid 5 (499.4 mg, 3.3 mmol) and Pd(PPh3) 4 (125.4 mg, 0.11 
mmol) were heated in toluene for 2.5 h. Following purification by chromatography 
(EtOAc:hexane 1:4), 2-(4’-methoxyphenyl)-4-chloro-7-methoxyquinoline 230 was 
obtained as a white coloured foam (0.49g, 75 %), (mp =102-103 oC); max (ATR) 1607, 
1577, 1498, 1447, 1425, 1396, 1372, 1332, 1247, 1215, 1175, 1132, 1028, 970, 838, 
820, 814, 700, 676, 645 cm-1; H (700 MHz, CDCl3) 8.1-8.8 (1H, m, 5-H), 8.8-8.0 (2H, m, 
2’,6’-H), 7.8 (1H, s, 3-H), 7.5 (1H, d, J = 2.5 Hz, 8-H), 7.22 (1H, dd, J = 9.1 Hz, J = 2.5Hz, 6-
H), 7.1-7.0 (2H, m, 3’,5’-H), 4.0 (3H, s, 7-OCH3), 3.9 (3H, s, 4’-OCH3); C (176 MHz, 
CDCl3) 161.7 (C-7), 161.2 (C-4’), 157.5 (C-2), 151.0 (C- 9), 142.9 (C-4), 131.4 (C-1’), 129.0 
(C-2’, 6’), 125.2 (C-5), 120.2 (C-6), 120.1 (C-10), 114.4 (C-3’,5’), 107.8 (C-8), 55.8 (C-7-
OCH3), 55.6 (C-4’-OCH3); m/z (GC-MS, EI+) 301 ([M (37Cl) ]+, 33.7%), 299 ([M (35Cl)]+, 
100%), 284 ([M (35Cl)-CH3]+, 12%), 270 ([MH (35Cl)-2CH3]+, 2%), 264 ([M-(35Cl)]+, 5%), 
256 (12%), 249 ([M-CH3-(35Cl)]+, 5%); HRMS (ASAP) found ([MH]+) 300.0783; 
C17H1535ClNO2 requires M, 300.0791.  
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6.2.7.2 2-(3’, 5’-Di-methylphenyl)-4-chloro-7-methoxyquinoline (233) 
N 2
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H3CO
Cl
 
Following procedure E, 2,4-di-chloro-7-methoxyquinoline 213 (501.6 mg, 2.2 mmol), 3, 
5-di-methylboronic acid 198 (330 mg, 2.2 mmol) and Pd (PPh3)4 (125.4 mg, 0.11 mmol) 
were heated in toluene for 30 min. Purification by chromatography (EtOAc:hexane 
1:9), afforded 2-(3',5'-di-methylphenyl)-4-chloro-7-methoxyquinoline 233 was 
obtained as a white coloured foam (395 mg, 60 %), (mp =165-166 oC); max (ATR) 1617, 
1578, 1503, 1450, 1336, 1217, 1131, 1025, 847, 823, 706, 690, 635 cm-1; H (600 MHz, 
CDCl3) 8.1 (1H, d, J = 9.1 Hz, 5-H), 7.8 (1H, s, 3-H), 7.7 (2H, m, 2’,6’-H), 7.5 (1H, d, J = 2.5 
Hz, 8-H), 7.24 (1H, dd, J = 9.1 Hz, J = 2.5Hz, 6-H), 7.13-7.09 (1H, m, 4’-H), 4.0 (3H, s, 7-
OCH3), 2.43 (6H, s, 3’,5’-CH3); C (151 MHz, CDCl3) 161.6 (C-7), 158.2 (C-2), 151.0 (C-9), 
142.8 (C-10), 138.8 (C-1’), 138.5 (C-3’,5’), 131.5 (C-4’), 125.4 (C-2’,6’), 125.1 (C-5), 120.5 
(C-4), 120.3 (C-6), 117.3 (C-3), 108.0 (C-8), 55.8 (C-7-OCH3), 21.6 (3’,5’-(CH3)2); m/z (LC-
MS, ES+) 300 ([M (37Cl)]+, 33%), 298 ([M (35Cl)]+, 100%); HRMS (ASAP) found ([MH]+) 
298.1009; C18H1735ClNO requires M, 298.0999.  
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6.2.7.3. 2-(4’-Methoxyphenyl)-4-chloro-5,7-di-methoxyquinoline (234) 
6.2.7.4 2,4-Di-(4-methoxyphenyl)-5,7-di-methoxyquinoline (235) 
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Following procedure E, 2,4-di-chloro-5,7-di-methoxyquinoline 214 (567.6 mg, 2.2 
mmol), 4-methoxyphenylboronic acid 5 (384.5 mg, 2.53 mmol) and Pd (PPh3) 4 (125.4 
mg, 0.11 mmol) were heated in DMF for 1 h. Purification by chromatography 
(EtOAc:hexane 1:4), afforded 2-(4’-methoxyphenyl)-4-chloro-5,7-di-methoxyquinoline 
234 was obtained as a yellow solid ( 0.23g, 32 %), (mp = 143-144 oC ); max (ATR) 1606, 
1574, 1523, 1496, 1363, 1250, 1201, 1173, 1157, 1133, 1115, 1028, 857, 824, 792, 615 
cm-1;  H (700 MHz, CDCl3) 8.1 (2H, m, 2’,6’-H), 7.7 (1H, s, 3-H), 7.1 (1H, d, J = 2.4 Hz, 8-
H), 7.05-7.0 (2H, m, 3’,5’-H), 6.5 (1H, d, J = 2.4 Hz, 6-H), 3.95-3.95 (3H, s, 7-OCH3), 3.94 
(3H, s, 5-OCH3), 3.9 (3H, s, 4’-OCH3); C (176 MHz, CDCl3) 161.4 (C-7), 161.2 (C-4’), 
157.1 (C-5), 157.0 (C-2), 153.0 (C-9), 141.4 (C-4), 131.0 (C-1’), 128.9 (C-2’,6’), 118.5 (C-
3), 114.3 (C-3’,5’), 112.9 (C-10), 101.1 (C-8), 99.6 (C-6), 56.0 (C-OCH3), 55.7 (C-OCH3), 
55.5 (C-OCH3); m/z (GC-MS, EI+) 331 ([M (37Cl)]+, 33.9%), 329 ([M (35Cl)]+, 100%), 314 
([M-CH3]+, 4%), 300 ([MH-(CH3)2]+, 9%), 294 ([M-(35Cl)]+, 3%), 286 (12%), 279 ([M-CH3-
(35Cl)]+, 2%), 271 ([MH (37Cl)-O-3CH3]+ 6%), 265 ([MH-2CH3-(35Cl)]+, 2%); HRMS (ASAP) 
found ([MH]+) 330.0902; C18H1735ClNO3 requires M, 330.0897.  
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Similarly, 2,4-di-(4’-methoxyphenyl)-5,7-di-methoxyquinoline 235 was also isolated as 
a yellow solid (0.08g, 9 %), (mp = 157-158 oC); max (ATR) 1606, 1582, 1516, 1346, 
1296, 1261, 1240, 1224, 1178, 1170, 1026, 844, 830, 802, 679 cm-1; H (700 MHz, 
CDCl3) 8.13-8.09 (2H, m, 2’,6’-H), 7.4 (1H, s, 3-H), 7.32-7.28 (2H, m, 2”,6”-H), 7.2 (1H, s, 
8-H), 7.04-6.99 (2H, m, 3’,5’-H), 6.96- 6.89 (2H, m, 3”,5”-H), 6.5 (1H, d, J 2.4 Hz, 6-H), 4 
(3H, s, 7-OCH3), 3.89 (3H, s, 4”-OCH3), 3.87 (3H, s, 4’-OCH3), 3.5 (3H, s, 5-OCH3); C (176 
MHz, CDCl3) 161.1 (C-5), 161.0 (C-4´), 159.0 (C-4”), 157.5 (C-7), 156.4 (C-2), 152.0 (C-9), 
148.3 (C-4), 135.6 (C-1”), 132.1 (C-1’), 129.7 (C-2”,6”), 129.0 (C-2’,6’), 119.1 (C-3), 114.3 
(C-3’,5’), 113.6 (C-10), 112.6 (C-3”,5”), 101.0 (C-8), 99.0 (C-6), 55.7 (C-7-OCH3), 55.5 (C-
OCH3), 55.5 (C-OCH3), 55.4 (C-OCH3); m/z (GC-MS, EI+) 403 ([M2H]+, 4.3%), 402 ([MH]+, 
26.2%), 401 ([M]+, 100%), 386 ([M-CH3]+, 12%), 370 ([M-OCH3]+, 11%), 355 ([M-O-
2CH3]+, 4%), 343 (4%), 327 (2%), 312 (2%); HRMS (ASAP) found ([MH]+) 402.1697; 
C25H24NO4 requires M, 402.1705.  
 
6.2.8 Preparation of quinoline 4-one, procedure F89 
4-Chloroquinoline compounds 230, 233 and 234 (1 eq.) were heated in glacial acetic 
acid (26 eq.) at 125 oC for 1 h. The reaction mixture was then cooled to room 
temperature, causing the product to precipitate, and diluted with water (15 ml). 3 M 
sodium hydroxide was added to give a basic solution (pH= 8-9). The resultant solid was 
collected by filtration, washed with water and dried in a desiccator. The products were 
purified by trituration and dried in vacuo. 
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6.2.8.1 2-(4’-Methoxyphenyl)-7-methoxyquinoline-4-one (192B) 
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Following procedure F, compound 230 (23 mg, 0.077 mmol) was heated in glacial 
acetic acid. Following trituration with THF, 2-(4’-methoxyphenyl)-7-methoxyquinoline-
4-one 192B was obtained as a white powder (10 mg, 45 %), (mp = 302-303 oC); max 
(ATR) 3241 (NH), 1626 (C=O), 1613, 1575, 1546, 1511, 1442, 1376, 1299, 1256, 1243, 
1206, 1178,1140,1020, 831, 812 cm-1; H (700 MHz, d6-DMSO) 11.4 (1H, s, NH), 8.0 (1H, 
d, J = 8.8 Hz, 5-H), 7.8 (2H, m, 2’,6’-H), 7.2 (1H, d, J = 2.4 Hz, 8-H), 7.1 (2H, m, 3’,5’-H), 
6.9 (1H, dd, J = 8.8 Hz, J = 2.4 Hz, 6-H), 6.2 (1H, s, 3-H), 3.86 (3H, s, 7-OCH3), 3.85 (3H, s, 
4’-OCH3); C (176 MHz, d6-DMSO) 176.4 (C-4), 161.8 (C-7), 161.0 (C-4’), 149.2 (C-2), 
142.2 (C-9), 128.6 (C-2’,6’), 126.5 (C-5), 126.2 (C-1’), 119.1 (C-10), 114.4 (C-3’,5’), 113 
(C-6), 106.2 (C-3), 99.6 (C-8), 55.4 (C-7-OCH3), 55.4 (C-4’-OCH3); m/z (LC-MS, ES+) 282 
([MH]+), 562 ([M2]+); HRMS (ASAP) found ([MH]+) 282.1120; C18H18NO4 requires M, 
282.1130. 
 
6.2.8.2 2-(3’,5’-Di-methylphenyl)-7-methoxyquinoline-4-one (240B) 
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Following procedure F, compound 233 (22.9 mg, 0.077 mmol) was heated in glacial 
acetic acid. Following trituration with hot EtOAc, 2-(3’,5’-di-methylphenyl)-7-
methoxyquinoline-4-one 240B was obtained as a white powder (8 mg, 37 %), (mp = 
265-266 oC); max (ATR) 3069 (NH), 1619 (C=O),  1589, 1546, 1505, 1464, 1257, 1210, 
1135, 1093, 1031, 853, 831, 715, 671, 624 cm-1; H (700 MHz, d4-Methanol) 8.13 (1H, d, 
J = 9.0 Hz, 5-H), 7.4 (2H, m, 2’,6’-H), 7.2 (1H, s, 4’-H), 7.5 (1H, d, J = 2.4 Hz, 8-H), 7.1 (1H, 
dd, J = 9.0 Hz, J = 2.4 Hz, 6-H), 6.4 (1H, s, 3-H), 3.93 (3H, s, 7-OCH3), 2.41 (6H, s, 3’,5’-
CH3); C (176 MHz, d4-Methanol) 180.2 (C-4), 164.7 (C-7), 153.4 (C-2), 143.9 (C-9), 140.2 
(C-3’,5’), 135.4 (C-1’), 133.3 (C-4’), 127.6 (C-5), 126.1 (C-2’,6’), 120.0 (C-10), 116.0 (C-6), 
108.0 (C-3), 100.1 (C-8), 56.2 (C-7-OCH3), 21.3 (3’,5’-(CH3)2); m/z (LC-MS, ES+) 559 
([M2H]+), 280 ([MH]+); HRMS (ASAP) found ([MH]+) 280.1336; C18H18NO2 requires M, 
280.1338. 
 
6.2.8.3 2-(4’-Methoxyphenyl)-5,7-di-methoxyquinoline-4-ol (241A) 
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Following procedure F, compound 233 (25 mg, 0.077 mmol) was heated in glacial 
acetic acid. Following trituration with ether, 2-(4’-methoxyphenyl)-5,7-di-
methoxyquinoline-4-ol 241A was obtained as a white powder (11 mg, 45 %), (mp = 
233-234 oC); max (ATR) 3360-2730 (broad OH), 1602, 1511, 1445, 1372, 1247, 1207, 
1166, 1136, 1111, 1037, 827, 672 cm-1; H (600 MHz, Methanol-d4) 7.7 (2H, m, 2’,6’-H), 
7.1 (2H, m, 3’,5’-H), 6.7 (1H, s, 8-H), 6.4 (1H, s, 6-H), 6.3 (1H, s, 3-H), 4.6 (1H, s, OH), 3.9 
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(3H, s, 7-OCH3), 3.88 (3H, s, 5-OCH3), 3.87 (3H, s, 4’-OCH3); C (151 MHz, Methanol-d4) 
180.5 (C-4), 164.9 (C-7), 163.2 (C-4’), 162.2 (C-5), 151.0 (C-2), 146.3 (C-9), 129.6 (C-
2’,6’), 127.0 (C-1’), 115.5 (C-3’,5’), 111.2 (C-10), 109.1, (C-3), 96.5 (C-6), 92.6 (C-8), 56.2 
(C-OCH3), 56.1 (C-OCH3), 56.0 (C-OCH3); m/z (LC-MS, ES+) 312 ([MH]+), 645 ([M2+Na]+); 
HRMS (ASAP) found ([MH]+) 312.1227; C18H18NO4 requires M, 312.1236. 
 
6.2.9 2-(4’-Methoxyphenyl)-4,7-di-methoxyquinoline (242) 
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Following the methylation procedure applied in 6.2.6, a mixture of 2-(4’-
methoxyphenyl)-7-methoxyquinoline-4-one 192B (171.4 mg, 0.61 mmol), sodium 
hydride 60% (27.2 mg, 0.68 mmol) and methyl iodide (0.19 ml, 3.1 mmol) was heated 
at 100 oC in DMF (3 ml) for 2 h. Purification by chromatography (2: 4 EtOAc:hexane), 
afforded 2-(4’-methoxyphenyl)-4,7-di-methoxyquinoline 242 as a white solid (36 mg, 
20 %), (mp = 108-109 oC ); max (ATR) 1595, 1507, 1453, 1361, 1332, 1252, 1224, 1207, 
1172, 1149, 1110, 1021, 835, 814 cm-1; H (700 MHz, CDCl3) 8.1-8.0 (3H, m, 5-H & 2’,6’-
H), 7.4 (1H, d, J = 2.5 Hz, 8-H), 7.1 (1H, dd, J = 9.1 Hz, J = 2.5 Hz, 6-H), 7.1-7.0 (3H, m, 3-
H, 3’,5’-H), 4.1 (3H, s, 4’-CH3), 4.0 (3H, s, 7-OCH3), 3.9 (3H, s, 4-OCH3); C (176 MHz, 
CDCl3) 162.9 (C-4’), 161.3 (C-7), 160.8 (C-4), 159.1 (C-2), 151.2 (C-9), 133.2 (C-1’), 128.9 
(C-2’,6’), 123.0 (C-5), 117.8 (C-6), 114.9 (C-10), 114.2 (C-3’,5’), 107.5 (C-8), 96.3 (C-3), 
55.7 (C-OCH3), 55.6 (C-OCH3), 55.5 (C-OCH3); m/z (GC-MS, EI+) 296 ([MH]+, 18.5%), 295 
([M]+, 100%), 294 ([M-H]+, 66%), 280 ([M-CH3]+, 27%), 265 ([M-2CH3]+, 29%), 250 ([M-
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3CH3]+, 13%), 235 ([MH-O-3CH3]+, 3%), 222 (3%); HRMS (ASAP) found ([MH]+) 
296.1276; C18H18NO3 requires M, 296.1287. 
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Chapter 3 
6.2.10 The preparation of 2-substituted pyridine derivatives 
In a round bottomed flask, nBuLi was added dropwise with stirring at -5 oC to a 
solution of 2-methylaminoethanol in hexane. After 30 min stirring, the 4-substituted 
pyridine was then added with stirring for 1h. A solution of the appropriate electrophile 
in the stated solvent was then added dropwise at -78 oC. After stirring for 1.5 h, water 
was added to quench the reaction. The crude mixture was extracted with DCM (2 x 10 
ml). The organic extracts were then dried over MgSO4 and concentrated in vacuo. 
Purification using chromatography on silica gel afforded the desired 2-substituted 
pyridine. 
 
Protocol G1: nBuLi (2.5 ml, 4 mmol), 2-methylaminoethanol (0.2 ml, 2 mmol) in 
hexane (1.25 ml), 4-substituted pyridine (0.5 mmol) and the appropriate electrophile 
(2.5 mmol) in THF (5 ml).  
 
Protocol G2: nBuLi (2.5 ml, 4 mmol), 2-methylaminoethanol (0.2 ml, 2 mmol) in 
hexane (10 ml), 4-substituted pyridine (1 mmol) and the appropriate electrophile (2.5 
mmol) in hexane (2.5 ml). 
 
6.2.10.1 4-Chloro-2-tri-methylsilylpyridine (254)140 
 
N
Cl
SiMe 32
3
4
5
6
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Following protocol G1, 4-chloropyridine 258 (56.7 mg) and TMSCl (317.5 µl) were 
combined to afford, following purification by chromatography (EtOAc:hexane: 1:8), 4-
chloro-2-tri-methylsilylpyridine 254 as a white liquid (41 mg, 44%); max (ATR) 1594, 
1505, 1417, 1255, 1155, 1107, 851, 769 cm-1; H (700 MHz, CDCl3) 8.6 (1H, d, J = 5.3 Hz, 
6-H), 7.5 (1H, d, J = 2.2 Hz, 3-H), 7.2 (1H, dd, J = 5.3 Hz, J = 2.2 Hz, 5-H), 0.3 (9H, s, CH3); 
C (176 MHz, CDCl3) 170.7 (C-2), 151.3 (C-6), 143.0 (C-4), 129.2 (C-3), 123.2 (C-5), -1.8 
(SiCH3); m/z (LC-MS, ES+) 190 ([MH (30Si,37Cl)]+, 30%), 189 ([MH (29Si,37Cl)]+, 35%), 188 
([MH (28Si,37Cl)]+, 100%), 187 ([M (30Si,35Cl)]+, 67%), 186 ([M (29Si,35Cl)]+, 30%), 185 ([M 
(28Si,35Cl)]+, 95%). 
 
6.2.10.2 4-Tert-butyl-2-tri-methylsilylpyridine (260)141 
 
 
Following protocol G1, 4-tert-butylpyridine 249 (67.6 mg) and TMSCl (317.5 µl) were 
combined to afford, following purification by chromatography (EtOAc:hexane: 1:3), 4-
tert-butyl-2-tri-methylsilylpyridine 260 as a white oil (35 mg, 17%); max (ATR) 1598, 
1409, 1273, 996, 842, 820, 569 cm-1; H (700 MHz, CDCl3) 8.7 (1H, d, J = 5.2 Hz, 6-H), 
7.5 (1H, d, J = 2.7 Hz, 3-H), 7.2 (1H, dd, J = 5.2 Hz, J = 2.7 Hz, 5-H), 1.3 (9H, s, CH3), 0.32 
(9H, s, SiCH3); C (176 MHz, CDCl3) 167.7 (C-2), 157.6 (C-4), 150.1 (C-6), 125.6 (C-3), 
120.0 (C-5), 34.7 (4-C), 30.7 (4-C-(CH3)3), -1.6 (SiCH3); m/z (LC-MS, ES+) 210 ([MH 
(Si30)]+, 30%), 209 ([MH (Si29)]+, 32%), 208 ([MH (Si28)]+, 100%). 
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6.2.11 Preparation of 4-Chloro-2,2’-bipyridine (255)142 using Hiyama 
cross-coupling reaction 92 
 
 
 
Under N2, in a closed microwave vessel, a solution of 2-bromopyridine 253 (79 mg, 0.5 
mmol), 4-chloro-2-tri-methylsilanylpyridine 254 (185 mg, 1 mmol) in DMF (1.25 ml) 
and TBAF (2 mL of a 1M solution in THF, 2 mmol) were added to a stirred mixture of 
PdCl2(PPh3)2 (35 mg, 0.05 mmol), PPh3 (26 mg, 0.1 mmol) and CuI (188 mg, 1 mmol) in 
DMF (5ml). The reaction mixture was allowed to stir for 18 h. The reaction mixture was 
quenched by adding NH4OH (5 ml), H2O (5 ml), then filtered over a pad celite. The 
resulting mixture was extracted with Et2O (2 x 20 ml). The organic extracts were dried 
over MgSO4 and concentrated in vacuo. Purification using chromatography on silica gel 
(hexane: EtOAc:Et3N 8:2:0.1), afforded the 4-chloro-2,2´-bipyridine 255  as a white 
solid (52 mg, 54%). (m.p= 71.8-72.8 oC, lit.,142 71.4-72.2 oC ); max (ATR) 1575, 1551, 
1453, 1390, 1281, 1087, 995, 835, 813, 786, 738, 726, 709, 618, 594, 478 cm-1; H (700 
MHz, CDCl3) 8.7 (1H, m, 6’-H), 8.6 (1H, d, J = 5.3 Hz, 6-H), 8.5 (1H, s, 3-H), 8.4 (1H, d, J = 
7.9 Hz, 3’-H), 7.83 (1H, t, J = 7.9 Hz, 4’-H ), 7.36-7.31 (1H, m, 5’-H), 7.32 (1H, d, J = 5.3 
Hz, 5-H); C (176 MHz, CDCl3) 157.7 (C-2), 154.9 (C-2’), 150.1 (C-6), 149.3 (C-6’), 145.4 
(C-4), 137.2 (C-4’), 124.4 (C-5’), 124.0 (C-5), 121.7 (C-3), 121.5 (C-3’); m/z (LC-MS, EI+) 
193 ([MH (37Cl)]+, 35%), 191 ([MH (35Cl)]+, 35%). 
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6.2.12 Preparation of 2,2’-bipyridine derivatives 
6.2.12.1 2-Bromo-4-tert-butylpyridine (252)141 
 
 
Following protocol G2, 4-tert-butylpyridine 249 (0.135 g) and CBr4 (0.830 g) were 
combined to afford, following purification by chromatography (EtOAc:hexane: 1:9), 2-
bromo-4-tert-butylpyridine 252 as an orange oil (112 mg, 52%); max (ATR) 1585, 1530, 
1476, 1378, 1265, 1144, 1085, 989, 854, 839, 756, 687, 618 cm-1; H (700 MHz, CDCl3) 
8.24 (1H, d, J = 5.3 Hz, 6-H), 7.43 (1H, d, J = 1.7 Hz, 3-H), 7.21 (1H, dd, J = 5.3 Hz, J = 1.7 
Hz, 5-H), 1.28 (9H, s, CH3); C (176 MHz, CDCl3) 163.4 (C-4), 150.0 (C-6), 142.7(C-2), 
125.2 (C-3), 120.2 (C-5), 35.1 (4-C), 30.5 (4-C-(CH3)3); m/z (LC-MS, ES+) 215 ([M (81Br)]+, 
90%), 213 ([M (79Br)]+, 87%). 
 
6.2.12.2 4-Di-methylamino-2-tri-butylstannylpyridine (266)97 
 
 
Following protocol G2, 4-di-methylaminopyridine 247 (122 mg) and tri-butyltin 
chloride (0.7 ml) were reacted. Purification by chromatography (EtOAc:hexane:Et3N 
1:2:0.1) afforded the 4-di-methylamino-2-tri-butylstannylpyridine 266 as a yellow oil 
(0.25 g, 61%); max (ATR) 1578, , 1534, 1490, 1464, 1444, 1365, 1275, 1215, 1070, 981, 
959, 805, 663, 596, 505, 432 cm-1; H (700 MHz, CDCl3) 8.32 (1H, d, J = 6 Hz, 6-H), 6.7-
6.6 (1H, d, 3J 1H-119Sn = 2.9 Hz, 3-H), 6.34 (1H, dd, J = 6 Hz, J = 2.9 Hz, 5-H), 2.94 (6H, s, N-
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CH3), 1.55 (6H, m, 2’-H), 1.32 (6H, m, 3’-H), 1.1 (6H, m, 1’-H), 0.86 (9H, t, J =7.4 Hz, 4’-
H); C (176 MHz, CDCl3) 172.1 (C-2, 1J13C-119Sn= 508.5 Hz), 152.1 (C-4, 3J13C-119Sn= 40.5 Hz), 
150.1 (C-6, 3J13C-119Sn= 69.5 Hz), 115.5 (C-3, 2J13C-119Sn= 78.2 Hz), 105.5 (C-5), 38.9 (N-
CH3), 29.2 (C-2’, 2J13C-119Sn= 20.1 Hz), 27.4 (C-3’, 3J13C-119Sn= 55.5 Hz), 13.8 (C-4’), 9.7 (C-
1’, 1J13C-119Sn= 326.8 Hz); m/z (LC-MS, ES+) 416 ([M (124Sn)]+), 414 ([M (122Sn)]+), 409 ([M 
(119Sn)]+). 
 
6.2.12.3 2-Bromo-4-di-methylaminopyridine (267)97,143 
 
 
Following protocol G2, 4-di-methylaminopyridine 247 (122 mg) and CBr4 (0.830 g) 
were reacted. Purification by chromatography (EtOAc:hexane: 1:1) afforded the 2-
bromo-4-di-methylaminopyridine 267 as a yellow solid (90 mg, 45%), (mp = 55.5-57.0 
oC); max (ATR) 1591, 1516, 1440, 1383, 1266, 1223, 1130, 1069, 975, 808, 689, 444 cm-
1; H (700 MHz, CDCl3) 7.9 (1H, d, J = 6 Hz, 6-H), 6.6 (1H, d, J = 2.4 Hz, 3-H), 6.4 (1H, dd, J 
= 6 Hz, J = 2.4 Hz, 5-H), 3.0 (6H, s, N-CH3); C (176 MHz, CDCl3) 155.9 (C-4), 149.2 (C-6), 
143.0 (C-2), 109.4 (C-3), 106.3 (C-5), 39.4 (N-CH3); m/z (GC-MS, ES+) 202 ([M 
(81Br)]+,97%), 200 ([M (79Br)]+, 100%), 121 ([M-(79Br)]+, 27%); HRMS (ES+) found ([MH]+) 
201.0007, C7H1079BrN2 requires M, 201.0027. 
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6.2.12.4 Stille cross-coupling reaction to prepare bipyridine derivatives  
6.2.12.4.1 Procedure H99 
Under N2, in a closed microwave vessel, 2-halo-4-substituted pyridine in DMF (2 ml) 
was added to a mixture of 4-di-methylamino-2-tri-butylstannylpyridine (0.1 g, 0.25 
mmol) and PdCl2(PPh3)2 (17.55 mg, 10 mol%, 0.025 mmol). The reaction mixture was 
heated at 110 oC for 18 h, H2O (5 ml) was then added to the solution and the resulting 
mixture extracted with DCM (2 x 20 ml). The organic extracts were then dried over 
MgSO4 and concentrated in vacuo. The residue was dissolved in DCM (10 ml) and then 
extracted by adding HCl (6M) (6 ml). Ammonium hydroxide 35% was then added to the 
aqueous solution to make the solution pH = 7-8. The crude mixture was extracted with 
DCM (2 x 20 ml). The organic extracts were then dried over MgSO4 and concentrated in 
vacuo. Purification using chromatography on silica gel (hexane: EtOAc: Et3N 5:1:5) 
afforded the desired bipyridine product. 
 
6.2.12.4.1.1 4’-Di-methylamino-4-tert-butyl-2,2’-bipyridine (250) 
 
 
Following procedure H in 6.2.12.4.1, 2-chloro-4-tert-butylpyridine 265 (42.3 mg, 0.25 
mmol), 4-di-methylamino-2-tri-butylstannylpyridine 266 and PdCl2(PPh3)2 were reacted 
to afford 4’-di-methylamino-4-tert-butyl-2,2’-bipyridine 250 as a white solid (20.5 mg, 
32%). (mp = 101.5-103 oC); max (ATR) 1641, 1570, 1464, 1433, 1419, 1378, 1228, 1073, 
998, 881, 851, 813, 800, 748, 588, 529 cm-1; H (700 MHz, CDCl3) 8.6 (1H, d, J = 5.2 Hz, 
6-H),  8.45-8.43 (1H, m, 3-H), 8.3 (1H, d, J = 6.0 Hz, 6’-H), 7.68 (1H, d, J = 2.7 Hz, 3’-H), 
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7.29 (1H, dd, J = 5.2, J = 1.9 Hz, 5-H ), 6.55(1H, dd, J = 6.0 Hz, J = 2.7 Hz, 5’-H), 3.11 (6H, 
s, N-CH3 ), 1.38 (9H, s, 8-CH3); C (176 MHz, CDCl3) 161.2 (C-4), 155.9 (C-2), 155.7 (C-4’), 
149.0 (C-6), 148.4 (C-6’), 121.0 (C-5), 118.7 (C-3), 106.6 (C-5’), 104.3 (C-3’), 39.6 (N-
CH3), 35.2 (4-C), 30.8 (4-C-(CH3)3), unobserved (C-2’); m/z (GC-MS, EI+) 256 ([MH]+, 
11%) , 255 ([M]+, 67%), 241 ([MH-CH3]+, 17%), 240 ([M-CH3]+, 100%), 224 found, 212 
([MH-N(CH3)2]+, 25%); HRMS (ES+) found ([MH]+) 256.1812, C16H22N3 requires M, 
256.1814. 
 
6.2.12.4.2 Procedure I:97  
6.2.12.4.2.1 4’-Di-methylamino-4-tert-butyl-2,2’-bipyridine (250) 
6.2.12.4.2.2 4,4’-Di-tert-butyl-2,2’-bipyridine (22) 
 
 
 
Under N2, in a round bottomed flask fitted with a condenser, 2-bromo-4-tert-
butylpyridine 252 (0.118g, 0.55 mmol), 4-di-methylamino-2-tri-butylstannylpyridine 
266 (0.205g, 0.5 mmol), PdCl2(PPh3) 2 (19 mg, 0.027 mmol) and PPh3 (0.014, 0.055 
mmol) in xylene (10 ml) were heated at 130 oC for 24 h. The crude mixture was filtered 
through celite and then extracted with DCM (2 x 20 ml). The organic extracts were 
then dried over MgSO4 and concentrated in vacuo. Purification using chromatography 
on silica gel (hexane:EtOAc:Et3N 5:1:5), afforded 4’-di-methylamino-4-tert-butyl-2,2’-
bipyridine 250 as a brown solid (44.6 gm, 32%); Data have been identified above in 
6.2.12.4.1.1. 
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Furthermore, 4,4’-di-tert-butyl-2,2’-bipyridine 22 was isolated as a white solid (21 mg, 
14%).  
 
6.2.13 Preparation of 6-chloro-2,2’-bipyridine derivatives 
6.2.13.1 Preparation of 2,6-di-chloro-4-substitutedpyridine: 
6.2.13.1.1 4-Tert-butylpyridine-N-oxide (270)98 
 
 
A mixture of 4-tert-butylpyridine 249 (4 ml, 27.3 mmol), H2O2 (22 ml, 35% 255 mmol) 
and glacial acetic acid (30 ml) was refluxed at 80 oC for 4 h. Another 22 ml of H2O2 was 
then added to the mixture of reaction. After refluxing overnight, 50 ml of solvent was 
removed in vacuo. H2O (5.5 ml) was then added and removed as well in vacuo. NaOH 
(6%) was then added to make the solution base (pH = 9, pH paper). The crude mixture 
was then extracted with DCM (2 x 20 ml). The organic extracts were dried over MgSO4 
and concentrated in vacuo to afford 4-tert-butylpyridine-N-oxide 270 (3.8 g), which 
was used directly in the next step without further purification. 
 
6.2.13.1.2 2-Chloro-4-tert-butylpyridine (265)98 
 
 
Under argon, pyridine-N-oxide 270 (3.8 g) and POCl3 (15.5 ml, 166.3 mmol) were 
combined and heated at 105 oC for 20 h. After cooling to room temperature, the POCl3 
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was removed in vacuo. NaHCO3 solution was then added to neutralise the solution (pH 
= 7). The crude mixture was then extracted with ether (2 x 20 ml). The organic extracts 
were then dried over MgSO4 and concentrated in vacuo. Purification using 
chromatography on silica gel (1:9) (EtOAc:hexane) afforded 2-chloro-4-tert-
butylpyridine 265 as a yellow oil (2.1 g, 45%); max (ATR) 1590, 1534, 1476, 1380, 1267, 
1150, 1092, 992, 864, 840, 773, 694, 628 cm-1; H (700 MHz, CDCl3) 8.2 (1H, d, J = 5.3 
Hz, 6-H), 7.24 (1H, d, J = 1.7 Hz, 3-H), 7.14 (1H, dd, J = 5.3 Hz, J = 1.7 Hz, 5-H), 1.24 (9H, 
s, CH3); C (176 MHz, CDCl3) 163.5 (C-4), 151.7 (C-2), 149.4 (C-6), 121.0 (C-3), 119.7 (C-
5), 35.0 (4-C), 30.4 (4-C-(CH3)3); m/z (GC-MS, EI+) 171 ([M (37Cl)]+, 14%), 169 ([M (35Cl)]+, 
44%), 156 ([M (37Cl)-CH3]+, 37%), 154 ([M (35Cl)-CH3]+, 100%). 
 
6.2.13.1.3 2-Chloro-4-tert-butylpyridine-N-oxide (274)98 
 
 
 
Following the protocol described above in 6.2.13.1.1, 2-chloro-4-tert-butylpyridine 265 
(416 mg, 2.46 mmol) was oxidized with H2O2 to afford, without further purification, 2-
chloro-4-tert-butylpyridine-N-oxide 274 as a brown solid (0.38 g, 83%), (mp = 125-
126.5 oC); max (ATR) 3026, 2957, 1717, 1613, 1524, 1476, 1405, 1365, 1249, 1157, 
1081, 891, 830, 822, 750, 678, 614 cm-1; H (700 MHz, CDCl3) 8.3 (1H, d, J = 6.9 Hz, 6-
H), 7.44 (1H, d, J = 2.7 Hz, 3-H), 7.18 (1H, dd, J = 6.9 Hz, J = 2.7 Hz, 5-H), 1.30 (9H, s, 
CH3); C (176 MHz, CDCl3) 151.415 (C-4), 141.4 (C-2), 139.9 (C-6), 124.2 (C-3), 121.5 (C-
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5), 34.8 (4-C), 30.5 (4-C-(CH3)3); m/z (LC-MS, ES+) 188 ([MH (37Cl)]+, 37%), 186 ([MH 
(35Cl) ]+, 100%). 
 
6.2.13.1.4 2,6-Di-chloro-4-tert-butylpyridine (276)98 
 
 
Following the protocol described above in 6.2.13.1.2, 2-chloro-4-tert-butylpyridine-N-
oxide 274 (0.34 g, 1.83 mmol) was reacted with POCl3 (1.1 ml, 11.8 mmol) to afford, 
following purification using chromatography on silica gel (0.5:9.5) (EtOAc:hexane) 2,6-
di-chloro-4-tert-butylpyridine 276 as a white crystal solid (0.26 g, 70%), (mp 82.5-84 
oC); max (ATR) 2968, 2870, 1581, 1531, 1479, 1368, 1360, 1263, 1250, 1171, 1101, 990, 
879, 861, 807, 772, 633 cm-1; H (700 MHz, CDCl3) 7.18 (2H, s, 3,5-H), 1.24 (9H, s, CH3); 
C (176 MHz, CDCl3) 166.5 (C-4), 150.7 (C-2,6), 120.4 (C-3,5), 35.6 (4-C), 30.5 (CH3); m/z 
(GC-MS, EI+) 207 ([M (37Cl,37Cl)]+, 4%), 205 ([M (35Cl,37Cl)]+, 23%), 203 ([M (35Cl,35Cl)]+, 
36%), 192 ([M (37Cl,37Cl)-CH3]+, 10%), 190 ([M (35Cl,37Cl)-CH3]+, 63%), 188 ([M (35Cl,35Cl)-
CH3]+, 100%). 
 
6.2.13.2 4’-Di-methylamino-4-tert-butyl-6-chloro-2,2’-bipyridine (277) 
 
 
Following procedure H in 6.2.12.4.1, 2,6-di-chloro-4-tetr-butylpyridine 276 (51 mg, 
0.25 mmol), 4-di-methylamino-2-tri-butylstannylpyridine 266 and PdCl2(PPh3)2 were 
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reacted to afford, 4’-di-methylamino-4-tert-butyl-6-chloro-2,2’-bipyridine 277 as a 
yellow solid (22.4 mg, 31%), (mp = 239.5-240.5 oC); max (ATR) 1582, 1538, 1379, 1300, 
1160, 990, 889, 853, 800, 776, 750, 675, 621, 558, 469, 448 cm-1; H (700 MHz, CDCl3) 
8.4 (1H, s, 3-H), 8.3 (1H, d, J = 6.0 Hz, 6’-H) 7.66 (1H, d, J = 2.7 Hz, 3’-H), 7.3 (1H, d, J = 
1.6 Hz, 5-H), 6.5 (1H, dd, J = 6.0 Hz, J = 2.7 Hz, 5’-H), 3.11 (6H, s, N-CH3), 1.38 (9H, s, 8-
CH3); C (176 MHz, CDCl3) 164.5 (C-4), 155.5 (C-4’), 151.0 (C-6), 148.8 (C-6’), 121.2 (C-
5), 117.4 (C-3), 106.9 (C-5’), 104.6 (C-3’), 39.5 (N-CH3), 35.5 (4-C), 30.7 (4-C-(CH3)3), 
unobserved (C-2’), (C-2); m/z (GC-MS, EI+) 291 ([M (37Cl)]+, 21%), 289 ([M (35Cl)]+, 63%), 
276 ([M (37Cl)-CH3]+, 31%), 274 ([M (35Cl)-CH3]+, 100%), 258 found, 246 ([MH (35Cl)-
N(CH3)2]+, 31%), 233 found; HRMS (ES+) found ([MH]+) 290.1431, C16H2135ClN3 requires 
M, 290.1424. 
 
6.2.14 Preparation of 2,2’-bipyridine derivatives using copper and 
lithium salts  
6.2.14.1 Procedure J:101  
6.2.14.1.1 4-Tert-butyl-2,2’-bipyridine (281)144 
 
 
 
Under N2, in a closed microwave vessel, a mixture of 2-bromo-4-tert-butylpyridine 252 
(64.2 mg, 0.3 mmol), 2-tri-butylstannylpyridine 272 (80%, 156 mg, 0.36 mmol), 
PdCl2(PPh3)2 (3.75 mol%, 0.011 mmol) and LiCl (93.1 mg, 2.2 mmol) in toluene (3 ml) 
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were heated at 120 oC for 48 h. H2O (5 ml) was then added to the solution,  and the 
crude mixture extracted with DCM (2 x 20 ml). The organic extracts were then dried 
over MgSO4 and concentrated in vacuo. The residue was dissolved in DCM (10 ml) and 
then extracted by adding HCl (6M) (6 ml). Ammonium hydroxide 35% was then added 
to the aqueous solution to make the solution pH = 7-8. The crude mixture was 
extracted with DCM (2 X 20 ml). The organic extracts were then dried over MgSO4 and 
concentrated in vacuo. Purification using reversed phase chromatography (C-18 SiO2), 
afforded 4-tert-butyl-2,2’-bipyridinyl 281 as an orange oil (26 mg, 40%); max (ATR) 
1600, 1584, 1546, 1458, 1391, 1257, 1072, 992, 866, 792, 743, 648, 618 cm-1; H (700 
MHz, CDCl3) 8.69 (1H, m, 6’-H) 8.59 (1H, d, J = 5.7 Hz, 6-H), 8.42 (1H, s, 3-H), 8.38 (1H, 
d, J = 8.0 Hz, 3’-H), 7.81 (1H, t, J = 8.0 Hz, 4’-H), 7.36-7.28 (2H, m, 5,5’-H), 1.39 (9H, s, 4-
(CH3)3); C (176 MHz, CDCl3) 161.2 (C-4), 156.7 (C-2’), 156.1 (C-2), 149.2 (C-6’,6), 137.0 
(C-4’), 123.7 (C-5’), 121.5 (C-3’), 121.1 (C-5), 118.3 (C-3), 35.2 (4-C), 30.7 (4-C-(CH3)3); 
m/z (LC-MS, ES+) 447 ([M2+ Na]+, 57%), 213 ([MH]+, 100%). 
 
6.2.14.2 Procedure K102  
Under N2, a mixture of 4-di-methylamino-2-tri-butylstannylpyridine 266 (0.83 g, 2 
mmol), 2-halo-4-substituted pyridine (2 mmol), Pd(PPh3)4 (0.12 g, 0.1 mmol, 5 mol%) 
and CuBr (0.02 g, 0.14 mmol, 7 mol%) in dry dioxane (15 ml) were refluxed at 101 oC 
for 17 h. The reaction mixture was then cooled and concentrated in vacuo. The crude 
mixture was then dissolved from DCM and washed by water three times. The organic 
phase was then dried over MgSO4 and concentrated in vacuo to afford, following 
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trituration with hexane to remove tri-butyltin chloride, chromatography in aluminum 
dioxide (PH= 7), the desired bipyridine product. 
 
6.2.14.2.1 4’-Di-methylamino-4-carboxylic acid methyl ester-2,2’-
bipyridine (285)  
6.2.14.2.2 4,4’-Di-carboxylic acid methyl ester-2,2’-bipyridine (286) 
 
 
 
Following procedure K in 6.2.14.2, methyl-2-bromo or chloroisonicotinate 284, 151 (2 
mmol) and 4-di-methylamino-2-tri-butylstannylpyridine 266 were coupled to afford, 
following chromatography (EtOAc:hexane 3:7), 4’-di-methylamino-4-carboxylic acid 
methyl ester-2,2’-bipyridine 285 as an off white solid (265 mg, 50%), (mp = 145.5-146.5 
oC); max (ATR) 2925, 1716, 1592, 1544, 1510, 1470, 1435, 1374, 1286, 1228, 1102, 980, 
858, 798, 768, 739 cm-1; H (700 MHz, CDCl3) 8.92-8.89 (1H, s, 3-H), 8.79 (1H, d, J = 4.9 
Hz, 6-H), 8.34 (1H, d, J = 5.8 Hz, 6’-H), 7.83 (1H, dd, J = 4.9 Hz, J = 1.6 Hz, 5-H), 7.71 (1H, 
d, J = 2.7 Hz, 3’-H), 6.55 (1H, dd, J = 5.8 Hz, J = 2.7 Hz, 5’-H), 3.96 (3H, s, OCH3 ), 3.1 (6H, 
s, N-CH3); C (176 MHz, CDCl3) 166.0 (C=O), 158.3 (C-2), 155.5 (C-2’), 155.4 (C-4’), 149.7 
(C-6), 149.6 (C-6’), 138.4 (C-4), 122.6 (C-5), 120.7 (C-3), 107.1 (C-5’), 104.1 (C-3’), 52.7 
(OCH3),  39.5 (N-CH3); m/z (GC-MS, EI+) 257 ([M]+, 77%), 242 ([M-CH3]+, 100%),  214 
found, 199 ([MH-COOMe]+, 41%); m/z (LC-MS, ES+) 257 ([M]+), 258 ([MH]+); HRMS (ES+) 
found ([MH]+) 258.1243, C14H16N3O2 requires M, 258.1243. 
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Furthermore, 4,4’-di-carboxylic acid methyl ester-2,2’-bipyridine 286 was isolated as a 
white solid (0.01g, 2%), (mp = 207.3-208.5 oC); max (ATR) 1728 (C=O), 1590, 1557, 
1433, 1358, 1290, 1244, 1123, 957, 757, 722, 696, 668, 401 H (700 MHz, CDCl3) 8.96-
8.90 (2H, m, 3, 3’-H), 8.86 (2H, d, J = 5 Hz, 6, 6’-H), 7.9 (2H, dd, J = 5 Hz, J = 1.6 Hz, 5,5’-
H), 4.0 (6H, s, (OCH3)2 ); C (176 MHz, CDCl3) 165.76 (C=O), 156.64 (C-2), 150.28 (C-6), 
138.74 (C-4), 123.4 (C-5), 120.7 (C-3), 52.9 (OCH3); m/z (LC-MS, ES+) 273 ([MH]+). 
 
6.2.14.2.3 4’-Di-methylamino-4-tert-butyl-2,2’-bipyridine (250) 
 
 
Following procedure K in 6.2.14.2, 2-bromo-4-tert-butylpyridine 252 (0.43 g, 2 mmol) 
and 4-di-methylamino-2-tri-butylstannylpyridine 266 were coupled to afford, following 
chromatography (EtOAc:hexane 2:8), 4’-Di-methylamino-4-tert-butyl-2,2’-bipyridine 
250 as a white solid (240 mg, 47%). Data have been identified above in 6.2.12.4.1.1. 
 
6.2.15 Evaluation of ligands in the borylation of aromatic compounds 
6.2.15.1 Evaluation of ligands using anisole in the borylation reaction:  
[Ir(OMe)cod]2 (0.01 g, 0.015 mmol, 1.5 mol %), ligand (3 mol %) and B2pin2 (254 mg, 
1.0 mmol) were added to a (5 ml) microwave vessel. The vessel was evacuated, 
backfilled with N2 and THF (2 ml) was then added. Anisole 35 (109 µl, 1.0 mmol) was 
added and the reaction mixture was carried out at r.t for the stated period before 
being quenched by the addition of DCM (2 ml). The reaction mixture was then 
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concentrated in vacuo to afford the crude product, which confirmed by GC MS and H 
NMR analysis. 
 
6.2.15.2 Evaluation of ligands using m-xylene in the borylation reaction:  
[Ir(OMe)cod]2 (0.01 g, 0.015 mmol, 1.5 mol %), ligand (3 mol %) and B2pin2 (305 mg, 
1.2 mmol) were added to a (5 ml) microwave vessel. The vessel was evacuated, 
backfilled with N2. THF (2 ml) was added, and then m-xylene 19 (0.124 ml, 1.0 mmol) 
added. The microwave vessel was vigorously shaken and 0.5 ml of reaction mixture 
was then transferred to a Young’s Tap-sealed NMR tub containing a coaxial tub filled 
with acetone-d6. The reaction was heated and monitored at the stated temperature 
for the stated period by 1H NMR spectrum. 
 
6.2.15.3 Evaluation of ligands using methyl-2-methoxybenzoate in the 
borylation reaction:  
[Ir(OMe)cod]2 (0.01 g, 0.015 mmole, 1.5 mol %), ligand (3 mol %) and B2pin2 (305 mg, 
1.2 mmol) and methyl-2-methoxybenzoate 57 (166 mg, 1.0 mmol) were added to a (5 
ml) microwave vessel. The vessel was evacuated, backfilled with N2. THF (2 ml) was 
then added. This reaction was carried out at r.t for the stated period before being 
quenched by the addition of DCM (2 ml). The reaction mixture was then concentrated 
in vacuo to afford the crude product, which confirmed by GC MS and H NMR analysis. 
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6.2.16 Preparation of 4, 4’-di-substituted-2,2’-bipyridine derivatives  
6.2.16.1 Preparation of carbamate derivatives, Procedure L 
In round bottom flask, acyl chloride (12.0 mmol) was added dropwise to a stirred 
solution of the amine derivative (8.0 mmol) and tri-ethylamine (1.12 ml, 8.0 mmol) in 
dry DCM (35 ml) at 0 oC. The reaction was allowed to warm-up slowly to room 
temperature and then stirred for further 17 h. The crude mixture was then washed 
with saturated aq. NaHCO3 until the aqueous washings were neutral. The organic 
phase was then dried over MgSO4 and concentrated in vacuo to afford the crude 
product. 
 
6.2.16.1.1 (2-Chloro-pyridin-4-yl)-carbamic acid ethyl ester (292) 
 
 
Following procedure L, ethyl chloroformate (1.2 ml, 12 mmol) and 2-chloro-4-
aminopyridine 291 (8 mmol, 1.0 g) were combined to afford, without further 
purification, (2-chloro-pyridin-4-yl)-carbamic acid ethyl ester 292 as a white solid (1.5 
g, 96%), (mp = 136.8-137.8 oC); max (ATR) 1739 (C=O), 1604, 1584, 1509, 1438, 1474, 
1391, 1315, 1279, 1273, 1240, 1214, 1131, 1080, 1064, 1007, 990, 937, 866, 830, 608, 
450 cm-1; H (700 MHz, CDCl3) 8.2 (1H, d, J = 5.7 Hz, 6-H), 7.6 (1H, s, NH) 7.5 (1H, d, J = 
2 Hz, 3-H), 7.3 (1H, dd, J = 5.7 Hz, J = 2 Hz, 5-H), 4.2 (2H, q, J = 7.1 Hz, CH2), 1.3 (3H, t, J 
= 7.1 Hz, CH3); C (176 MHz, CDCl3) 153.0 (C=O), 152.0 (C-2), 150.0 (C-6), 148.0(C-4), 
112.4 (C-3), 112.0 (C-5), 62.2 (CH2), 14.5 (CH3); m/z (GC-MS, EI+) 202 ([M (37Cl)]+, 35%), 
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200 ([M (35Cl)]+, 100%), 156 ([M (37Cl)-C2H6O]+, 26%), 154 ([M (35Cl)-C2H5O]+, 79%), 143 
& 141 found, 130 ([MH (37Cl)-C3H5O2]+, 23%), 128 ([MH (35Cl)-C3H5O2]+, 66%), 119 ([M- 
(35Cl) C2H6O]+, 53%); HRMS (ES+) found ([MH]+) 201.0422, C8H1035ClN2O2 requires M,  
201.0431. 
 
6.2.16.2 2-Chloro-4-(N-methylamino)-pyridine (293) 
 
 
Under N2, in a 50 ml round bottomed flasks, LiAlH4 (2.5 ml of a 2.4 M solution in THF, 
6.0 mmol) was added dropwise to a stirred solution of (2-chloro-pyridin-4-yl)-carbamic 
acid ethyl ester 292 (1.0 g, 5.0 mmol) in dry THF (20 ml) at 0 oC. The reaction was then 
allowed to stir at room temperature for 17 h and then quenched by the dropwise 
addition of H2O (0.23 ml), 15% NaOH (0.23 ml) and H2O (0.7 ml). The mixture was then 
filtered through celite and the solid phase was washed with THF. The organic phase 
was then dried over MgSO4 and concentrated in vacuo to afford, following 
chromatography (EtOAc:hexane 1:1), 2-chloro-4-(N-methylamino)-pyridine 293 as a 
white solid (0.54 g, 76%), (mp = 73.9-74.9 oC); max (ATR) 3244 (NH), 1592, 1464, 1429, 
1356, 1264, 1256, 1120, 1070, 980, 867, 834, 811, 717, 613, 443 cm-1; H (700 MHz, 
CDCl3) 7.9 (1H, d, J = 5.8 Hz, 6-H), 6.4 (1H, d, J = 2.2 Hz, 3-H), 6.3 (1H, dd, J = 5.8 Hz, J = 
2.2 Hz, 5-H), 4.9 (1H, bs, NH), 2.8 (3H, d, J = 4.8 Hz, CH3); C (176 MHz, CDCl3) 156.4 (C-
4), 152.1 (C-2), 149.0 (C-6), 107.1 (C-5), 105.7 (C-3), 29.4 (CH3); m/z (GC-MS, EI+) 144 
([M (37Cl)]+, 34%), 142 ([M (35Cl)]+, 100%). HRMS (ES+) found ([MH]+) 143.0355, 
C6H835ClN2 requires M, 143.0376. 
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6.2.16.3 N-(2-Chloropyridin-4-yl)-N-methylacetamide (294) 
 
 
Following procedure L, 2-chloro-4-(N-methylamino)-pyridine 293 (1.14 g, 8.0 mmol) 
and acetyl chloride (0.85 ml, 12.0 mmol) were combined to afford, following 
chromatography (CHCl3:EtOAc 2.0:1.0), N-(2-chloropyridin-4-yl)-N-methylacetamide 
294 as a white solid (0.62g, 42%), (mp = 62.5-63.5 oC); max (ATR), 1652 (C=O), 1582, 
1549, 1471, 1425, 1379, 1360, 1301, 1082, 992, 982, 946, 858, 782, 734, 618, 596, 486, 
446, 437,  cm-1; H (700 MHz, CDCl3) 8.3 (1H, d, J = 5.5 Hz, 6-H), 7.2 (1H, d, J = 2.0 Hz, 3-
H), 7.1 (1H, dd, J = 5.5 Hz, J = 2.0 Hz, 5-H), 3.25 (3H, s, N-CH3), 3.05 (3H, s, 2’-H), C (176 
MHz, CDCl3) 169.8 (C-1’), 153.3 (C-4), 152.27 (C-2), 150.4 (C-6), 120.5 (C-3), 119.1 (C-5), 
36.8 (C-N-CH3), 22.9 (C-2’); m/z (LC-MS, ES+) 185 ([MH (35Cl)]+, 100%), 187 ([MH (37Cl)]+, 
30%); m/z (GC-MS, EI+) 186 ([M (37Cl)]+, 8%), 184 ([M (35Cl)]+, 25%), 144 ([MH (37Cl)-
C2H3O]+, 34%), 142 ([MH (35Cl)-C2H3O]+, 100%). HRMS (ES+) found ([MH]+) 185.0486, 
C8H1035ClN2O requires M, 185.0482. 
 
6.2.16.4 2-Chloro-N-(2-chloropyridin-4-yl)-N-methylacetamide (295) 
 
 
Following procedure L, 2-chloro-4-(N-methylamino)-pyridine 293 (1.14 g, 8.0 mmol) 
and 2-chloroacetylchloride (0.96 ml, 12.0 mmol) were combined to afford, following 
chromatography (MeOH:DCM 1.0:20), 2-chloro-N-(2-chloropyridin-4-yl)-N-methyl-
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acetamide 295 as an off white solid (1.58 g, 90%), (mp = 86.5-87.5 oC); max (ATR) 1677 
(C=O), 1581, 1549, 1467, 1367, 1259, 1117, 1084, 1046, 991, 943, 801, 785, 734, 712, 
652, 639, 562, 479, 431 cm-1; H (700 MHz, CDCl3) 8.44 (1H, d, J = 5.4 Hz, 6-H), 7.31 (1H, 
d, J = 1.9 Hz, 3-H), 7.21 (1H, dd, J = 5.4 Hz, J = 1.9 Hz, 5-H), 4.03 (2H, s, 2’-H), 3.37 (3H, s, 
N-CH3); C (176 MHz, CDCl3) 166.0 (C-1’), 153.0 (C-2), 152.4 (C-4), 151.1 (C-6), 121.0 (C-
3), 119.4 (C-5), 41.4 (C-2’), 37.5 (CH3); m/z (GC-MS, EI+) 222 ([M (37Cl,37Cl)]+, 6%), 220 
([M (35Cl,37Cl)]+, 35%), 218 ([M (35Cl,35Cl)]+, 54%), 185 ([M (37Cl)-(37Cl)]+, 8%), 183 ([M 
(35Cl)-(35Cl)]+, 27%), 171 ([M (37Cl)-(37Cl)-CH2]+, 31%), 169 ([M (35Cl)-(35Cl)-CH2]+, 100%), 
144 ([MH (37Cl)-(37Cl)-C2H2O]+, 25%), 142 ([MH (35Cl)-(35Cl)-C2H2O]+, 81%); HRMS (ES+) 
found ([MH]+) 219.0079, C8H935Cl2N2O requires M, 219.0092. 
 
6.2.16.5 2-(4’-Di-methylamino-2,2’-bipyridine-4-yl)-N-methylacetamide 
(296) 
 
 
Following procedure K in 6.2.14.2, N-(2-chloropyridin-4-yl)-N-methylacetamide 294 
(0.37 g, 2 mmol) and 4-di-methylamino-2-tri-butylstannylpyridine 266 were coupled to 
afford, following chromatography (MeOH:DCM 1:40), 2-(4´-di-methylamino-2,2´-
bipyridine-4-yl)-N-methylacetamide) 296 as an off white solid (27 mg, 5%), (mp = 
122.5-123.5 oC); max (ATR) 1666 (C=O), 1576, 1473, 1463, 1375, 1334, 1252, 1223, 
1146, 988, 829, 750, 611, 554 cm-1; H (700 MHz, CDCl3) 8.68 (0.1H, d, J = 5.2 Hz, 6-H, 
rotamer A), 8.65 (0.9H, d, J = 5.2 Hz, 6-H, rotamer B), 8.32 (1H, m, 3-H), 8.29 (1H, d, J = 
6.0 Hz, 6’-H), 7.72 (1H, d, J = 2.7 Hz, 3’-H), 7.24-7.4 (1H, m, 5-H rotamers A and B), 6.56 
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(1H, dd, J = 6.0 Hz, J = 2.7 Hz, 5’-H), 3.37 (3H, s, NCH3 ), 3.12 (6H, s, N-(CH3)2), 2.09-2.07 
(3 H, s, CH3, rotamers A and B); C (176 MHz, CDCl3) 170.1 (C=O), 155.7 (C-4’), 155.0 (C-
2’), 152.7 (C-4), 150.7 (C-6, rotamer A), 150.3 (C-6, rotamer B), 121.4 (C-5, rotamer A), 
121.1 (C-5, rotamer B ), 118.4 (C-3), 107.1 (C-5’), 104.2 (C-3’), 39.6 (N-(CH3)2), 37.0 
(NCH3), 22.9 (CH3, rotamer A and B), unobserved (C-2, C-6’); m/z (LC-MS, EI+) 271 
([MH]+). HRMS (ES+) found ([MH]+) 271.1554, C15H19N4O requires M, 271.1559. 
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Chapter 4 
6.2.17 The borylation of pyridine derivatives  
[Ir(OMe)cod]2 (X mmol, X mol %), dtbpy (2X mmol, 2X  mol%), B2pin2 (X mmol) and the 
substrate (1.0 mmol). 
 
Protocol M1: All reagents above except the substrate were placed in the reaction 
vessel which was then sealed, evacuated, backfilled with N2 and the stated solvent was 
then added. The substrate was placed in a second vessel, sealed, evacuated, backfilled 
with N2, dissolved in the stated solvent and transferred to vessel 1 using a syringe. 
 
Protocol M2: All reagents above were placed in the reaction vessel which was then 
sealed, evacuated, backfilled with N2 and MTBE (2 ml) was then added. 
 
Protocol M3: All reagents above except the substrate were placed in the reaction 
vessel which was then sealed, evacuated, backfilled with N2 and MTBE (2 ml) was then 
added. The substrate was added using a syringe. 
All the reaction mixtures above were heated in µW reactor at the stated temperature 
for the stated period. After cooling, the reaction mixture was concentrated in vacuo to 
afford the crude borylated product. Where relevant, this crude borylated product was 
used in the Suzuki-Miyaura cross-coupling reaction, without further purification. 
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6.2.18 General procedure N: Susuki Miyaura-cross coupling  
Following borylation using protocol M1 or M2, a mixture of Ar-Bpin (1.0 mmol), aryl 
halide (1.5 or 1.1 mmol), PdCl2(dppf) (5 mol%) and Cs2CO3 (0.65 g, 2.0 mmol) were 
placed in dry microwave vessel (5 ml) while was then evacuated and backfilled with N2. 
DMA (2 ml) was then added. The reaction mixture was heated in microwave reactor at 
the stated temperature for the stated period. After cooling, the reaction mixture was 
concentrated in vacuo then re-dissolved by EtOAc (40 ml) and wash with NaHCO3 (aq.) 
to afford, following chromatography the desired product. 
 
6.2.18.1 Methyl-6-chloro-2-(4’-nitrophenyl)-pyridine-4-carboxylate (310) 
 
 
Methyl-2-chloroisonicotinate 151 (171.5 mg, 1.0 mmol) in MTBE (1.0 ml) was borylated 
following standard protocol M1 [[Ir(OMe)cod]2 (33.15 mg, 0.05 mmol, 5 mol%), dtbpy 
(10 mol%, 26.8 mg) and B2pin2 (1.2 mmol, 305 mg) in MTBE (1.5 ml), reaction time= 30 
min, reaction temperature= 120 oC]. The crude boronate ester (~1.0 mmol) was 
directly used in Suzuki Miyaura coupling following general procedure N with 4-
iodonitrobenzene (374 mg, 1.5 mmol) at 100 oC for 3 h to afford, following 
chromatography (DCM:toluene 3:7), Methyl-6-chloro-2-(4’-nitrophenyl)-pyridine-4-
carboxylate 310 as a yellow solid (130 mg, 45 %), (mp = 165.5-166 oC); max (ATR) 1733 
(C=O), 1591, 1557, 1514, 1439, 1404, 1340, 1317, 1252, 1244, 1156, 1104, 982, 857, 
818, 770, 755, 742, 722, 689 cm-1; H (700 MHz, CDCl3) 8.36-8.33 (2H, m, 3’,5’-H), 8.3 
(1H, d, J = 1.1 Hz, 3-H), 8.3-8.23 (2H, m, 2’,6’-H), 7.9 (1H, d, J = 1.1 Hz, 5-H), 4.0 (3H, s, 
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OCH3); C (176 MHz, CDCl3) 164.3 (C=O),156.9 (C-2), 152.9 (C-6), 149.0 (C-4’), 142.8 (C-
1’), 141.5 (C-4), 128.1 (C-2’,6’), 124.3 (C-3’,5’), 123.8 (C-3), 119.0 (C-5), 53.4 (O-CH3); 
m/z (GC-MS, EI+) 294 ([M (37Cl)]+, 33%), 292 ([M (35Cl)]+, 100%), 264 ([MH (37Cl)-OMe]+, 
4%), 262 ([MH (35Cl)-OMe]+, 14%), 248 ([M (37Cl)-NO2]+, 10%), 246 ([M (35Cl)-NO2]+, 
3%), 236 ([MH (37Cl)-COOCH3]+, 17%), 234 ([MH (35Cl)-COOCH3]+, 52%); HRMS (ES+) 
found ([MH]+) 293.0344; C13H1035ClN2O4 requires M, 293.0329. 
 
6.2.18.2 Methyl-6-chloro-2-(3’-thiophen-yl)-pyridine-4-carboxylate (311)  
 
 
 
Methyl-2-chloroisonicotinate 151 (171.5 mg, 1.0 mmol) in MTBE (1.0 ml) was borylated 
following standard protocol M1 [[Ir(OMe)cod]2 (33.15 mg, 0.05 mmol, 5 mol%), dtbpy 
(10 mol%, 26.8 mg) and B2pin2 (1.2 mmol, 305 mg) in MTBE (1.5 ml), reaction time= 30 
min, reaction temperature= 120 oC]. The crude boronate ester (~1.0 mmol) was 
directly used in Suzuki Miyaura coupling following general procedure N with 3-
bromothiophene (0.28 ml, 1.5 mmol) at 100 oC for 3 h to afford, following 
chromatography (EtOAc:hexane 1:12), methyl-6-chloro-2-(3’-thiophen-yl)-pyridine-4-
carboxylate 311 as a brown solid (25.2 mg, 10 %), (mp = 79.5-80 oC); max (ATR) 1723 
(C=O), 1596, 1550, 1525, 1444, 1432, 1361, 1346, 1290, 1235, 1204, 1198, 1163, 1071, 
977, 919, 873, 833, 801, 729, 714, 697, 655 cm-1; H (700 MHz, CDCl3) 8.04 (1H, d, J = 
1.0 Hz, 3-H) 8.03 (1H, dd, J = 3.0, 1.3 Hz, 2’-H), 7.7 (1H, d, J = 1.0 Hz, 5-H), 7.68 (1H, dd, 
J = 5.1, 1.3 Hz, 5’-H), 7.4 (1H, dd, J = 5.1, 3.0 Hz, 4’-H), 4.0 (3H, s, OCH3); C (176 MHz, 
CDCl3) 164.7 (C=O), 155.0 (C-2), 152.1 (C-6), 141.0 (C-4), 140.1 (C-3’), 127.0 (C-4’), 
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126.2 (C-5’), 125.7 (C-2’), 121.6 (C-5), 118.0 (C-3), 53.1 (OCH3); m/z (GC-MS, EI+) 255 
([M (37Cl)]+, 37%), 253 ([M (35Cl)]+, 100%), 224 ([M (37Cl)-OCH3]+, 8%), 222 ([M (35Cl)-
OCH3]+, 24%), 197 ([MH (37Cl)-COOCH3]+, 8%), 195 ([MH (35Cl)-COOCH3]+, 22%); HRMS 
(ES+) found ([MH]+) 254.0052; C11H935ClNO2S requires M, 254.0043. 
 
6.2.18.3 Methyl-6-chloro-2-(4’-methoxyphenyl)-pyridine-4-carboxylate 
(312)88  
 
 
Methyl-2-chloroisonicotinate 151 (0.17 g, 1.0 mmol) in MTBE (1.0 ml) was borylated 
following standard protocol M1 [[Ir(OMe)cod]2 (33.15 mg, 0.05 mmol, 5 mol%), dtbpy 
(10 mol%, 26.8 mg) and B2pin2 (1.2 mmol, 305 mg) in MTBE (1.5 ml), reaction time= 30 
min, reaction temperature= 120 oC]. The crude boronate ester (~1.0 mmol) was 
directly used in Suzuki Miyaura coupling following general procedure N with 4-
iodoanisole (350 mg, 1.5 mmol) at 100 oC for 3 h to afford, following chromatography 
(EtOAc:hexane 1:10), methyl-6-chloro-2-(4’-methoxyphenyl)-pyridine-4-carboxylate 
312 as a white solid (134.5 mg, 48 %), (mp = 101.5-102.5 oC); max (ATR) 1734 (C=O), 
1606, 1597, 1583, 1549, 1519, 1441, 1404, 1390, 1302, 1256, 1180, 1161, 1113, 1071, 
1021, 981, 824, 761, 732, 615, 585 cm-1; H (700 MHz, CDCl3) 8.11 (1H, d, J = 1.2 Hz, 3-
H), 8.03-7.96 (2H, m, 2’,6’-H), 7.7 (1H, d, J = 1.2 Hz, 5-H), 7.01-6.93 (2H, m, 3’,5’-H), 4.0 
(3H, s, OCH3 ester), 3.86 (3H, s, OCH3); C (176 MHz, CDCl3) 164.8 (C=O),161.4 (C-4’), 
158.7 (C-2), 152.0 (C-6), 140.8 (C-4), 129.6 (C-1’), 128.6 (C-2’,6’), 121.1 (C-5), 117.3 (C-
3), 114.4 (C-3’,5’), 55.5 (4’-OCH3), 53.1 (O-CH3 ester); m/z (GC-MS, EI+) 279 ([M (37Cl)]+, 
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32%), 277 ([M (35Cl)]+, 100%), 264 ([M (37Cl)-CH3]+, 1%), 262 ([M (35Cl)-CH3]+, 4%), 248 
([M (37Cl)-OMe]+, 2%), 246 ([M (35Cl)-OMe]+, 4%), 234 & 236 found, 221 ([MH (37Cl)-
C2H3O2]+, 6%), 219 ([MH (35Cl)-C2H3O2]+, 17%); HRMS (ES+) found ([MH]+) 278.0600; 
C14H1335ClNO3 requires M, 278.0584. 
 
6.2.18.4 4-Tert-butyl-6-chloro-2-(4’-nitrophenyl)-pyridine (313) 
 
 
2-Chloro-4-tert-butylpyridine 265 (170 mg, 1.0 mmol) was borylated following 
standard protocol M2 [[Ir(OMe)cod]2 (0.01 g, 0.015 mmol, 1.5 mol %), dtbpy (8.0 mg, 
0.03 mmol, 3 mol%) and B2pin2 (1.0 mmol, 254 mg), reaction time= 1 h, reaction 
temperature= 80 oC]. The crude boronate ester (~ 1.0 mmol) was directly used in a 
Suzuki-Miyaura coupling following general procedure N, with 4-iodo-nitrobenzene 
(374 mg, 1.5 mmol) at 100 oC for 3 h, to afford, following chromatography 
(EtOAc:hexane 1:15), 4-tert-butyl-6-chloro-2-(4’-nitrophenyl)-pyridine 313 as an off 
white solid (117 mg, 40 %), (mp = 192-193 oC); max (ATR), 1588, 1533, 1509, 1410, 
1338, 1171, 1104, 856, 813, 762, 731, 698, 644 cm-1; H (700 MHz, CDCl3) 8.33-8.27 
(2H, m, 3’,5’-H) 8.19-8.12 (2H, m, 2’,6’-H), 7.69 (1H, d, J = 1.5 Hz, 3-H), 7.34 (1H, d, J = 
1.5 Hz, 5-H), 1.38 (9H, s, 4-C(CH3)3); C (176 MHz, CDCl3) 164.8 (C-4), 155.3 (C-2), 152.3 
(C-6), 148.5 (C-4’), 144.3 (C-1’), 128.0 (C-2’,6’), 124.1 (C-3’,5’), 121.4 (C-5), 117.2 (C-3), 
35.5 (4-C), 30.6 (4-C-(CH3)3)); m/z (GC-MS, EI+) 292 ([M(37Cl)]+, 26%), 290 ([M (35Cl)]+, 
76%), 277 ([M (37Cl)-CH3]+, 34%), 275 ([M(35Cl)-CH3]+, 100%); HRMS (ES+) found ([MH]+) 
291.0904; C15H1635ClN2O2 requires M, 291.0900.  
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6.2.18.5 4-Tert-butyl-6-chloro-2,2’-bipyridinyl-4’-carboxylic acid methyl 
ester (314) 
 
 
2-Chloro-4-tert-butylpyridine 265 (170 mg, 1.0 mmol) was borylated following 
standard protocol M2 [[Ir(OMe)cod]2 (0.01 g, 0.015 mmol, 1.5 mol %), dtbpy (8.0 mg, 
0.03 mmol, 3 mol%) and B2pin2 (1.0 mmol, 254 mg), reaction time= 1 h, reaction 
temperature= 80 oC]. The crude boronate ester (~ 1.0 mmol) was directly used in 
Suzuki-Miyaura coupling following general procedure N, with methyl-2-
bromoisonicotinate (32.4 mg, 1.5 mmol) at 100 oC for 3 h, to afford, following 
chromatography (EtOAc:CHCl3 1:23), 4-tert-butyl-6-chloro-2,2’-bipyridinyl-4’-carboxylic 
acid methyl ester 314 as a white solid (200 mg, 66 %), (mp = 102.5-103.5 oC); max 
(ATR), 1726 (C=O), 1585, 1532, 1478, 1438, 1373, 1365, 1356, 1315, 1294, 1268, 1165, 
1133, 1100, 966, 891, 859, 769, 751, 694, 674, 650 cm-1; H (600 MHz, CDCl3) 8.9 (1H, 
bs, 3’-H) 8.8 (1H, d, J = 5.0 Hz, 6’-H), 8.4 (1H, d, J = 1.6 Hz, 3-H), 7.86 (1H, dd, J = 5.0, 1.6 
Hz, 5’-H), 7.3 (1H, d, J = 1.6 Hz, 5-H), 4.0 (3H, s, OCH3), 1.38 (9H, s, 4-C(CH3)3); C (151 
MHz, CDCl3) 165.8 (C=O), 164.7 (C-4), 156.3 (C-2’), 155.7 (C-2), 151.5 (C-6), 150.0 (C-6’), 
138.7 (C-4’), 123.3 (C-5’),122.0 (C-5), 121.0 (C-3’), 117.2 (C-3), 52.8 (O-CH3), 35.5 (4-C), 
30.6 (4-C-(CH3)3)); m/z (GC-MS, EI+) 306 ([M(37Cl)]+, 8%), 304 ([M (35Cl)]+, 25%), 291 ([M 
(37Cl)-CH3]+, 37%), 289 ([M (35Cl)-CH3]+, 100%); HRMS (ES+) found ([MH]+) 305.1065; 
C16H1735ClN2O2 requires M, 305.1057.  
 
 
2
3
4
5
6 N
N
Cl
3'
4'
5'
6'
2'
O
OMe
195 
 
6.2.18.6 4-Tert-butyl-6-chloro-2-(3’-thiophen-yl)-pyridine (315)  
 
 
2-Chloro-4-tert-butylpyridine 265 (170 mg, 1.0 mmol) was borylated following 
standard protocol M2 [[Ir(OMe)cod]2 (0.01 g, 0.015 mmol, 1.5 mol %), dtbpy (8.0 mg, 
0.03 mmol, 3 mol%) and B2pin2 (1.0 mmol, 254 mg), reaction time= 1 h, reaction 
temperature= 80 oC]. The crude boronate ester (~ 1.0 mmol) was directly used in 
Suzuki Miyaura coupling following general procedure N with 3-bromothiophene (0.14 
ml, 1.5 mmol) at 100 oC for 3 h to afford, following chromatography (ether:hexane 
1:16), 4-tert-butyl-6-chloro-2-(3’-thiophen-yl)-pyridine 315 as a white solid (168 mg, 
67%), (mp = 50-51 oC); max (ATR) 1591, 1540, 1477, 1434, 1422, 1362, 1346, 1287, 
1200, 1165, 1079, 1062, 861, 831, 794, 774, 731, 671 cm-1; H (700 MHz, CDCl3) 8.95 
(1H, dd, J = 3.0, 1.3 Hz, 2’-H), 7.6 (1H, dd, J = 5.0, 1.3 Hz, 4’-H), 7.5 (1H, d, J = 1.5 Hz, 3-
H), 7.3 (1H, dd, J = 5.0, 3.0 Hz, 5’-H), 7.18 (1H, d, J = 1.5 Hz, 5-H), 1.35 (9H, s, 4-C(CH3)3); 
C (176 MHz, CDCl3) 164.2 (C-4), 153.9 (C-2), 151.6 (C-6), 141.2 (C-3’), 126.5 (C-5’), 
126.3 (C-4’), 124.5 (C-2’), 119.4 (C-5), 116.1 (C-3), 35.3 (4-C), 30.6 (4-C-(CH3)3)); m/z 
(GC-MS, EI+) 253 ([M(37Cl)]+), 37%, 251 ([M (35Cl)]+, 100%), 238 ([M (37Cl)-CH3)]+, 31%), 
236 ([M(35Cl)-CH3]+, 87%); HRMS (ES+) found ([MH]+) 252.0596; C13H1535ClNS requires 
M, 252.0614. 
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6.2.18.7 4-Tert-butyl-6-chloro-2-(2’-thiazol-yl)-pyridine (316)  
 
 
2-Chloro-4-tert-butylpyridine 265 (170 mg, 1.0 mmol) was borylated following 
standard protocol M2 [[Ir(OMe)cod]2 (0.01 g, 0.015 mmol, 1.5 mol %), dtbpy (8.0 mg, 
0.03 mmol, 3 mol%) and B2pin2 (1.0 mmol, 254 mg), reaction time= 1 h, reaction 
temperature= 80 oC]. The crude boronate ester (~ 1.0 mmol) was directly used in 
Suzuki Miyaura coupling following general procedure N with 2-bromothiazole (0.135 
ml, 1.5 mmol) at 100 oC for 3 h to afford, following chromatography (EtOAc:hexane 
1:9), 4-tert-butyl-6-chloro-2-(2’-thiazol-yl)-pyridine 316 as an off white solid (106 mg, 
42%), (mp = 96.5-97.5 oC); max (ATR) 1591, 1541, 1500, 1478, 1440, 1381, 1242, 1168, 
1151, 1048, 874, 863, 794, 770, 745, 723, 620, 583, 515 cm-1; H (700 MHz, CDCl3) 8.12 
(1H, d, J = 1.5 Hz, 3-H) 7.9 (1H, d, J = 3.1 Hz, 5’-H), 7.5 (1H, d, J = 3.1 Hz, 4’-H), 7.3 (1H, 
d, J = 1.5 Hz, 5-H), 1.36 (9H, s, 4-C(CH3)3); C (176 MHz, CDCl3) 168.2 (C-2’), 165.0 (C-4), 
151.6 (C-2), 151.4 (C-6), 144.1 (C-5’), 122.2 (C-5), 122.0 (C-4’), 115.6 (C-3), 35.5 (4-C), 
30.6 (4-C-(CH3)3)); m/z (GC-MS, EI+) 254 ([M (37Cl)]+, 24%), 252 ([M (35Cl)]+, 65%), 239 
([M (37Cl)-CH3]+, 36%), 237 ([M (35Cl)-CH3]+, 100%); HRMS (ES+) found ([MH]+) 253.0584; 
C12H1535ClN2S requires M, 253.0566. 
 
6.2.18.8 4-Tert-butyl-6-chloro-2-(4’-methoxyphenyl)-pyridine (317) 
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2-Chloro-4-tert-butylpyridine 265 (170 mg, 1.0 mmol) was borylated following 
standard protocol M2 [[Ir(OMe)cod]2 (0.01 g, 0.015 mmol, 1.5 mol %), dtbpy (8.0 mg, 
0.03 mmol, 3 mol%) and B2pin2 (1.0 mmol, 254 mg), reaction time= 1 h, reaction 
temperature= 80 oC]. The crude boronate ester (~ 1.0 mmol) was directly used in 
Suzuki Miyaura coupling following general procedure N with 4-iodoanisole (350 mg, 
1.5 mmol) at 100 oC for 3 h to afford, following chromatography (ether:hexane 1:20), 
4-tert-butyl-6-chloro-2-(4’-methoxyphenyl)-pyridine 317 as a colorless oil (121 mg, 44 
%); max (ATR) 1607, 1591, 1535, 1514, 1462, 1410, 1385, 1303, 1247, 1175, 1111, 
1074, 1031, 878, 831, 780, 650, 585, 507 cm-1; H (700 MHz, CDCl3) 7.96-7.92 (2H, m, 
2’, 6’-H), 7.55 (1H, d, J = 1.5 Hz, 3-H), 7.18 (1H, d, J = 1.5 Hz, 5-H), 7.00-6.95 (2H, m, 
3’,5’-H), 3.86 (3H, s, OCH3), 1.35 (9H, s, 4-C(CH3)3); C (176 MHz, CDCl3) 164.0 (C-4), 
160.9 (C-4’), 157.7 (C-2), 151.6 (C-6), 131.0 (C-1’), 128.5 (C-2’, 6’), 119.0 (C-5), 115.5 (C-
3), 114.2 (C-3’, 5’), 55.5 (OCH3), 36.3 (4-C), 30.6 (4-C-(CH3)3)); m/z (GC-MS, EI+) 277 ([M 
(37Cl)]+, 31%), 275 ([M (35Cl)]+, 100%), 262 ([M (37Cl)-CH3]+, 14%), 260 ([M (35Cl)-CH3]+, 
42%); HRMS (ES+) found ([MH]+) 276.1159; C16H1935ClNO requires M, 276.1155. 
 
6.2.18.9 4-Tri-fluoromethyl-6-chloro-2-(4’-methoxyphenyl)-pyridine (318)  
 
 
 
2-Chloro-4-(tri-fluoromethyl)-pyridine 307 (0.13 ml, 1.0 mmol) was borylated following 
standard protocol M3 [[Ir(OMe)cod]2 (0.01 g, 0.015 mmol, 1.5 mol %), dtbpy (8.0 mg, 
0.03 mmol, 3 mol%) and B2pin2 (1.0 mmol, 254 mg), reaction time= 1 h, reaction 
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temperature= 80 oC]. The crude boronate ester (~ 1.0 mmol) was directly used in 
Suzuki Miyaura coupling following general procedure N with 4-iodoanisole (350 mg, 
1.5 mmol) at 100 oC for 3 h to afford, following chromatography (ether:hexane 1:20), 
4-tri-fluoromethyl-6-chloro-2-(4’-methoxyphenyl)-pyridine 318 as a yellow oil (105 mg, 
36 %);max (ATR) 1606, 1557, 1518, 1408, 1394, 1331, 1265, 1253, 1175, 1135, 1098, 
1072, 1031, 830, 694, 665, 581 cm-1; H (700 MHz, CDCl3) 7.99-7.94 (2H, m, 2’,6’-H), 
7.73 (1H, d, J = 0.6 Hz, 3-H), 7.37 (1H, d, J = 0.6 Hz, 5-H), 6.99-6.94 (2H, m, 3’,5’-H), 3.85 
(3H, s, OCH3); C (176 MHz, CDCl3) 161.7 (C-4’), 159.1 (C-2), 151.2 (C-6), 141.5 (q, J = 
34.1 Hz, C-4), 129.0 (C-1’), 128.6 (C-2’,6’), 122.4 (q, J = 273 Hz, CF3), 117.0 (q, J = 3.7 Hz, 
C-5), 114.4 (C-3’,5’), 113.4 (q, J = 3.7 Hz, C-3), 55.4 (O-CH3); m/z (GC-MS, EI+) 289 ([M 
(37Cl)]+, 33%), 287 ([M (35Cl)]+, 100%), 274 ([M (37Cl)-CH3]+, 3%), 272 ([M (35Cl)-CH3]+, 
9%), 246 & 244 found; HRMS (ES+) found ([MH]+) 288.0401; C13H1035ClF3NO requires M, 
288.0403. 
 
6.2.18.10 4-Tri-fluoromethyl-6-chloro-2(4’-nitrophenyl)-pyridine (319) 
 
 
 
2-Chloro-4-(tri-fluoromethyl)-pyridine 307 (0.13 ml, 1.0 mmol) was borylated following 
standard protocol M3 [[Ir(OMe)cod]2 (0.01 g, 0.015 mmol, 1.5 mol %), dtbpy (8.0 mg, 
0.03 mmol, 3 mol%) and B2pin2 (1.0 mmol, 254 mg), reaction time= 1 h, reaction 
temperature= 80 oC]. The crude boronate ester (~ 1.0 mmol) was directly used in 
Suzuki Miyaura coupling following general procedure N with 4-iodonitrobenzene (350 
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mg, 1.5 mmol) at 100 oC for 3 h to afford, following chromatography (toluene:hexane 
1:1), 4-tri-fluoromethyl-6-chloro-2(4’-nitrophenyl)-pyridine 319 as an off white solid 
(175 mg, 58 %), (mp = 120-121 ºC); max (ATR) 1601, 1564, 1516, 1409, 1350, 1328, 
1263, 1173, 1140, 1101, 1071, 860, 873, 818, 760, 707, 696, 675 cm-1; H (700 MHz, 
CDCl3) 8.36-8.33 (2H, m, 3’,5’-H), 8.24-8.20 (2H, m, 2’,6’-H), 7.9 (1H, s, 3-H), 7.6 (1Hs,5-
H); C (176 MHz, CDCl3) 156.9 (C-2), 153.0 (C-6), 149.2 (C-4’), 142.3 (q, J = 34.7 Hz, C-4), 
142.1 (C-1’), 128.2 (C-2’,6’), 124.3 (C-3’,5’), 122.1 (q, J = 274 Hz, CF3), 120.3 (q, J = 3.6 
Hz, C-5), 115.4 (q, J = 3.4 Hz, C-3); m/z (GC-MS, EI+) 304 ([M] (37Cl)]+, 31%), 302 ([M] 
(35Cl)]+, 100%), 285 ([M] (37Cl)-F]+, 3%), 283 ([M] (35Cl)-F]+, 10%), 274 ([M] (37Cl)-NO]+, 
8%), 272 ([M] (35Cl)-NO]+, 23%), 258 ([M] (37Cl)-NO2]+, 14%), 256 ([M] (35Cl)-NO2]+, 
43%), 246 & 244 found; HRMS (ES+) found ([MH]+) 303.0138; C12H735ClF3N2O2 requires 
M, 303.0148. 
 
6.2.19 General procedure O: Preparation of multidirectionalpyridine 
derivatives111 
2- or 6-Chloropyridine derivatives (1 mmol) was placed in the vessel which was then 
sealed, evacuated, backfilled with N2 and secondary amine (excess amount) was then 
added. The reaction mixture was heated in µW reactor at the 130 oC for the stated 
period. After cooling the reaction mixture, DCM (2 x 10 ml) was then added to the 
reaction mixture, and then washed with NaHCO3 (aq.). The organic extracts were then 
dried over MgSO4 and concentrated in vacuo to afford following chromatography the 
desired product. 
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6.2.19.1 4-Tri-fluoromethyl-6-(N-pyrrolidin-yl)-2(4’-nitrophenyl)-pyridine 
(320) 
 
 
 
Following procedure O, 4-tri-fluoromethyl-6-chloro-2(4’-nitrophenyl)-pyridine 319 (303 
mg, 1.0 mmol) and pyrrolidine (0.46 ml, 5.5 mmol) were combiend at 130 oC for 1 h to 
afford, following (EtOAc:hexane 1:12), 4-tri-fluoromethyl-6-(N-pyrrolidin-yl)-2(4’-
nitrophenyl)-pyridine 320 as an off yellow soli (263 mg, 78 %), (mp = 211.5-212.5 oC); 
max (ATR) 1616, 1601, 1564, 1519, 1492, 1480, 1443, 1390, 1344, 1322, 1290, 1249, 
1159, 1108, 1093, 1010, 972, 849, 826, 756, 722, 694, 671 cm-1; H (700 MHz, CDCl3) 
8.31-8.27 (2H, m, 3’,5’-H), 8.22-8.18 (2H, m, 2’,6’-H), 7.19 (1H, s, 3-H), 6.57 (1H, s, 5-H), 
3.63-3.59 (4H, m, 2”,5”-H), 2.11-2.04 (4H, m, 3”, 4”-H); C (176 MHz, CDCl3) 157.16 (C-
6), 154.3 (C-2), 148.3 (C-4’), 145.1 (C-1’), 140.39 (q, J = 32.9, C-4), 127.7 (C-2’,6’), 123.9 
(C-3’,5’), 123.43 (q, J = 273 Hz, CF3), 103.6 (q, J = 3.3 Hz, C-3), 102.44 (q, J = 4.0 Hz, C-5), 
47.1 (C-2”,5”), 25.6 (C-3”,4”); m/z (GC-MS, EI+) 337 ([M]+, 39%), 309 ([MH-C2H5]+, 28%), 
308 ([M-C2H5]+, 100%), 262 ([M-C2H5NO2]+, 26%); HRMS (ES+) found ([MH]+) 338.1105; 
C16H15F3N3O2 requires M, 338.1116. 
 
6.2.19.2 Butyl-[6-(4’-nitrophenyl)-4-tri-fluoromethylpyridine-2-yl]-amine 
(321) 
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Following procedure O, 4-tri-fluoromethyl-6-chloro-2(4’-nitrophenyl)-pyridine 319 (303 
mg, 1.0 mmol) and butylamine (0.54 ml, 5.5 mmol) were combiend at 130 oC for 1 h to 
afford, following chromatography (EtOAc:hexane 1:12), Butyl-[6-(4’-nitrophenyl)-4-tri-
fluoromethylpyridine-2-yl]-amine 321 as a yellow solid (255 mg, 75 %), (mp = 162.8-
163.8 oC); max (ATR) 3401 (NH), 1625, 1604, 1573, 1533, 1459, 1413, 1396, 1331, 
1257, 1158, 1117, 1096, 860, 830, 757, 723, 695, 678, 639 cm-1; H (700 MHz, CDCl3) 
8.31-8.26 (2H, m, 3’,5’-H), 8.18-8.11 (2H, m, 2’,6’-H), 7.2 (1H, d, J = 0.6 Hz, 3-H), 6.6 
(1H, s, 5-H), 4.9 (1H, s broad, NH), 3.44-3.39 (2H, m, 2”-H), 1.69-1.64 (2H, m, 3”-H), 1.5-
1.44 (2H, m, 4”-H), 1.0 (3H, t, J = 7.4 Hz, 5”-H); C (176 MHz, CDCl3) 159.1 (C-6), 154.7 
(C-2’), 148.4 (C-4’), 144.7 (C-1’), 140.8 (q, J = 33.2 Hz, C-4), 127.7 (C-2’,6’), 124.0 (C-
3’,5’), 123.2 (q, J = 273 Hz, CF3), 105.3 (q, J = 3.3 Hz, C-3), 102.8 (C-5), 42.0 (C-2”), 31.6 
(C-3”), 20.3 (C-4”), 14.0 (C-5”); m/z (GC-MS, EI+) 339 ([M]+, 31%), 320 ([M-F]+, 8%), 310 
([M-C2H5]+, 52%), 296 ([M-C3H7]+, 100%), 283 ([MH-C2H5]+, ([MH-F3]+ 61%), ([M-
C3H7NO2]+, 60%); HRMS (ES+) found ([MH]+) 340.1276; C16H17F3N3O2 requires M, 
340.1273. 
 
6.2.19.3 4-Tri-fluoromethyl-6-(N-morpholin-yl)-2(4’-nitrophenyl)-pyridine 
(322) 
 
 
Following procedure O, 4-tri-fluoromethyl-6-chloro-2(4’-nitrophenyl)-pyridine 319 (303 
mg, 1.0 mmol) and morpholine (0.48 ml, 5.5 mmol) were combined at 130 oC for 1 h to 
afford, following chromatography (EtOAc:hexane 1:8), 4-tri-fluoromethyl-6-(N-
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morpholin-yl)-2(4’-nitrophenyl)-pyridine 322 as a yellow solid (325 mg, 92 %), (mp = 
267.5-268.5 oC); max (ATR) 1603, 1567, 1517, 1438, 1324, 1302, 1242, 1161, 1111, 
982, 967, 847, 825, 757, 711, 695, 675 cm-1; H (700 MHz, CDCl3) 8.35-8.26 (2H, m, 
3’,5’-H), 8.23-8.12 (2H, m, 2’,6’-H), 7.33 (1H, s, 3-H), 6.85 (1H, s, 5-H), 3.9-3.86 (4H, m, 
3”,5”-H), 3.71-3.67 (4H, m, 2”,6”-H); C (176 MHz, CDCl3) 159.4 (C-6), 154.4 (C-2), 148.5 
(C-4’), 144.6 (C-1’), 141.3 (q, J = 33.0 Hz, C-4), 127 (C-2’, 6’), 124.1 (C-3’, 5’), 123.2 (q, J 
= 273 Hz, CF3), 106.1 (q, J = 3.3 Hz, C-3), 102.6 (q, J = 4.0 Hz, C-5), 66.7 (C-3”,5”), 45.4 
(C-2”,6”); m/z (GC-MS, EI+) 353 ([M]+, 68%), 334 ([M-F]+, 17%), 322 ([MH-O2]+, 100%), 
308 ([MH-NO2]+, 24%), 296 ([M-F3]+, 73%), 353 ([M-CF3O]+, 76%); HRMS (ASAP) found 
([MH]+) 354.1067; C16H15F3N3O3 requires M, 354.1066. 
 
6.2.19.4 Di-ethyl-[6-(4’-nitrophenyl)-4-tri-fluoromethylpyridine-2-yl]-
amine (323) 
 
 
Following procedure O, 4-tri-fluoromethyl-6-chloro-2(4’-nitrophenyl)-pyridine 319 (303 
mg, 1.0 mmol) and di-ethylamine (3.0 ml, 29.0 mmol) were combiend at 130 oC for 6 h 
to afford, following chromatography (EtOAc:hexane 1:12), di-ethyl-[6-(4’-nitrophenyl)-
4-tri-fluoromethylpyridine-2-yl]-amine 323 as a yellow solid (207 mg, 61 %), (mp = 
87.9-88.9 oC); max (ATR) 1616, 1601, 1566, 1516, 1503, 1442, 1349, 1344, 1332, 1263, 
1249, 1175, 1123, 1110, 979, 853, 829, 758, 710, 695, 676 cm-1; H (700 MHz, CDCl3) 
8.32-8.27 (2H, m, 3’,5’-H),  8.21-8.15 (2H, m, 2’,6’-H), 7.20 (1H, s, 3-H), 6.7 (1H, s, 5-H), 
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3.63-3.59 (4H, q, J = 7.1 Hz, 2”,4”-H), 1.26 (6H, t, J = 7.1 Hz, 3”,5”-H); C (176 MHz, 
CDCl3) 157.5 (C-6), 154.3 (C-2), 148.3 (C-4’), 145.2 (C-1’), 140.7 (q, J = 32.7, C-4), 127.6 
(C-2’,6’), 124.0 (C-3’,5’), 123.4 (q, J = 273 Hz, CF3), 103.5 (q, J = 3.3 Hz, C-3), 101.4 (q, J = 
4.0 Hz, C-5), 43.13 (C-2”,4”), 12.9 (C-3”,5”); m/z (GC-MS, EI+) 339 ([M]+, 43%), 324 ([M-
CH3]+, 64%), 310 ([M-C2H5]+, 100%), 296 ([MH-C3H8]+, 56%), 264 ([M-C2H5NO2]+, 31%); 
HRMS (ES+) found ([MH]+) 340.1270; C16H17F3N3O2 requires M, 340.1273. 
 
6.2.19.5 4-Tri-fluoromethyl-6-(N-pyrrolidin-yl)-2-(4’-methoxyphenyl)-
pyridine (324) 
 
 
Following procedure O, the crude mixture of 4-tri-fluoromethyl-6-chloro-2-(4’-
methoxyphenyl)-pyridine in 6.2.18.9 (~1.0 mmol) and pyrrolidine (0.46 ml, 5.5 mmol) 
were combined at 130 oC for 30 min to afford, following chromatography 
(ether:hexane 1:20), 4-tri-fluoromethyl-6-(N-pyrrolidin-yl)-2(4’-methoxyphenyl)-
pyridine 324 as an off white solid (65 mg, 20 %), (mp = 103.3-104.5 oC); max (ATR) 
1613, 1563, 1497, 1460 1439, 1408, 1389, 1351, 1333, 1304, 1293,1246, 1183, 1157, 
1120, 1105, 1097, 1051, 1032, 1014, 1004, 842, 825, 804, 782, 711, 680, 671, 648, 637, 
618, 586, 522, 504 cm-1; H (700 MHz, CDCl3) 8.06-8.00 (2H, m, 2’, 6’-H), 7.11 (1H, s, 3-
H), 7.01-6.96 (2H, m, 3’,5’-H), 6.42 (1H, s, 5-H), 3.86 (3H, s, OCH3), 3.64-3.53 (4H, m, 
2”,5”-H), 2.08-2.00 (4H, m, 3”,4”-H); C (176 MHz, CDCl3) 160.7 (C-4’),157.0 (C-6), 156.6 
(C-2), 140.0 ( q, J = 32.4 Hz, C-4), 132.0 (C-1’), 128.3 (C-2’,6’), 123.77 (q, J = 273 Hz, CF3), 
2
3
4
5
6 N
OCH 3
CF3
N
2'
3'
4'
5'
6'
1'2"
5"
4"
3"
204 
 
114.0 (C-3’,5’), 102.1 (q, J = 3.4 Hz, C-3), 100.0 (q, J = 4.0 Hz, C-5), 55.4 (O-CH3), 46.9 (C-
2”,5”), 25.6 (C-3”,4”); m/z (GC-MS, EI+) 323 ([MH]+, 7%), 322 ([M]+, 42%), 293 ([MH-
OCH3]+, 100%); HRMS (ES+) found ([MH]+) 323.1364; C17H18F3N2O requires M, 
323.1371. 
 
6.2.19.6 4-Tert-butyl-6-(N-pyrrolidin-yl)-2(4-methoxyphenyl)-pyridine 
(325) 
 
 
Following procedure O, 4-tert-butyl-6-chloro-2-(4’-nitrophenyl)-pyridine 313 (291 mg, 
1.0 mmol) and pyrrolidine (0.46 ml, 5.5 mmol) were combiend at 130 oC for 30 min to 
afford, following chromatography (EtOAc:hexane 1:15), 4-tert-butyl-6-(N-pyrrolidin-yl)-
2(4’-methoxyphenyl)-pyridine 325 as a red solid (100 mg, 31 %), (mp = 180.5-182.5 oC); 
max (ATR) 1597, 1549, 1501, 1476, 1456, 1323, 1107, 1101, 1011, 865, 850, 842, 832, 
760, 698, 659, 631, 495 cm-1; H (700 MHz, CDCl3) 8.3-8.23 (2H, m, 3’,5’-H), 8.21-8.17 
(2H, m, 2’,6’-H), 7.09 (1H, d, J = 1.3 Hz, 3-H), 6.38 (1H, d, J = 1.3 Hz, 5-H), 3.55-3.60 (4H, 
m, 2”,5”-H), 2.06-2.01 (4H, m, 3”,4”-H), 1.35 (9H, s, CH3); C (176 MHz, CDCl3) 161.9 (C-
4),157.7 (C-6), 152.6 (C-2), 147.7 (C-4’), 146.9 (C-4’), 127.6 (C-2’,6’), 123.8 (C-3’,5’), 
107.03 (C-3), 103.4 (C-5), 47.0 (C-2”,5”), 35.12 (4-C), 30.8 (4-C-(CH3)3)), 25.7 (C-3˶, 4˶); 
m/z (GC-MS, EI+) 326 ([MH]+, 16%), 325 ([M]+, 78%), 296 ([MH-(CH3)2]+, 16%); HRMS 
(ES+) found ([MH]+) 326.1869; C19H24N3O2 requires M, 326.1869. 
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6.2.19.7 [2-(4’-Nitrophenyl)-6-pyrrolidin-1-yl-pyridin-4-yl]-pyrrolidin-1-yl-
methanone (327) 
 
 
 
Following procedure O, 4-tri-fluoromethyl-6-chloro-2(4’-nitrophenyl)-pyridine 310 (293 
mg, 1.0 mmol) and pyrrolidine (0.92 ml, 11.0 mmol) were combiend at 130 oC for 1 h 
to afford, following chromatography (EtOAc:hexane 1:1), [2-(4’-nitrophenyl)-6-
pyrrolidin-1-yl-pyridin-4-yl]-pyrrolidin-1-yl-methanone 327 as a yellow solid (275 mg, 
75 %), (mp = 239.5-240.5 oC); max (ATR) 1618, 1616, 1598, 1541, 1512, 1478, 1456, 
1442, 1419, 1344, 1322, 1102, 858, 755, 702, 513 cm-1; H (500 MHz, CDCl3) 8.29-8.21 
(2H, m, 3’,5’-H), 8.21-8.14 (2H, m, 2’,6’-H), 7.1 (1H, s, 3-H), 6.4 (1H, s, 5-H), 3.7 (2H, t, J 
= 7.0 Hz, 2”’-H), 3.60-3.49 (4H, m, 2”,5”-H), 3.43 (2H, t, J = 6.7 Hz, 5”’-H), 2.06-2.01 (4H, 
m, 3”,4”-H), 2.0 (2H, p, J = 7.0 Hz, 3”’-H), 1.9 (2H, p, J = 6.7 Hz, 4”’-H); C (125 MHz, 
CDCl3) 168.4 (C=O), 157.2 (C-6), 153.3 (C-2), 148.0 (C-4’), 146.9 (C-4), 145.8 (C-1’), 
127.5 (C-2’,6’), 123.8 (C-3’,5’), 106.0 (C-3), 104.1 (C-5), 49.4 (C-5“’), 46.9 (C-2”,5”), 46.2 
(C-2”’), 26.4 (C-4”’), 25.6 (C-3”,4”), 24.5 (C-3”’); m/z (LC-MS, ES+) 1121 ([M3Na]+, 38%), 
755 ([M2Na]+, 81%), 366 ([M]+, 100%); HRMS (ES+) found ([MH]+) 367.1781; C20H23N4O3 
requires M, 367.1770. 
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6.2.19.8 4-Tri-fluoromethyl-6-(N-pyrrolidin-yl)-2(4’-nitrophenyl)-pyridine 
(320) 
6.2.19.8.1 4-Tri-fluoromethyl-6-(N-pyrrolidin-yl)-pyridine (328)145 
 
 
Following procedure O, 2-chloro-4-tri-fluoromethylpyridine 307 (128 µl) and 
pyrrolidine (0.46 ml, 5.5 mmol) were combined at 130 oC for 1h to afford, following 
chromatography (EtOAc:hexane 1:10), 4-tri-fluoromethyl-6-(N-pyrrolidin-yl)-pyridine 
328 as a white solid (195 mg, 90 %), (mp = 57.2-58 oC); max (ATR) 1611, 1559, 1505, 
1460, 1335, 1310, 1288, 1165, 1118, 1101, 1006, 841, 813, 679, 666, 488, 460 cm-1; H 
(700 MHz, CDCl3) 8.32 (1H, d, J = 5.2 Hz, 2-H), 6.6 (1H, dd, J = 1.5, 5.2 Hz, 3-H), 6.47 (1H, 
s, 5-H), 3.49-3.37 (2H, m, 2’,5’-H), 2.03-1.93 (2H, m, 3’,4’-H); C (176 MHz, CDCl3) 157.4 
(C-6), 149.5 (C-2), 139.2 (q, J = 32.9 Hz, C-4), 123.4 (q, J = 273 Hz, CF3), 106 (q, J = 3.3 
Hz, C-3), 102.1 (q, J = 4.2 Hz, C-5), 46.9 (C-2’,5’), 25.5 (C-3’,4’); m/z (GC-MS, EI+) 216 
([M]+, 41%), 187 ([M-C2H5]+, 100%), 188 ([M-C2H4]+, 35%), 161 ([MH-C4H8]+, 18%), 146 
([M-C4H8N]+, 21%), 147 ([MH-C4H8N]+, 18%); HRMS (ES+) found ([MH]+) 217.0962; 
C10H12F3N2 requires M, 217.0953. 
 
6.2.19.8.2 4-Tri-fluoromethyl-6-(N-pyrrolidin-yl)-2(4’-nitrophenyl)-
pyridine (320) 
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4-Tri-fluoromethyl-6-(N-pyrrolidin-yl)-pyridine 328 (216 mg, 1.0 mmol) in MTBE (1.0 
ml) was borylated following standard protocol M2 [[Ir(OMe)cod]2 (33.15 mg, 0.05 
mmol, 5 mol%), dtbpy (8.0 mg 0.03 mmol, 3 mol%) and B2pin2 (1.2 mmol, 305 mg) in 
MTBE (1.0 ml), reaction time= 3 h, reaction temperature= 80 oC]. The crude boronate 
ester (~ 1.0 mmol) was directly used in Suzuki Miyaura coupling following general 
procedure N with 4-iodonitrobenzene (350 mg, 1.5 mmol) at 100 oC for 3 h to afford, 
following chromatography (EtOAc:hexane 1:12), 4-tri-fluoromethyl-6-(N-pyrrolidin-yl)-
2(4-nitrophenyl)-pyridine 320 as an off yellow soli (165 mg, 49 %); Data have been 
identified above in (Section 6.2.19.1). 
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Chapter 5 
6.2.20 Preparation of 1,2-bis-[(2,2-di-methyl-4,6-dioxo-1,3-dioxan-5-
ylidenemethyl)-amino]benzene derivatives, procedure P:   
In a round bottom flask equipped with a condenser, a mixture of Meldrum’s acid (6.72 
g, 46.6 mmol) and tri-methyl orthoformate (50 ml, 457 mmol) were heated under 
reflux at 101 oC for 2 h. The reaction temperature was then cooled to 80 oC, and the 
1,2-phenylenediamine derivative (20 mmol) added portionwise. The reaction mixture 
was then refluxed at 101 oC for an additional 1 h, resulting a solid product. The 
reaction mixture was cooled to r.t and then filtered in vacuo to afford, following 
washing with ether, the desired product was isolated requiring no further purification. 
 
6.2.20.1 1,2-Bis-[(2,2-di-methyl-4,6-dioxo-1,3-dioxan-5-ylidenemethyl)- 
amino]-benzene (337)112 
 
 
 
Following procedure P, Meldrum’s acid, tri-methyl orthoformate and 1,2-
phenylenediamine 334 (2.16 g) were combined to afford 1,2-bis-[(2,2-di-methyl-4,6-
dioxo-1,3-dioxan-5-ylidenemethyl)-amino]-benzene 337 as an off white solid (6.8 g, 
82%), (mp > 200 oC, decomp., lit.,112 208-210 oC, decomp.); max (ATR) 3264 (NH), 1725 
(C=O), 1674, 1612, 1568, 1426, 1365, 1305, 1262, 1216, 1199, 1138, 999, 931, 804, 
786, 756, 704, 646, 604, 544, 500, cm-1; H (700 MHz, CDCl3) 11.3 (2H, d, J = 13.5 Hz, 
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NH), 8.5 (2H, d, J = 13.5 Hz, CH-NH), 7.4 (4H, m, Ar-H), 1.8 (12H, s, 2’,2”-(CH3)4); C (176 
MHz, CDCl3) 166.0 (C=O), 163.2 (C=O), 155.0 (CH-NH), 131.1 (C-1 and C-2), 129.0 (C-3 
and C-6), 121.3 (C-5 and C-4), 106.0 (C-2’ and C-2”), 90.0 (C-5’ and C-5”), 27.3 (2’,2”-
C(CH3)4) ; m/z (LC-MS, ES+) 854 ([M2-H+Na]+, 100%), 855 ([M2 +Na]+, 28%). 
 
6.2.20.2 4-Bromo-1,2-bis-[(2,2-di-methyl-4,6-dioxo-1,3-dioxane-5-
ylidenemethyl)-amino]-benzene (340)  
 
 
 
Following procedure P, Meldrum’s acid, tri-methyl orthoformate and 4-bromo1,2-
phenylenediamine 338 (3.75 g) were combined to afford 4-bromo-1,2-bis-[(2,2-di-
methyl-4,6-dioxo-1,3-dioxane-5-ylidenemethyl)-amino]-benzene 340 as a brown solid 
(5.9 g, 60%), (mp > 200 oC, decomp.); max (ATR) 3165 (NH), 1724(C=O), 1665, 1629, 
1606, 1564, 1429, 1415, 1388, 1263, 1198, 1143, 1026, 966, 927, 888, 803, 755, 731, 
662, 647, 575, 502, 468, 441 cm-1; H (700 MHz, CDCl3) 11.32 (1H, d, J = 13.4 Hz, 1’-NH), 
11.27 (1H, d, J = 13.5 Hz, 1”-NH), 8.5 (1H, d, J = 13.4 Hz, 5’-CH), 8.4 (1H, d, J = 13.5 Hz, 
5”-CH), 7.6 (1H, d, J = 2.1 Hz, 3-H), 7.5 (1H, dd, J = 2.1 Hz, J = 8.6 Hz, 5-H), 7.3 (1H, d, J = 
8.6 Hz, 6-H), 1.7 (12H, s, 2’,2”-(CH3)4); C (176 MHz, CDCl3) 165.5 (C=O), 165.4 (C=O), 
163.0 (C=O), 162.9 (C=O), 154.9 (5”-CH), 154.5 (5’-CH), 132.4 (C-2), 131.4 (C-5), 130.2 
(C-1), 124.2 (C-3), 122.8 (C-6), 121.6 (C-4), 105.8 (2’,2”-(CH3)2), 105.7 (2’,2”-(CH3)2), 
90.3 (C-5’), 90.0 (C-5”), 27.3 (2’,2”-(CH3)4); m/z (LC-MS, ES+) 1012 ([M2H+Na (79Br)]+, 
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100%), 1014 ([M2H+Na (81Br)]+, 80%); HRMS (ES+) found ([M2+Na]+) 1011.0571; 
C40H3879Br2N4NaO16 requires M, 1011.0547.  
 
6.2.20.3 4-Cyano-1,2-bis-[(2,2-di-methyl-4,6-dioxo-1,3-dioxane-5-
ylidenemethyl)-amino]-benzene (341)  
 
 
 
Following procedure P, Meldrum’s acid, tri-methyl orthoformate and 3,4-di-
aminobenzonitrile 339 (2.66 g) were heated at 101 oC to afford 4-Cyano-1,2-bis-[(2,2-
di-methyl-4,6-dioxo-1,3-dioxane-5-ylidenemethyl)-amino]-benzene 341 as a brown 
solid (5.9 g, 60%), (mp > 200 oC, decomp.); max (ATR) 3120 (NH), 2239(CN), 1724(C=O), 
1716, 1674, 1629, 1571, 1436, 1425, 1392,1380, 1266, 1220, 1193, 1140, 999, 917, 
855, 805, 788, 643, 619, 508, 414 cm-1; H (700 MHz, CDCl3) 11.6 (1H, d, J = 13.1 Hz, 1”-
NH), 11.3 (1H, d, J = 13.2 Hz, 1’-NH), 8.58 (1H, d, J = 13.1 Hz, 5”-CH), 8.44 (1H, d, J = 
13.2 Hz, 5’-CH), 7.82-7.63 (2H, m, 3,5-H), 7.55 (1H, d, J = 8.9 Hz, 6-H), 1.77-1.76 (12H, s, 
2’,2”-(CH3)4); C (176 MHz, CDCl3) 165.5 (C=O), 165.4 (C=O), 162.6 (C=O), 162.5 (C=O), 
155.15 (5’-CH), 152.8 (5”-CH), 135.2 (C-1), 132.3 (Ar-C), 131.1 (C-2), 126.1 (Ar-C), 120.0 
(C-6), 116.8 (4-CN), 111.5 (C-4), 106.0 (2’,2”-(CH3)4), 91.7 (C-5”), 91.2 (C-5’), 27.43 
(2’,2”-CH3), 27.39 (2’,2”-CH3); m/z (LC-MS, ES+) 904 ([M2-H+Na]+, 100%); HRMS (ES+) 
found ([M2+Na]+) 905.2257; C42H38N6NaO16 requires M, 905.2242. 
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6.2.21 Preparation of [1,10]-phenanthroline derivatives, procedure Q:112   
In a round two neck bottom flask equipped with a long condenser, under N2, 1,2-bis-
[(2,2-di-methyl-4,6-dioxo-1,3-dioxan-5-ylidenemethyl)-amino]-benzene derivatives (2.0 
mmol) were added in small portions to di-phenyl ether (21 ml) at 240 oC resulting in 
vigorous gas evolution. The reaction temperature was then increased to 260 oC for 30 
min. The reaction mixture was then allowed to cool to 80 oC and isolated by filtration 
to afford, following washing with acetone, hexane and ether, the title phenanthroline 
compound without requiring further purification.  
 
6.2.21.1 4,7-Di-hydroxy-[1,10]-phenanthroline (342)112 
 
 
 
Following procedure Q, 1,2-bis-[(2,2-di-methyl-4,6-dioxo-1,3-dioxan-5-ylidenemethyl)-
amino]-benzene 337 (0.832 g) was heated in di-phenylether to afford, following 
washing with acetone, hexane and ether, 4,7-di-hydroxy-[1,10]-phenanthroline 342 as 
a brown solid (255 mg, 60%), (mp > 300 oC, decomp., lit.,112 stable up to 250 oC); max 
(ATR) 3333(OH), 1505, 1386, 1307, 1236, 1190, 907, 821, 698, 685, 661, 544, 506 cm-1; 
H (400 MHz, NaOD) 8.1 (2H, d, J = 5.6 Hz, 2,9-H), 7.6(2H, s, 5,6-H), 6.3 (2H, d, J = 5.6 
Hz, 3,8-H); m/z (LC-MS, ES+) 212 ([M]+, 100%), 213 ([MH]+, 72%), 424 ([M2]+, 57%). 
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6.2.22 Preparation of mono- and di-alkylation of 4,7-di-hydroxy-[1,10]-
phenanthroline derivatives 
6.2.22.1 Procedure R113 
In a round bottomed flask, 4,7-di-hydroxy-[1,10]-phenanthroline (0.132 g, 0.628 mmol) 
was added to NaH (60% dispersion in mineral oil) (xx mmol) in dry DMF:THF 1:1 (6.5 
ml) at 0 oC. After stirring for 30 min, CH3I (xx mmol) was added slowly and the reaction 
mixture was allowed to stir for 18 h at r.t before being quenched by the addition of 
water (5 ml). The crude mixture was extracted with DCM (30 ml x 3). The organic phase 
was dried over MgSO4 and concentrated in vacuo to afford, following reversed phase 
chromatography (C-18 SiO2), the title phenanthroline compound. 
 
6.2.22.1.1 4,7-Di-methoxy-[1,10]-phenanthroline (343)112  
6.2.22.1.2 N-Methyl-7-methoxy-[1,10]-phenanthroline-4-one (344) 
 
 
 
Following procedure R, CH3I (0.09 ml, 1.38 mmol) was added to mixture of 4,7-di-
hydroxy-[1,10]-phenanthroline 342 (0.132 g, 0.628 mmol) and NaH 60% (55.5 mg, 1.38 
mmol)  to afford 4,7-di-methoxy-[1,10]-phenanthroline 343 as a brown solid (15 mg, 
10%), (mp = 206.5- 208.5 oC, lit.,112 210-212 oC); max (ATR) 1588, 1566, 1505, 1419, 
1350, 1313, 1287, 1249, 1056, 1020, 828, 816, 732, 672, 551, 523 cm-1; H (700 MHz, 
CDCl3) 9.0 (2H, d, J = 5.2 Hz, 2,9-H), 8.2 (2H, s, 5,6-H), 7.0 (2H, d, J = 5.2 Hz, 3,8-H), 4.1 
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(6H, s, OCH3); C (176 MHz, CDCl3) 162.5 (C-4,7), 151.3 (C-2,9), 147.0 (C-11,12), 121.1 
(C-13,14), 119.1 (C-5,6), 103.0 (C-3,8), 56.0 (OCH3); m/z (LC-MS, ES+) 240 ([M]+, 100%), 
241 ([MH]+, 48%). 
Furthermore, N-methyl-7-methoxy-[1,10]-phenanthroline-4-one 344 was isolated as a 
yellow solid (12 mg, 8%), (mp > 150 oC, decomp., lit.,114 190-190.5 oC); max (ATR) 1737, 
1622, 1591, 1547, 1501, 1416, 1376, 1204, 1102, 976, 932, 824, 735, 528 cm-1; H (700 
MHz, CDCl3) 8.8 (1H, d, J = 5.1 Hz, 9-H), 8.5 (1H, d, J = 8.9 Hz, 5-H), 8.1 (1H, d, J = 8.9 Hz, 
6-H), 7.6 (1H, d, J = 7.6 Hz, 2-H), 6.9 (1H, d, J = 5.1 Hz, 8-H), 6.5 (1H, d, J = 7.6 Hz, 3-H), 
4.6 (3H, s, N-CH3), 4.1 (3H, s, O-CH3); C (176 MHz, CDCl3) 177.6 (C-4), 162.2 (C-7), 148.0 
(C-9 ), 146.6 (C-2), 143.0 (C-12), 139.0(C-11), 128.2 (C-13), 124.0 (C-14), 123.1 (C-5), 
117.4 (C-6), 112.3 (C-3), 102.1 (C-8), 56.1 (OCH3), 49.5 (NCH3); m/z (LC-MS, ES+) 240 
([M]+, 61%), 241 ([MH]+, 100%). 
 
6.2.22.1.3 4-Hydroxy-7-methoxy-[1,10]-phenanthroline (345) 
 
 
Following procedure R, 4,7-di-hydroxy-[1,10]-phenanthroline 342 (0.628 mmol, 0.132 
g), CH3I (0.045 ml, 0.69 mmol) and NaH 60% (0.69 mmol, 27.6 mg) were combined to 
afford, 4-hydroxy-7-methoxy-[1,10]-phenanthroline 345 as a yellow solid (36.6 mg, 
26%). m.p = 275-276 oC; max (ATR) 3175-2838 (OH, broad, 1612, 1593, 1557, 1520, 
1425, 1276, 1179, 1163, 1046, 963, 807, 798, 730, 696, 664, 552, 532, 497 cm-1; H 
(700 MHz, CDCl3) 10.5 (1H, s, OH), 8.7 (1H, d, J = 5.2 Hz, 9-H), 8.3 (1H, d, J = 9.0 Hz, 5-
H), 8.0 (1H, d, J = 9.0 Hz, 6-H), 7.8 (1H, d, J = 7.4 Hz, 2-H), 7.0 (1H, d, J = 5.2 Hz, 8-H), 6.5 
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(1H, d, J = 7.4 Hz, 3- H), 4.1 (3H, s,7-OCH3); C (176 MHz, CDCl3) 178.6 (C-4), 163.0 (C-7), 
150.0 (C-9), 139.5 (C-12), 136.7 (C-11), 136.6(C-2), 125.2 (C-13), 122.2 (C-5), 121.9 (C-
14), 116.3 (C-6), 113.3 (C-3), 103.1 (C-8), 56.2 (7-OCH3); m/z (LC-MS, ES+) 227 ([MH]+, 
100%), 475 ([M2+Na]+, 18%); HRMS (ES+) found ([MH]+) 227.0825; C13H11N2O2 requires 
M, 227.0821. 
 
6.2.22.2 Procedure S: 
In a round bottomed flask equipped with a condenser, 2-iodopropane (xx mmol) was 
added to a mixture of 4,7-di-hydroxy-[1,10]-phenanthroline derivative (xx mmol) and 
Cs2CO3 (xx mmol) in dry DMF (xx ml) at 100 oC. The reaction mixture was heated under 
reflux for 6h then cooled to room temperature. The residue of Cs2CO3 was removed by 
filtration. The crude mixture was then concentrated in vacuo to afford, following 
chromatography or trituration, the title phenanthroline compound. 
 
6.2.22.2.1 4,7-Di-isopropoxy-[1,10]-phenanthroline (347)  
6.2.22.2.2 N-Isopropyl-7-isopropoxy-[1,10]-phenanthroline-4-one (349) 
 
 
 
Following procedure S, 4,7-di-hydroxy-[1,10]-phenanthroline 342 (2.0 mmol, 424 mg), 
2-iodopropane (0.48 ml, 2.4 eq., 4.8 mmol) and Cs2CO3 (3.9 g, 6.0 eq., 12.0 mmol) in 
dry DMF (35 ml) were heated to afford, following purification using reversed phase 
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chromatography (C-18 SiO2), 4,7-di-isopropoxy-[1,10]-phenanthroline 347 as a brown 
solid (310 mg, 52%), (mp = 209.5-211.0 OC); max (ATR) 1612, 1581, 1563, 1511, 1498, 
1450, 1417, 1384, 1309, 1287, 1264, 1229, 1100, 1016, 961, 865, 845, 827, 807,732, 
696, 628, 594, 558, 545, 518, 453, 409 cm-1; H (700 MHz, CDCl3) 8.9 (2H, d, J = 5.3 Hz, 
2,9-H), 8.1 (2H, s, 5,6-H), 6.9 (2H, d, J = 5.3 Hz, 3,8-H), 4.7 (2H, hept, J = 6.1 Hz, 
OCH(CH3)2), 1.5 (12H, d, J = 6.1 Hz, (CH3)4); C (176 MHz, CDCl3) 161.0 (C-4,7), 151.0 (C-
2,9), 147.0 (C-11,12), 122.0 (C-13,14), 119.1 (C-5,6), 104.1 (C-3,8), 71.1 (4,7-O-CH), 22.0 
(4,7-CH(CH3)4); m/z (LC-MS, ES+) 296 ([M]+, 100%), 297 ([MH]+, 73%), 615([M2+Na]+, 
38%); HRMS (ES+) found ([MH]+) 297.1609; C18H21N2O2 requires M, 297.1603. 
Similarly, N-isopropyl-7-isopropoxy-[1,10]-phenanthroline-4-one 349 was isolated as a 
brown oil (35 mg, 6%); max (ATR) 1620 (C=O), 1592, 1501, 1412, 1385, 1291, 1221, 
1196, 1107, 1026, 927, 820, 732, 525 cm-1; H (700 MHz, CDCl3) 8.7 (1H, d, J = 5.2 Hz, 9-
H), 8.5 (1H, d, J = 8.9 Hz, 5-H), 8.1 (1H, d, J = 8.9 Hz, 6-H), 7.9 (1H, d, J = 7.8 Hz, 2-H), 
7.2-7.3 (1H, m, N-CH), 6.9 (1H, d, J = 5.2 Hz, 8-H), 6.6 (1H, d, J = 7.8 Hz, 3-H), 4.8-4.9 
(1H, m, O-CH), 1.6 (6H, d, J = 6.7 Hz, N-CH(CH3)2), 1.5 (6H, d, J = 6.0 Hz, O-CH(CH3)2); C 
(176 MHz, CDCl3) 177.5 (C-4), 161.0 (C-7), 148.0 (C-9 ), 143.0 (C-12), 140.0 (C-2), 138.5 
(C-11), 128.5 (C-13), 125.0 (C-14), 123.0 (C-5), 117.5 (C-6), 113.0 (C-3), 103.0 (C-8), 71.0 
(7-OCH), 55.0 (N-CH), 23.0 (N-CH(CH3)2), 22.0 (7-OCH(CH3)2); m/z (LC-MS, ES+) 296 
([M]+, 100%), 297 ([MH]+, 98%), 615 ([M2+Na]+, 22%); HRMS (ES+) found ([MH]+) 
297.1592; C18H21N2O2 requires M, 297.1603. 
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6.2.22.2.3 4,7-Di-isopropoxy-5-bromo-[1,10]-phenanthroline (350) 
 
 
 
4-Bromo-1,2-bis-[(2,2-di-methyl-4,6-dioxo-1,3-dioxane-5-ylidenemethyl)-amino]- 
benzene 340 (988 mg, 2.0 mmol) was heated in di-phenyl ether, following standard 
procedure Q. The resulting product (0.42g, 1.44 mmol) was directly alkylated with 2-
iodopropane (0.34 ml, 3.46 mmol) in DMF (21 ml) following general procedure S, to 
afford, following trituration with ether, 5-bromo-4,7-di-isopropoxy-[1,10]-
phenanthroline 350 as a brown solid (385 mg, 51 %), (mp = 171.5-173.5 oC); max (ATR) 
1581, 1557, 1509, 1482, 1414, 1384, 1371, 1285, 1213, 1106, 1024, 959, 915, 857, 833, 
601 cm-1; H (700 MHz, CDCl3) 8.9-8.8 (2H, m, 2,9-H, overlap), 8.4 (1H, s, 6-H), 7.0 (1H, 
d, J = 5.4 Hz, 3-H), 6.9 (1H, d, J = 5.4 Hz, 8-H), 4.88-4.83 (1H, m, 4-O-CH, overlap), 4.83-
4.79 (1H, m, 7-O-CH, overlap), 1.52 (6H, d, J = 6.1 Hz, 4-O-CH(CH3)2), 1.47 (6H, d, J = 6.1 
Hz, 7-O-CH(CH3)2); C (176 MHz, CDCl3) 161.0 (C-4), 160.0 (C-7), 151.3 (Ar-C), 151.0 (Ar-
C), 148.5 (C-12), 146.4 (C-11), 125.9 (C-6), 121.4 (C-14), 119.7 (C-13) 113.2 (C-5), 105.5 
(C-3), 104.6 (C-8), 72.2 (4-O-CH), 71.5 (7-O-CH), 21.81 (O-CH(CH3)4), 21.80 (O-
CH(CH3)4); m/z (LC-MS, ES+) 377 ([MH (81Br)]+, 96%), 375 ([MH (79Br)]+, 100%); HRMS 
(ES+) found ([MH]+) 375.0703; C18H2080BrN2O2 requires M, 375.0708. 
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6.2.22.2.4 4,7-Di-isopropoxy-5-cyano-[1,10]-phenanthroline (351) 
 
 
 
4-Cyano-1,2-bis-[(2,2-di-methyl-4,6-dioxo-1,3-dioxane-5-ylidenemethyl)-amino]-
benzene 341 (882 mg, 2.0 mmol) was heated in di-phenyl ether, following standard 
procedure Q. The resulting product (441 mg, 1.86 mmol) was directly alkylated with 2-
iodopropane (0.45 ml, 4.46 mmol) in DMF (25 ml) following general procedure S, to 
afford, following recrystallization from EtOAc, 5-cyano-4,7-di-isopropoxy-[1,10]-
phenanthroline 351 as a brown solid (418 mg, 65 %), (mp = 207.3-208.3 oC); max (ATR) 
2220 (CN), 1583, 1569, 1516, 1489, 1374, 1293, 1237, 1106, 1031, 962, 829, 720, 636 
cm-1; H (600 MHz, CDCl3) 8.92 (1H, d, J = 5.4 Hz, 9-H), 8.88 (1H, d, J = 5.4 Hz, 2-H), 8.6 
(1H, s, 6-H), 7.0 (1H, d, J = 5.4 Hz, 3-H), 6.9 (1H, d, J = 5.4 Hz, 8-H), 4.85 (1H, hept, J = 
6.1 Hz, 4-O-CH), 4.78 (1H, hept, J = 6.1 Hz, 7-O-CH), 1.5 (6H, d, J = 6.1 Hz, 4-O-
CH(CH3)2), 1.4 (6H, d, J = 6.1 Hz, 7-O-CH(CH3)2); C (151 MHz, CDCl3) 161.0 (C-7), 160.0 
(C-4), 153.8 (C-9), 152.0 (C-2), 148.0 (C-12), 147.0 (C-11), 131.0 (C-6), 119.8 (C-14), 
119.2 (5-CN) 118.4 (C-13), 105.1 (C-3), 104.7 (C-8), 103.8 (C-5), 72.7 (4-O-CH), 71.8 (7-
O-CH), 21.6 (O-CH(CH3)2), 21.3 (O-CH(CH3)2); m/z (LC-MS, ES+) 322 ([MH]+, 96%), 321 
([M]+, 89%), 665 ([M2+Na]+, 38%); HRMS (ES+) found ([MH]+) 322.1563; C19H20N3O2 
requires M, 322.1556. 
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6.2.23 Borylation of (2,6-di-methyl-phenoxy)-acetic acid ethyl ester 
6.2.23.1 Preparation of (2,6-di-methyl-phenoxy)-acetic acid ethyl ester 
(353)146 
 
 
In a round bottom flask, equipped with a condenser, 2,6-di-methylphenol 352 (0.49 g, 
4 mmol) and potassium carbonate (0.66 g, 4.8 mmol) in acetone (20 ml) were refluxed 
at 80 oC for 15 min, ethyl bromoacetate (0.67 ml, 6 mmol) was then added dropwise. 
The reaction mixture was heated under reflux overnight before cooling to r.t. The 
solvent residue was removed in vacuo to afford, following chromatography 
(hexane:EtOAc 9:1), (2,6-di-methylphenoxy)acetic acid ethyl ester 353 as a yellow oil 
(0.8 g, 96%); max (ATR) 1760 (C=O ester), 1476, 1379, 1263, 1185, 1094, 1068, 1031, 
768 cm-1; H (700 MHz, CDCl3) 7.03-6.98 (2H, m, 3,5-H), 6.9 (1H, m, 4-H), 4.4 (2H, s, 2’-
H), 4.3 (2H, q, J = 7.1 Hz, 1”-H), 2.35 (6H, s, 2,6-(CH3)2), 1.33 (3H, t, J = 7.1 Hz, 2”-H); C 
(176 MHz, CDCl3) 169.2 (C=O), 155.4 (C-1), 130.7 (C-2), 129.0 (C-3), 124.5 (C-4), 69.2 (C-
2’), 61.2 (C-1”), 16.3 (2,6-(CH3)2), 14.3 (C-2”); m/z (GC-MS, EI+) 208 ([M]+, 40%), 162 
found, 135 ([M-C3H5O2]+, 41%), 121 ([M-C4H7O2]+, 100%), 105 ([M-C4H7O3]+, 41%) . 
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6.2.23.2 Preparation of [2,6-di-methyl-4-(4,4,5,5-tetra-methyl-[1,3,2]- 
diox-aborolan-2-yl)-phenoxy]-acetic acid ethyl ester (354) 
 
 
 
 
[Ir(OMe)cod]2 (0.02 g, 0.03 mmol, 3.0 mol%), dtbpy ( 16 mg, 0.06 mmol, 6.0 mol%,) 
and B2pin2 (1.5 mmol, 381 mg) and (2,6-di-methyl-phenoxy)-acetic acid ethyl ester 353 
(0.21 g, 1.0 mmol) were placed in the vessel which was then sealed, evacuated, 
backfilled with N2 and THF (8 ml) was then added. The reaction mixture was heated in 
oil bath at 80 oC for 4 h. The reaction mixture was cooled to r.t and concentrated in 
vacuo to afford, following chromatography (hexane:EtOAc 9:1), [2,6-di-methyl-4-
(4,4,5,5-tetra-methyl-[1,3,2]-dioxaborolan-2-yl)phenoxy]-acetic acid ethyl ester 354 as 
a white colorless oil (186 mg, 56 %); max (ATR) 2979, 1761, 1603, 1366, 1312, 1184, 
1141, 1069, 966, 853, 736, 687 cm-1; H (700 MHz, CDCl3) 7.5 (2H, d, J = 1.3 Hz, 3,5-H), 
4.4 (2H, s, 2’-H), 4.3 (2H, q, J = 7.1 Hz, 1”-H), 2.3 (6H, s, 2,6-(CH3)2), 1.35-1.25 (15H, m, 
2”-H,,OC(CH3)4); C (176 MHz, CDCl3) 168.9 (C=O), 158.1 (C-1), 135.8 (C-3), 130.0 (C-2), 
83.7 (OC-(CH3)4), 69.2 (C-2’), 61.2 (C-1”), 24.8 (OC-(CH3)4), 16.1 (2,6-(CH3)2), 14.2 (C-2”), 
unobserved (C-4); m/z (GC-MS, EI+) 334 ([M]+, 100%), 319 ([M-CH3]+, 20%), 261 ([M-
C3H5O2]+, 25%), 247 ([M-C4H7O2]+, 72%). 
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6.2.24 4-Hydroxy-7-isopropoxy-[1,10]-phenanthroline (348) 
 
 
Following procedure S in section 6.2.22.2, 2-iodopropane (0.24 ml, 2.4 mmol) was 
added portionwise to a mixture of 4,7-di-hydroxy-[1,10]-phenanthroline 342 (2.0 
mmol, 424 mg) and Cs2CO3 (1.95 g, 6.0 mmol) in dry DMF (35 ml) at 100 oC. The 
reaction mixture was concentrated in vacuo to remove solvent. The resulting crude 
mixture was then re-dissolved in DCM, filtrated and washed with DCM. The solid 
residue was dissolved in H2O (20 ml) before adding 3 M HCl until the pH reached 7. The 
resulting brown solid was filtered and dried in vacuo to recover 4,7-di-hydroxy-[1,10]-
phenanthroline 342 (0.5 mmol). The DCM filtrate was concentrated in vacuo to afford 
a white solid, which was purified using reversed phase chromatography C18-SiO2 or 
dissolving the resulting crude mixture with EtOAc (50 ml) and washing with 10% NaOH 
(aq.) (3 x 30 ml). The aqueous solution was then neutralised with HCl (pH = 7) and 
extracted with EtOAc (2 x 30 ml). The organic layer was then concentrated in vacuo, 
dissolved in H2O and washed with NaHCO3 (aq.) to remove the resulting acetic acid, 
then extracted with DCM (50 ml). The organic phase was dried over MgSO4 and 
filtered. The solvent was removed in vacuo to afford, 4-hydroxy-7-isopropoxy-[1,10]-
phenanthroline 348 as an off white solid (230 mg, 45%), (mp = 205.5-206 oC); max 
(ATR) 3301-2827 (OH broad), 1623, 1586, 1554, 1512, 1425, 1280, 1239, 1186, 1167, 
1108, 1010, 939, 835, 822, 738, 670, 530, 463 cm-1; H (700 MHz, CDCl3) 10.8 (1H, s, 
OH), 8.6 (1H, d, J = 5.3 Hz, 9-H), 8. 3 (1H, d, J = 9.0 Hz, 5-H), 8.0 (1H, d, J = 9.0 Hz, 6-H), 
7.8 (1H, d, J = 7.3 Hz, 2-H), 6.9 (1H, d, J = 5.3 Hz, 8-H), 6.5 (1H, d, J = 7.3 Hz, 3-H), 4.8 
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(1H, hept, J = 6.1 Hz, 7-OCH(CH3)2), 1.5 (6H, d, J = 6.1 Hz, 7-OCH(CH3)2); C (176 MHz, 
CDCl3) 178.7 (C-4), 161.1 (C-7), 150.1 (C-9), 140.3 (C-12), 136.9 (C-11), 136.7(C-2), 125.1 
(C-13), 122.4 (C-14), 121.7 (C-5) 116.6 (C-6), 113.1 (C-3), 104.3 (C-8), 71.5 (7-
OCH(CH3)2), 21.8 (7-OCH(CH3)2); m/z (LC-MS, ES+) 254 ([M]+, 75%), 255 ([MH]+, 100%), 
509 ([M2H]+, 13%); HRMS (ES+) found ([MH]+) 255.1131; C15H15N2O2 requires M, 
255.1134. 
 
6.2.25 General procedure T: Alkylation of 4-hyroxy-7-isopropyl-[1,10]-
phenanthroline 
In a round bottom flask, equipped with a condenser, 4-hydroxy-7-isopropyl-[1,10]-
phenanthroline (1.0 mmol, 254  mg), cesium carbonate (3.0 mmol, 0.98 g) and Bu4NI 
(10 mol%, 0.2 mmol, 73.9 mg) in DMF (15 ml) were heated at the stated temperature, 
alkyl bromide (X mmole) was then added dropwise. The reaction mixture were allowed 
to heat at the stated temprature for 17 h then cooled to r.t. The residue of Cs2CO3 was 
removed by filtration and the solvent was then concentrated under reduce pressure to 
afford, following chromatography or recrystallization from EtOAc, the desired product. 
 
6.2.25.1 (7-Isopropoxy-4-oxo-4H-[1,10]-phenanthrolin-1-yl)-acetic acid 
ethyl ester (370) 
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Following procedure T, 4-hydroxy-7-isopropyl-[1,10]-phenanthroline 348 and ethyl 
bromoacetate (0.22 ml, 2 mmol) were combined at 100 oC to afford, following 
chromatography (MeOH:DCM 1.0:14), (7-isopropoxy-4-oxo-4H-[1,10]-phenanthrolin-1-
yl)-acetic acid ethyl ester 370 as a yellow color solid (70 mg, 21 %), (mp > 160 oC, 
decomp.); max (ATR) 1739, 1623, 1587, 1549, 1501, 1416, 1377, 1278, 1199, 1173, 
1111, 1028, 982, 824, 734, 529 cm-1, H (600 MHz, CDCl3) 8.6 (1H, d, J = 5.2 Hz, 9-H), 8. 
4 (1H, d, J = 9.0 Hz, 5-H), 8.1 (1H, d, J = 9.0 Hz, 6-H), 7.5 (1H, d, J = 7.7 Hz, 2-H), 6.8 (1H, 
d, J = 5.2 Hz, 8-H), 6.5 (1H, d, J = 7.7 Hz, 3-H), 5.5 (2H, s, N-CH2), 4.8 (1H, hept, J = 6.1 
Hz, 7-OCH(CH3)2), 4.2 (2H, q, J = 7.1 Hz, OCH2-CH3), 1.5 (6H, d, J = 6.1 Hz, 7-OCH(CH3)2), 
1.2 (3H, t, J = 7.1 Hz, OCH2-CH3); C (151 MHz, CDCl3) 177.7 (C-4), 168.8 (C=O, ester), 
160.6 (C-7), 147.5 (C-9), 146.4 (C-2), 142.0 (C-12), 137.6 (C-11), 127.7 (C-13), 124.3 (C-
14), 122.6 (C-5), 117.8 (C-6), 112.7 (C-3), 103.3 (C-8), 71.3 (7-OCH(CH3)2), 61.4 (OCH2-
CH3), 61.2 (N-CH2), 21.7 (7-OCH(CH3)2), 14.3 (OCH2-CH3); m/z (LC-MS, ES+) 681 ([M+H]+, 
82%), 341 ([MH]+, 63%), 340 ([M]+, 100%); HRMS (ES+) found ([MH]+) 341.1498; 
C19H20N2O4 requires M, 341.1501 
 
6.2.25.2 2-(7-Isopropoxy-[1,10]-phenanthrolin-4-yloxy)-propionic acid 
ethyl ester (367) 
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Following procedure T, 4-hydroxy-7-isopropyl-[1,10]-phenanthroline 348 and ethyl-2-
bromopropinoate (0.26 ml, 2 mmol) were combined at 100 oC to afford, following 
reversed phase chromatography (C18-SiO2), 2-(7-isopropoxy-[1,10]-phenanthrolin-4-
yloxy)-propionic acid ethyl ester 367 as a white color solid (0.23 g, 65 %), (mp = 153-
154 oC); max (ATR) 1733 (C=O), 1585, 1564, 1509, 1498, 1446, 1418, 1307, 1285, 1260, 
1229, 1186, 1093, 1049, 999, 956, 824, 739, 700, 450 cm-1; H (700 MHz, CDCl3) 8.91-
8.88 (2H, m, 2,9-H), 8.18-8.12 (2H, m, 5,6-H), 6.9 (1H, d, J = 5.2 Hz, 8-H), 6. 75 (1H, d, J 
= 5.2 Hz, 3-H), 4.9 (1H, q, J = 6.8 Hz, 2’-H), 4.8 (1H, hept, J = 6.1 Hz, 7-OCH(CH3)2), 4.17 
(2H, q, J = 7.2 Hz, O-CH2), 1.74 (3H, d, J = 6.8 Hz, 3’-H), 1.4 (6H, d, J = 6.1 Hz, 7-
OCH(CH3)2), 1.16 (3H, t, J =7.2 Hz, CH3); C (176 MHz, CDCl3) 170.9 (C=O), 160.6 (C-7), 
160.3 (C-4), 151.0 (Ar-C), 150.6 (Ar-C),  147.2 (C-11), 147.0 (C-12), 121.6 (C-14), 120.9 
(C-13), 119.5 (Ar-C) 118.7 (Ar-C), 104.1 (C-8), 103.7 (C-3), 73.0 (C-2’), 71.0 (7-
OCH(CH3)2), 61.6 (O-CH3), 21.7 (7-OCH(CH3)2), 18.3 (C-3’), 14.0 (CH3); m/z (LC-MS, ES+) 
354 ([M]+, 100), 731 ([M2Na]+); HRMS (ES+) found ([MH]+) 355.1666, C20H23N2O4 
requires M, 355.1658; CHN found C% 67.62, H% 6.26, N% 7.74; C20H22N2O4 required 
C% 67.78, H% 6.26, N% 7.9.  
 
6.2.26 Coupling of primary amine with carboxylic acid 
6.2.26.1 General procedure U 
In a round bottomed flask, acyl chloride (2.0 mmol) was added dropwise to a mixture 
of primary amine derivatives (2.0 mmol) and base (2.4 mmol) in dry DCM (10 ml) at 0 
oC. The reaction mixture was then allowed to stir for 17 h to afford, following 
chromatography or trituration, the title amide compound. 
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6.2.26.1.1. 2-Bromo-N-(prop-2-yn-1-yl)-propanamide (378)147 
 
 
2-Bromo-propionyl chloride 376 (0.2 ml, 2.0 mmol) and propargylamine 377 (0.13 ml, 
2.0 mmol) were combined following standard procedure S using tri-ethyamine (0.3 ml, 
2.4 mmol) as base in DCM (10 ml) to afford, following chromatography (EtOAc:hexane 
3:8), 2-bromo-N-(prop-2-yn-1-yl)-propanamide 378 as a yellow solid (335 mg, 88%), 
(mp = 53-54 oC); max (ATR) 3279 (≡-H), 3063 (NH, amide), 1645 (C=O, amide), 1539, 
1444, 1373, 1334, 1249, 1189, 1076, 1053, 1008, 975, 654, 512 cm-1; H (700 MHz, 
CDCl3) 7.35 (1H, s broad, N-H), 4.43 (1H, q, J = 7.0 Hz, 2-H), 4.05-3.94 (2H, m, 2’-H), 2.23 
(1H, t, J = 2.6 Hz, 4’-H), 1.77 (3H, d, J = 7.0 Hz, 3-H); C (176 MHz, CDCl3) 169.7 (C=O), 
78.9 (C-3’), 71.86 (C-4’), 43.6 (C-2), 29.8 (C-2’), 22.4 (C-3); m/z (LC-MS, EI+) 191 ([M 
(81Br)]+, 100%), 189 ([M (79Br)]+, 92%); HRMS (ES+) found ([MH]+) 189.9883; C6H979BrNO 
requires M, 189.9868.  
 
6.2.27 2-(7-Isopropoxy-[1,10]-phenanthrolin-4-yloxy)-N-prop-2-ynyl-
propionamide (379) 
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Following procedure T, 4-hydroxy-7-isopropyl-[1,10]-phenanthroline 348 and 2-bromo-
N-(prop-2-yn-1-yl)-propanamide 378 (254 mg, 1.0 mmol) were combined at r.t to 
afford, following recrystallization from EtOAc, 2-(7-isopropoxy-[1,10]-phenanthrolin-4-
yloxy)-N-prop-2-ynyl-propionamide 379 as an off-white solid (60 mg, 17 %), (mp = > 
200 oC decomp.); max (ATR) 3336 (Alkyne), 1662, 1585, 1569. 1508, 1423, 1309, 1281, 
1228, 1089, 995, 953, 818, 730, 628 cm-1; H (700 MHz, CDCl3) 8.93 (1H, d, J = 5.2 Hz, 9-
H), 8.86 (1H, d, J = 5.2 Hz, 2-H), 8.1 (1H, d, J = 9.2 Hz, 6-H), 7.9 (1H, d, J = 9.2 Hz, 5-H), 
7.22 (1H, s, NH, broad), 7.0 (1H, d, J = 5.2 Hz, 8-H), 6.9 (1H, d, J = 5.2 Hz, 3-H), 5.0 (1H, 
q, J = 6.7 Hz, 15-H), 4.9 (1H, hept, J = 6.1 Hz, 7-OCH(CH3)2), 4.19-4.08 (2H, m, NH-CH2), 
2.18 (1H, t, J = 2.5 Hz, 4’-H), 1.8 (3H, d, J = 6.7 Hz, 15-CH3), 1.54 (3H, d, J = 6.1 Hz, 7-
OCH(CH3)2), 1.51 (3H, d, J = 6.1 Hz, 7-OCH(CH3)2); C (176 MHz, CDCl3) 170.8 (C=O), 
160.8 (C-7), 159.5 (C-4), 151.2 (C-9), 150.9 (C-2),  147.1 (C-11), 147.0 (C-12), 121.7 (C-
14), 120.7 (C-13), 120.0 (C-6) 118.0 (C-5), 104.5 (C-3), 104.4 (C-8), 79.0 (C-3’), 75.6 (C-
15), 71.7 (C-4’), 71.3 (7-OCH(CH3)2), 29.0 (NH-CH2), 21.94 (7-OCH(CH3)2), 21.92 (7-
OCH(CH3)2), 18.8 (15-CH3); m/z (LC-MS, ES+) 364 ([MH]+, 100%), 749 ([M2Na]+, 20%); 
HRMS (ES+) found ([MH]+) 364.1655; C21H22N3O3 requires M, 364.1661.  
 
6.2.28 6-(2-Bromo-propionylamino)-hexanoic acid (381) 
 
 
2-Bromo-propionyl chloride 376 (0.2 ml, 2.0 mmol) and 6-aminocaproic acid 380 (262 
mg, 2.0 mmol) were combined following standard procedure U using potassium 
carbonate (332 mg, 2.4 mmol) as base. 40 ml of H2O was added to the reaction 
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mixture. The aqueous phase was separated and washed with DCM (10 ml). HCl was 
added to the aqueous solution to make (PH=2-3) then extracted with EtOAc (20 ml x 
3). The organic phase was then dried over MgSO4 and concentrated in vacuo to afford, 
following trituration with ether, 6-(2-bromo-propionylamino)-hexanoic acid 381 as a 
white solid (0.23 g, 43 %), (mp = 89.8-90.8 oC); max (ATR) 3277 (NH), 1700 (C=O, acid), 
1652 (C=O, amide),1569, 1429, 1250, 1197, 1070, 980, 899, 594, 489 cm-1; H (700 
MHz, CDCl3) 10.4 (1H, s, OH), 6.6 (1H, s, NH), 4.4 (1H, q, J = 7.0 Hz, 2’-H), 3.26 (2H, d, J = 
6.8 Hz, 6-H), 2.3 (2H, t, J = 7.4 Hz, 2-H), 1.8 (3H, d, J = 7.0 Hz, 3’-H), 1.66-1.6 (2H, m, 3-
H), 1.57-1.51 (2H, m, 5-H), 1.39-1.33 (2H, m, 4-H); C (176 MHz, CDCl3) 174.0 (C=O 
carboxylic acid), 169.7 (C=O amide), 45.3 (C-2’), 40.0 (C-6), 34.0 (C-2), 29.0 (C-5), 26.2 
(C-4), 24.3 (C-3), 23.2 (C-3’); m/z (LC-MS, EI-) 266 ([M (81Br)-H]-, 100%), 264 ([M (79Br)-
H]-, 100%); HRMS (ES+) found ([M-H]-) 264.0227; C9H1579BrNO3 requires M, 264.0235.  
 
6.2.29 6-(2-Bromo-propionylamino)-hexanoic acid methyl ester (383) 
 
In a round bottomed flask, TMS-diazomethan solution in 2 M hexane (1.8 mmol, 0.9 
ml) was added dropwise under N2 to 6-(2-bromo-propionylamino)-hexanoic acid 381 
(0,25 mmol, 532 mg) in mixture of MeOH:EtOAc 1:1 (10 ml) at 0 0C. The reaction 
mixture was then allowed to stir at room temperature overnight. The solvent was 
removed in vacuo and the resultant crude mixture re-dissolved in DCM (30 ml), 
washed (aq. NaHCO3), dried over MgSO4 and concentrated to afford, without further 
purification, 6-(2-Bromo-propionylamino)-hexanoic acid methyl ester 383 as a white oil 
(0.5 g, 89%); max (ATR) 3273 (NH, amide), 1734 (C=O, ester), 1647 (C=O, amide), 1557, 
N
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1431, 1370, 1302, 1237, 1190, 1172, 982, 882, 729 cm-1H; (700 MHz, CDCl3) 6.9 (1H, t, 
J = 5.8 Hz, NH), 4.3 (1H, q, J = 6.9 Hz, 2’-H), 3.5 (3H, s, OCH3), 3.14 (2H, m, 6-H), 2.2 (2H, 
t, J = 7.5 Hz, 2-H), 1.7 (3H, d, J = 6.9 Hz, 3’-H), 1.56-1.48 (2H, m, 3-H), 1.43 (2H, pent, J = 
7.2 Hz, 5-H), 1.3-1.2 (2H, m, 4-H); C (176 MHz, CDCl3) 173.8 (C=O ester), 169.5 (C=O 
amide), 51.3 (OCH3), 44.4 (C-2’), 39.6 (C-6), 33.7 (C-2), 28.7 (C-5), 26.1 (C-4), 24.3 (C-3), 
22.5 (C-3’); m/z (LC-MS, EI+) 585 ([M2 (81Br)+Na]+, 10%), 582 ([M2H (79Br)+Na]+, 19%), 
282 ([MH (81Br)]+, 80%), 280 ([MH (79Br)]+, 100%); HRMS (ES+) found ([M-H]-) 280.0554; 
C10H1979BrNO3 requires M, 280.0548.  
 
6.2.30 Preparation of silica supported iridium catalysis 
6.2.30.1 Grafting the N-methylaminopropyltri-ethoxysilane onto MCM-
41 (386)  
Si
O
O
OH
OH
OMe
NH
 
In a 25 ml microwave vessel, following Yuan's procedure,121 MCM-41 (0.8 g) was 
dehydrated in vacuo at 200 oC for 2 h before adding dry toluene (15 ml) under 
nitrogen. N-methylaminopropyltri-methoxysilane 373 (1.1 ml, 5.56 mmol) was added 
portionwise to the reaction vessel. The reaction mixture was heated at 120 oC for 35 h, 
then cooled and filtered in vacuo and the resulting solid washed with dry toluene, 
MeOH, then dried in vacuo overnight at 60 oC to afford the (MCM-41) 386 as a white 
solid (0.95 gm, 1.21 mmol/g polymer); max (ATR) 1050, 1614, 844, 800, 438 cm-1; C 
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VNMRS CP (100.562 MHz) 50 (NCH2, SiOCH3), 34 (NCH3), 22 (CH2), 10 (SiCH2); CHN 
found C% 10.58, H% 2.65, N% 2.70; C5H13NOSi required C% 45.76, H% 9.98, N% 10.67.  
 
Weight of MCM-41= 0.8 g; weight of the resulting polymer= 0.95 g 
Grafting the N-methylpropyltri-methoxysilane onto MCM-41= 0.15 g 
Depending on the percentage of C/N with the number of methoxy group in CHN 
analysis  
Si N
H
MeO
      Molecular weight = 131 
mmol/ 0.95 g= 0.15/131= 1.145 
mmol/ g= 1.205  
 
 
 
 
 
y = 0.8523x + 3.4347
R² = 1
0
1
2
3
4
5
6
7
0 1 2 3 4
C
/N
%
No of MeO group
No  MeO (C/N)%
0 3.43
1 4.29
2 5.146
3 5.986
0.577 3.927
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6.2.30.2 End-Capping the functionalized MCM-41 (387) 
Si
O
O
O
SiMe 3
O
SiMe 3
OMe
NH
 
In a 25 ml microwave vessel, a mixture of polymer 386 (1.0 gm) and HMDS (6 ml, 28.6 
mmol) in dry toluene (15 ml) was stirred at room temperature overnight. The resulting 
solid washed by dry toluene, hexane and DCM, then dried in vacuo overnight at 60 oC 
to afford (MCM-41) 387 as a white solid (1.054 gm, 1.14 mmol/g); C VNMRS CP 
(100.562 MHz) 50 (NCH2, SiOCH3), 34 (NCH3), 22 (CH2), 10 (SiCH2), 0.0 (Si(CH3)3) . 
 
6.2.31 6-(9H-Fluoren-9-ylmethoxycarbonylamino)-hexanoicacid (389)127 
 
  
In round bottomed flask, 6-amino caproic acid 380 (656 mg, 5.0 mmol) and Na2CO3 
(1.59 g, 15.0 mmol) in a mixture of dioxane:H2O 1:1 ( 16 ml) were stirred at 0 oC for 10 
min. Fmoc-Cl 388 (1.3 g, 5.0 mmol) was then added portionwise to the reaction 
mixture . The reaction mixture was allowed to warm to r.t and stirred for further 6 h. 
50 ml of H2O was added to the reaction mixture before adding 3 M HCl until the pH 
reached 5-6. The resulting precipitate was then filtrated in vacuo to afford, following 
washing with H2O and hexane, chromatography (MeOH:DCM 1:9), 6-(9H-fluoren-9-
ylmethoxycarbonylamino)-hexanoic acid 389 as a white solid (1.53 g, 87%), (mp = 
118.5 – 119.5 oC); max (ATR) 3339 (NH, OH), 1687 (C=O, carbamate, acid), 1530, 1269, 
N
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O
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1253, 1237, 1130, 1102, 995, 758, 735, 621, 577, 528, 427 cm-1; H (700 MHz, CDCl3) 
7.8 (2H, d, J = 7.6 Hz, 4,5-H), 7.6 (2H, d, J = 7.7 Hz, 1,8-H), 7.4 (2H, t, J = 7.5 Hz, 3,6-H), 
7.3 (2H, t, J = 7.5 Hz, 2,7-H), 6.1 (0.3H, s, NH rotamer A), 4.9 (0.7H, s, NH rotamer B), 
4.52-4.45 (0.7H, m, O-CH2, rotamer A), 4.4 (1.3H, d, J = 7.0 Hz, O-CH2, rotamer B), 4.23 
(1H, m, 9-H, rotamers A and B), 3.2 (1.4H, q, J = 6.6 Hz, 6’-H, rotamer B), 3.1 (0.6H, q, J 
= 6.6 Hz, 6’-H, rotamer A), 2.4 (2H, t, J = 7.5 Hz, 2’-H), 1.6 (2H, m, 3’-H, rotamers A and 
B), 1.5 (1.4H, m, 5’-H, rotamer B), 1.38-1.33 (0.6H, m, 5’-H, rotamer A), (1.3H, m, 4’-H, 
rotamer A), 1.3 (0.7H, m, 4’-H, rotamer B); C (176 MHz, CDCl3) 179.2 (C=O carboxylic 
acid, rotamers A and B), 157.9 (C=O amide, rotamer A), 156.6 (C=O amide, rotamer B), 
144.0 (C-10, 13, rotamers A and B), 141.3 (C-11, 12), 127.7 (C-3,6), 127.1 (C-2,7), 125.1 
(C-1,8, rotamers A and B), 120.0 (C-4,5), 67.2 (OCH2, rotamer A), 66.6 (OCH2, rotamer 
B), 47.3 (C-9, rotamers A and B), 41.4 (C-6’, rotamer A), 40.8 (C-6’, rotamer B), 34.0 (C-
2’, rotamers A and B), 29.6 (C-5’, rotamers A and B), 26.2 (C-4’, rotamers A and B), 24.3 
(C-3’, rotamers A and B); m/z (LC-MS, EI-) 705 ([M2-H]-, 100%), 352 ([M-H]-, 16%). 
 
6.2.32 The coupling of sec amine with carboxylic acid 
Under N2, in a round bottomed flask, EDCI (X mmol) was dissolved in dry DCM (X ml), 
and solution was cooled to 0 oC before carboxylic acid (X mmol) was added. The 
reaction mixture was allowed to stir at 0 oC for 1.5 h. DMAP (X mmol), DIPEA (X mmol) 
and sec amine (X mmol) were then added to the reaction mixture. The reaction 
mixture was allowed to warm to room temperature and allowed to stir overnight. The 
reaction mixture was worked up and purification carried out by the stated method. 
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Protocol V1: The reaction mixture was quenched by addition of NH2Cl (aq.) and 
extracted with EtOAc (2 x 20 ml), dried over MgSO4 and concentrated in vacuo to 
afford, following chromatography (MeOH:DCM 1.0:12), the title amide compound. 
 
Protocol V2: The reaction mixture was filtered in vacuo, and then washed with dry 
DMF, DCM and MeOH. The resulting solid was dried in vacuo at 650C overnight to 
afford the title amid compound. 
 
6.2.32.1 [5-(Benzyl-methyl-carbamoyl)-pentyl]-carbamic acid 9H-fluoren-
9-ylmethyl ester (393) 
 
 
Following procedure V1, EDCI (0.66 mmol, 126.5 mg) in DCM (5 ml), 6-(9H-fluoren-9-
ylmethoxycarbonylamino)-hexanoic acid 389 (0.3 mmol, 106 mg), DMAP (0.12 mmol, 
14.7 mg), DIPEA (0.75 mmol, 0.13 ml) and N-benzylmethylamine 392 (0.6 mmol, 0.08 
ml) were coupled at room temperature to afford the [5-(benzyl-methyl-carbamoyl)-
pentyl]-carbamic acid 9H-fluoren-9-ylmethyl ester 393 as a clear oil (37.5 mg, 27%); 
max (ATR) 3311 (NH broad), 1700 (C=O, carbamate), 1627 (C=O, amide), 1533, 1450, 
1244, 1135, 759, 738, 697, 621, 426 cm-1; H (600 MHz, CDCl3) 7.8 (2H, d, J = 7.6 Hz, 
4,5-H), 7.6 (2H, d, J = 7.5 Hz, 1,8-H), 7.42-7.21 (8H, m, 2,3,6,7-H and Ar-H), 7.1 (1H, d, J 
= 7.5 Hz, Ar-H), 5.0 (1H, m, NH rotamers A and B), 4.6 (1.2H, s, Ar-CH2, rotamer A), 4.5 
(0.8H, s, Ar-CH2, rotamer B), 4.4 (2H, m, O-CH2, rotamers A and B), 4.2 (1H, t, J = 7.1 Hz, 
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9-H, rotamers A and B), 3.25-3.15 (2H, m, 1’-H, rotamers A and B), 3.0 (1.3H, s, NCH3, 
rotamer B), 2.9 (1.7H, s, NCH3, rotamer A), 2.41-2.32 (2H, m, 5’-H, rotamers A and B), 
1.75-1.65 (2H, m, 4’-H, rotamers A and B), 1.6 (1.0H, m, 2’-H, rotamer A), 1.5 (1.0H, m, 
2’-H, rotamer B), 1.40 (1.0H, m, 3’-H, rotamer A), 1.34 (1.0H, m, 3’-H, rotamer B); C 
(151 MHz, CDCl3) 173.4 (C=O amid, rotamer A), 173.0 (C=O amid, rotamer B), 156.6 
(C=O carbamate, rotamers A and B), 144.1 (C-10,13), 141.4 (C-11, 12), 137.6 (Ar-CH2, 
rotamer A), 136.8 (Ar-CH2, rotamer B), 129.0 (Ar-C), 128.7 (Ar-C), 128.1 (Ar-C), 127.7 
(Ar-C), 127.1 (Ar-C), 126.3 (Ar-C), 125.2 (C-1,8), 120.0 (C-4,5), 67.0 (OCH2, rotamer A), 
66.6 (OCH2, rotamer B), 53.4 (Ar-CH2, rotamer B), 50.9 (Ar-CH2, rotamer A), 47.4 (C-9, 
rotamer A and B), 40.9 (C-1’, rotamer A), 40.8 (C-1’, rotamer B), 34.9 (NCH3, rotamer 
A), 34.1 (NCH3, rotamer B), 33.4 (C-5’, rotamer A), 32.9 (C-5’, rotamer B), 29.8 (C-2’, 
rotamer A), 29.7 (C-2’, rotamer B), 26.6 (C-3’, rotamer A), 26.5 (C-3’, rotamer B), 24.8 
(C-4’, rotamer A), 24.6 (C-4’, rotamer B); m/z (LC-MS, EI+) 936 ([M2H+Na]+, 100%), 457 
([MH]+, 56%); HRMS (ES+) found ([MH]+) 257.2484; C29H33N2O3 requires M, 257.2491.  
 
6.2.32.2 Immobilisation of Fmoc onto MCM-41 (390) 
Si
O
O
O
SiMe 3
O
SiMe 3
OMe
N
O
H
N
Fmoc
5
 
Following procedure V2, EDCI (7.52 mmol, 1.44 gm) in DCM (45 ml), 6-(9H-fluoren-9-
ylmethoxycarbonylamino)-hexanoic acid 389 (1.21 gm, 3.42 mmol), DMAP (167 mg, 
1.37 mmol), DIPEA (1.5 ml, 8.55 mmol) and (MCM-41) 387 (1 gm, 1.14 mmol) were 
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coupled at room temperature. This reaction was repeated on the same scale as above 
for the resulting polymer to afford the MCM-41-Fmoc 390 as a white solid (1.135 g); 
max (ATR) 1600 (C=O, amide), 1050, 1614, 844, 800, 438 cm-1; C VNMRS CP (100.562 
MHz) 174 (C=O amide), 141 (Ar-C), 125 (Ar-C), 51 (NCH2, SiOCH3), 40 (Alk-C), 33 (NCH3), 
27 (CH2), 10 (SiCH2), 0.35 (Si(CH3)3). 
 
6.2.33 Cleavage of Fmoc (369) 
Si
O
O
O
SiMe 3
O
SiMe 3
OMe
N
O
NH2
5
 
In a 25 ml microwave vessel, a mixture of polymer 390 (0.5 gm) and 20% of piperidine 
in dry DMF (15 ml) was shaken at r.t for 1 h. The resulting solid was washed by dry 
toluene, hexane and DCM, then dried in vacuo overnight at 60 oC to afford amine-
MCM-41 369 as a white solid (~0.50 gm); C VNMRS CP (100.562 MHz) 174 (C=O 
amide), 141 (Ar-C), 125 (Ar-C), 51 (NCH2, SiOCH3), 40 (Alk-C), 33 (NCH3), 27 (CH2), 10 
(SiCH2), 0.35 (Si(CH3)3). The Beer-Lambert law was used to determine the 
concentration of the piperidine-fulvene adduct in both solutions described below in 
(Table 45) Lambert law:  
 A = C Ɛ l 
 
 
234 
 
 
Entry 
No 
 
A (X) 
 
mmol/g 
 
A (Y) 
 
mmol/g 
 
Solution taken 
(ml) 
1 0.233 0.018 0.229 0.0177 0.15 ml to 3 ml 
2 0.297 0.0172 0.297 0.0172 0.2 ml to 3 ml 
3 0.372 0.0172 0.37 0.0171 0.25 ml to 3 ml 
4 0.444 0.0171 0.443 0.0171 0.3 ml to 3 ml 
 
Table 45: Determination of the loading on polymer using Lambert law 
 
C = A/ Ɛ     Ɛ = 7800, l = 1 cm at λ = 300 
C = 0.233/7800 = 0.00002987 mol/dm = 0.02987 mmol/dm 
Total mass before remove Fmoc = 500 mg/15 ml 
The mass in 0.15 ml solution after remove Fmoc = 5 mg/3 ml = 1.66 g/dm 
mmol/ g = (A/ Ɛ)/1.66 = 0,018 
 
6.2.34 Hydrolysis of ester group 
In a round bottomed flask, a mixture of ester  (1.0 mmol) and LiOH.H2O (125 mg, 3.0 
mmol) in 10 ml of (H2O:MeOH 1:1) was stirred at room temprature for 18h.  
 
Protocol W1: HCl solution was then added to acidify (pH = 4-5) and extracted into 
EtOAc (20 ml x 2). The aqueous layer was concentrated in vacuo to afford the title 
carboxylic acid compound without further purification. 
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Protocol W2: The reaction mixture was stirred overnight, solvent was then removed 
in vacuo to afford the 2-(7-isopropoxy-[1,10]-phenanthrolin-4-yloxy)-lithium 
propanoate. 
6.2.34.1 2-(7-Isopropoxy-[1,10]-phenanthrolin-4-yloxy)-propionic acid 
(395) 
 
 
Following protocol W1, 2-(7-isopropoxy-[1,10]-phenanthrolin-4-yloxy)-propionic acid 
ethyl ester 367 (354 mg) was hydrolysed by LiOH.H2O to afford without further 
purification, giving 2-(7-isopropoxy-[1,10]-phenanthrolin-4-yloxy)-propionic acid 395 as 
an orange solid (0.1 g, 31%), (mp = > 150 oC decomp.); max (ATR) 3391 (OH broad), 
1614, 1587, 1538, 1479, 1411, 1295, 1284, 1241, 1209, 1188, 1091, 1048, 1015, 958, 
847, 828, 731 626 cm-1; H (600 MHz, CDCl3) 8.7 (2H, d, J = 6.1 Hz, 2,9-H), 7.9 (1H, d, J = 
9.2 Hz, 5-H), 7.8 (1H, d, J = 9.2 Hz, 6-H), 7.4 (1H, d, J = 6.1 Hz, 8-H), 7.1 (1H, d, J = 5.9 Hz, 
3-H), 5.1 (1H, hept, J = 6.1 Hz, 7-OCH(CH3)2), 5.0 (1H, q, J = 6.7 Hz, 4-OCH(CH3)), 1.8 (3H, 
d, J = 6.7 Hz, 4-OCH(CH3)), 1.6-1.5 (6H, m, 7-OCH(CH3)2)); C (151 MHz, CDCl3) 176.5 
(C=O), 165.1 (C-7), 164.9 (C-4), 150.1 (Ar-C), 149.4 (Ar-C), 140.0 (C-11), 139.7 (C-12), 
122.1 (C-14), 122.0 (C-13), 120.9 (C-5), 120.1 (C-6), 107.2 (C-3), 107.0 (C-8), 77.8 (4-
OCH(CH3)), 75.2 (7-OCH(CH3)2), 22,0 (Ala-C), 21.9 (Ala-C), 19.1 (4-OCH(CH3)); m/z (LC-
MS, EI-) 651 ([M2-H]-, 100%),  325 ([M-H]-, 48%); HRMS (ES+) found ([MH]+) 327.1355; 
C18H19N2O4 requires M, 327.1345.  
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6.2.35 The coupling of lithium carboxylic salt with amine 
Under N2, in a round bottomed flask, 2-(7-Isopropoxy-[1,10]-phenanthrolin-4-yloxy)-
lithium propanoate (X mmol) was added to the amine (X mmol) in dry DMF (X ml) at 0 
oC, HBTU (X mmol) was then added and the mixture was stirred at r.t oC for 24 h. The 
reaction mixture was worked up and purification achieved by the stated method. 
 
Protocol X1: DMF solvent was removed in vacuo then re-dissolved in DCM, washed 
(aq. NaHCO3), dried over MgSO4 and concentrated in vacuo to afford, following 
chromatography (C-18 SiO2), the title amide compound.  
 
Protocol X2: The reaction mixture was filtered in vacuo and then washed with dry 
DMF, DCM and MeOH. The resulting solid was dried in vacuo at 65 oC overnight to 
afford the title amid compound. 
 
6.2.35.1 2-(7-Isopropoxy-[1,10]-phenanthrolin-4-yloxy)-propionic acid 
lithium salt (368) 
 
 
 
Following protocol W2, 2-(7-isopropoxy-[1,10]-phenanthrolin-4-yloxy)-propionic acid 
ethyl ester 367 (354 mg) hydrolysed by LiOH . H2O to afford the 2-(7-isopropoxy-[1,10]-
N
N
O
O OLi
O
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phenanthrolin-4-yloxy)-lithium propanoate 368 (0.52 g), which was used directly in the 
next step with no purification required. 
 
6.2.35.2 N-Benzyl-2-(7-isopropoxy-[1,10]-phenanthrolin-4-yloxy)-N-
methyl-propionamide (396) 
 
 
 
 
Following protocol X1, 2-(7-isopropoxy-[1,10]-phenanthrolin-4-yloxy)-lithium 
propanoate 368 (0.275 mmol, 91.3 mg), N-benzylmethylamine 392 (0.25 mmol, 33 µl) 
in DMF (2 ml) and HBTU (0.275 mmol, 104.3 mg) were coupled at r.t oC to afford the N-
benzyl-2-(7-isopropoxy-[1,10]-phenanthrolin-4-yloxy)-N-methyl-propionamide 396 as 
an orange solid (25 mg, 23%). (mp = undetected); max (ATR) 1652 (C=O, amide), 1585, 
1568, 1511, 1498, 1421, 1308, 1283, 1229, 1082, 1008, 955, 823, 733, 698 cm-1H; (700 
MHz, CDCl3) 9.0 (1H, d, J = 5.2 Hz, 9-H), 8.95 (0.7H, d, J = 5.2 Hz, 2-H, rotamer A), 8.9 
(0.3H, d, J = 5.2 Hz, 2-H, rotamer B), 8.23-8.15 (1.4H, m, 5, 6-H, rotamer A), 8.13-8.1 
(0.6H, m, 5, 6-H, rotamer B), 7.30-7.20 (3H, m, Ar-H), 7.2-7.13 (1.6H, m, Ar-H, rotamer 
A), 7.1 (0.6H d, J = 7.5 Hz, Ar-H, rotamer B), 7.0 (1H, d, J = 5.2 Hz, 8-H), 6.9 (0.7H, d, J = 
5.2 Hz, 3-H, rotamer A), 6.8 (0.3H, d, J = 5.2 Hz, 3-H, rotamer B), 5.36-5.3 (1H, m, 4-O-
CH, rotamers A and B), 4.91-4.85 (1H, m, 7-OCH(CH3), rotamers A and B), 4.78-4.65 
(0.5H, m, Ar-CH2, rotamer A), 4.65-4.53 (1.5H, m, Ar-CH2, rotamer B), 3.0 (2H, s, NCH3, 
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rotamer B), 2.9 (1H, s, NCH3, rotamer A), 1.9 (2H, d, J = 6.7 Hz, 15-CH3, rotamer B), 1.8 
(1H, d, J = 6.7 Hz, 15-CH3, rotamer A), 1.5 (6H, m, 7-OCH(CH3)2, rotamer A and B); C 
(176 MHz, CDCl3) 170.4 (C=O, rotamer A), 170.0 (C=O, rotamer B), 161.1 (C-7), 160.3 
(C-4, rotamer B), 160.2 (C-4, rotamer A), 151.0 (C-9), 150.9 (C-2, rotamer A and B), 
146.8 (C-11), 146.6 (C-12), 136.6 (C-1’, rotamer B), 135.9 (C-1’, rotamer A), 129.0 (Ar-
C), 128.8 (Ar-C), 128.1 (Ar-C), 127.9 (Ar-C), 127.8 (Ar-C), 126.5 (Ar-C), 121.8 (C-14, 
rotamer A), 121.7 (C-14, rotamer B), 120.1 (C-13, rotamer B), 120.0 (C-13, rotamer A), 
119.8 (Ar-C, rotamer A), 119.7 (Ar-C, rotamer B), 118.8 (Ar-C, rotamer B), 118.7 (Ar-C, 
rotamer A), 104.3 (C-8), 104.2 (C-3, rotamers A and B), 74.5 (4-O-CH, rotamer A), 74.1 
(4-O-CH, rotamer B), 71.4 (7-O-CH), 52.8 (Ar-CH2, rotamer A), 51.9 (Ar-CH2, rotamer B), 
34.9 (NCH3, rotamer A), 34.3 (NCH3, rotamer B), 21.94 (7-O-CH(CH3)2, rotamers A and 
B), 18.6 (4-OCH(CH3), rotamer A), 17.6 (4-OCH(CH3), rotamer B); m/z (ASAP) 881 
([M2H]+, 15%), 430 ([MH]+, 100%), 749 ([M2Na]+, 20%); HRMS (ASAP) found ([MH]+) 
430.2131; C26H28N3O3 requires M, 430.2131. 
   
6.2.35.3 Coupling of amine-MCM-41 with carboxylic lithium salt (391) 
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Following protocol X2, a mixture of 2-(7-isopropoxy-[1,10]-phenanthrolin-4-yloxy)-
lithium propanoate 368 (18.4 mg, 55.5 µmol), amine-MCM-41 369 (1 gm, 0.018 mmol) 
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in dry DMF (10 ml) and HBTU (21 mg, 55.5 µmol) was coupled at r.t oC to afford the 
(MCM-41) 391 as a white solid which was then used as ligand in the next section. 
 
6.2.36 Preparation of silica supported iridium catalyst (397) 
N
N
O
O
O
Ir
Bpin
Bpin
Bpin
Si
O
O
O
SiMe 3
O
SiMe 3
N
H
OMe
N
O
4
 
A mixture of [Ir(OMe)(cod)]2 (3.6 mg, 0.0054 mmol), silica supported ligand 391 (0.3 
gm, 0.0054 mmol) and B2pin2 (4.1 mg, 0.0162 mmol) was placed in the reaction vessel 
(a filter tube) which was then sealed, evacuated and backfilled with N2. THF (2 ml) was 
then added and the reaction mixture was heated at 50 oC for 10 min before washing 
with dry THF (3 x 10 ml). The resulting product was dried in vacuo, which was used 
directly in the borylation reaction in next section. 
 
6.2.37 Borylation of m-xylene 
Under N2, m-xylene was added to the filter tube containing silica supported iridium 
397 in THF (2 ml). The reaction mixture was heated at 80 oC for 6 h before washing 
with dry THF (3 x 10 ml). The resulting product solution was then concentrated in 
vacuo. 
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